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The fluorinated 4-quinolone, ofloxacin, interacts with, and inhibits the negative DNA supercoiling 
activity of the bacterial tetrameric enzyme, DNA gyrase. DNA gyrase is one of several
chromosomal and plasmid DNA. Inhibition of this process is recognised as the precursor to a 
cascade of cytopathic events that leads to bacterial death.
within RP4. Most Tn7 insertions were found to be increased In the 22.2kb Kpnl-Smal fragment 
and reduced in the 5kb Kpnl-Smal RP4 fragment. Although, fewer insertions were found in the 
other Kpnl-Smal fragments in RP4, subinhibitory ofloxacin reduced insertions into the 8.5kb and 
5.8 fragments. It is proposed this high and low density of Tn7 insertions results from changes in
Î
I
topoisoraerases that homeostatically regulates the tertiary structure and function of both
I1
.It is recognised that in stationary phase, changes in gene expression promote diverse mechanisms
■
in bacteria to maintain their 'living state'. Analysis of changes in stationary phase has become 
increasingly important, since Enterobacteria in many environments are in a constant state of 
stationary phase primarily through nutrient competition, and that rapid growth is not possible.
The transposition of Tn7 into the /ncP plasmid RP4, and the stability and variation of a natural
Sco-integrate plasmid, pOG669, were studied in E. coli K12. The reversion of a spontaneous 
pleiotropic mutant of Seiratia marcescens was investigated in relation to both different growth 
conditions together with pigmentation and antibiotic resistance. In each of the experimental systems 
the time course was extended to incorporate possible changes that occurred in stationary phase.
Restriction endonuclease fragmentation patterns (REFP) techniques were used to identify DNA 
rearrangements in the co-integrate R-plasmid pOG669 and to analyse the insertion of Tn7 into RP4. 
Subinhibitory ofloxacin lead to DNA rearrangements, that encompassed alteratioyn the insertion of 
Tn7, IncX & ZrzcP plasmid maintenanc^and expression of antibiotic resistance.
Subinhibitory ofloxacin significantly altered the distribution )f Tn7 insertion in multiple sites
" V-local DNA superhelicity, and led to exposure of insertion sites to Tn7. Preliminary evidence 
suggests the and frfiA genes may be contiguous in the RP4 molecule, since no Tnl insertions
were detected in these regions.
I
Under different growth conditions, the instability of pOG669 was demonstrated. During j
logarithmic growth, (repeated subculture) pOG669 was found to be completely eliminated.
Subinhibitory ofloxacin increased loss of the co-integrate plasmid pOG669 in non-dividing bacteria 
(stationary phase) and decreased plasmid loss in bacteria that were in maintenance subculture. 
pOG669 was found to be unstable in stationary phase and molecular variants were isolated, and 
included pOG669 variants with DNA rearrangements, kanamycin sensitive variants (KSV). Mixed 
population variants (MPV) were also isolated, and these comprised of different populations of 
E. coli K12 J62-1, on the basis of variations in expressed antibiotic resistance of the co-integrate 
R-plasmid pOG669. MPVl comprised two populations of E. coli K12 J62-1 with 
variations in pOG669, and included E. coli K12 J62-1, pOG669 - Ap^Km^ & E. coli K12 J62-1, 
pOG669 - AfFKm^. MPV2 also comprised two populations of E. coli K12 J62-1 with 
variations in pOG669, and included E. coli K12 J62-1, pOG669 - Ap^KmS & E. coli K12 J62-1,
pOG669 - AfffCm®. KSV DNA rearrangements extended into the pOG660 component of pOG669, 
and this region was identified as the source of pOG669 instability. The KSV were derived from a 
junctional deletion that was adjacent to the Km gene.
S. marcescens G RI2677-8 is spontaneous non-pigmented resistant mutant and reverted at high 
frequency to the parental red-pigmented phenotype. Subinhibitory ofloxacin reduced reversion to 
the pigmented phenotype and data presented shows growth and pigmentation to be closely 
associated. Spontaneous reversion to the pigmented phenotype of S. marcescens gave rise to loss 
of resistance to carbenicillin and unrelated antimicrobial agents that included the aminoglycosides, 
trimethoprim, and chloramphenicol. The evidence suggests that pigmentation and expression of
antibiotic, resistance are co-regulated by a Regulator of Antibiotic resistance and Pigmentation 
(RAP). Evidence is also presented that reversion from the non-pigmented phenotype to the
pigmented phenotype is coupled with changes in antibiotic resistance, and is linked to functional 
changes in the RAP  regulator(s).
4
When antimicrobial therapy is optimised for a specific site, subinhibitory concentrations of 
an antibiotic may occur peripherally to the infection. Similarly, non-compliance and the post­
antibiotic effect both generate subinhibitory concentrations of antibiotics. From the results 
described, exposure of the commensal flora to subinhibitory concentrations of 4-quinolones has the 
potential to alter the location and mobility of unrelated resistance determinants and effect other 
evolutionary changes and is therefore likely to be of clinical, significance.
This study has demonstrated that changes in antibiotic expression are induced by subinhibitory 
ofloxacin, as observed in the plasmids pOG669 and RP4. The mobility of these plasmids are also 
influenced by subinhibitory ofloxacin through their elimination. The insertion and transposition of 
Tn7 and therefore mobility and transposon resistance determinants have also been influenced by 
subinhibitory ofloxacin. Therefore, the results presented in this study describe ofloxacin to act on 
several genetic processes. I
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1.1. The quinolone antibacterials
1.1.1. Historical development and molecular biochemistry of the 4-quinolones
Although the origins of empirical antimicrobial therapy can be traced back several centuries, the 
modem era, has been characterised by a wide choice of therapeutic agents since tlie discovery of 
sulphonamides in the 1930's. The last six decades have seen an enormous development in available 
antimicrobial agents tailored to meet the changes in types of infection encountered as well as 
bacterial susceptibility. These have stimulated an ongoing search for broader spectrum, more 
active therapeutic alternatives. The last two decades, however, have been dominated by the 
expansion of the cephalosporins, the development of the p-lactamase inhibitors, and synthetic 
modification of the 4-quinolone generic group of antimicrobial agents in response to the increasing 
fi-equency of bacterial resistance and nosocomial infections.
Nalidixic acid (1-ethyl-l,4-dihydro-7-methyl-4-oxo-l,8-naphthyridine-3-carboxylic acid), is the 
archetypal member of the first generation quinolones (Figure 1.1), and was originally isolated from 
a distillate during the synthesis of the antimalarial compound chloroquine (Lesher et aU 1962). It 
was also the first 4-quinolone introduced into clinical practice for the treatment of Gram-negative 
urinary tract infections.
Nalidixic acid is more active against Gram-negative than against Gram-positive bacteria, and has 
proved beneficial in the treatment of urinary tract infections (Stamey et al, 1969), and enteric 
infections, including dysentry caused by Shigella sonnet (Moorhead & Parry, 1965). Although, 
nalidixic acid is bactericidal, and attains high urinary concentrations of active dmg, it is however, 
considered far from ideal.
The clinical use of nalidixic acid has been limited because of its narrow spectrum of activity, 
poorer pharmacology, and reputed ease for the rapid emergence of both in vitro and in vivo 
resistant organisms (Buchbinder et al, 1962; Barlow, 1963) by mutation (Smith, 1984). In the 
thirty or so years since the discovery of nalidixic acid, it appears to be exempt from plasmid- 
mediated resistance (Burman, 1977; Crumplin, 1987). It has also been shown that the mechanism 
of action of nalidixic acid involves a specific inhibition of chromosome replication (Goss et al.
27
Figure 1.1. The first generation quinoione analogues.
FIRST GENERATION QUINOLONES
(a) 1,8 - naphthyridine
(b) Cinnoline
(c) Pyrido-pyrimidines
COOH
Nalidixic acid
CH2CH3
Cinoxacin
CH2CH3
Piromidic acid
COOH
COOH
COOH
N
Pipemidic acid
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Figure 1.1. (Continued).
(d) Quinol F ne derivatives
CH2CH3
Oxolinic acid
COOH
F
CH
Fiumequine
COOH
1
a
: , ï ;
29
1964; Crumplin & Smith, 1976). Such findings have led to the synthesis of novel analogues that 
would display both improved potency and pharmacology.
The first generation quinolone analogues are shown in Figure 1.1. Nalidixic acid is a 
naphthyridine, cinnoxacin is a cinnoline derivative, pipemidic and piromidic acids are pyrido- 
pyrimidines, and fiumequine and oxolinic acid are quinoline derivatives. The antibacterial activity 
of oxolinic acid was found to be approximately 5-10 times that of nalidixic acid (Kaminsky & 
Meltzer, 1968), and that subsequent development of cinoxacin (Stilwell et aU 1975) differed from 
oxolinic acid through the use of a cinnoline nucleus rather than a quinoline nucleus. Tlie latter 
demonstrated that the quinoline nucleus (Figure 1.2) improved antibacterial activity (Stilwell et al, 
1975).
Nalidixic acid and its derivatives have now become known generically as the 4-quinolones by 
virtue of their common molecular skeleton (Smith, 1984), 4-oxo-l, 4-dihydroquinoline (Figure 1.2). 
The antibacterial activity of these agents was found to increase significantly with the addition of a 
fluorine residue at position C-6 (Wick et al, 1975). Fiumequine (Figure 1.1) was the first 
fluorinated 4-quinolone. Although, it never reached clinical use, it was a significant discovery in 
the evolution of the 4-quinolones because of the introduction of a fluorine residue, and that it was 
comprised of an equimolar mixture of enantiomers. Subsequent attempts were made to derive an 
agent that possessed a broader spectrum of antibacterial activity. The first of these, was the 
development of the pyrido-pyrimidine, pipemidic acid (Figure 1.1). Pipemidic acid contains a 
piperazine substitution at position 7 (Figure 1.1), and this not only eiüianced the activity against the 
Enterobacteria (Matsumoto & Minami^ 1975), but there was also significant activity against 
Pseudomonas aeruginosa (Shimizu et al, 1975), which is intrinsically resistant to nalidixic acid. 
Despite its extended spectrum of activity, pipemidic acid has only been used clinically in a limited 
number of coimtries. Although, pipemidic acid, was the first 4-quinolone with a piperazine 
substitute, it has nevertheless played a significant role in their evolution.
The first generation 4-quinolones were essentially the prototypes for more recent developments. 
The knowledge gained from the chemistry of these compounds and the abundance of laboratory data 
obtained from the investigation of the mechanism of action of nalidixic acid (Goss et al, 1964 &
30
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Figure 1.2, The quinoUne nucleus, 4-oxo-l, 4-dihydroquinoline, 
is the common molecular skeleton of the 4-quinolones.
The side-chains (R) provide structure-activity 
relationships. Rj (3-6 C-ring or linear branch) controls 
potency and some effect on pharmacokinetics, R^
(H-atom) is involved with the gyrase binding site, Rg 
(H-atom or NH2 ) controls potency and adds Gram- 
positive activity, R7  (aminopyrrolidine or piperazine) 
controls potency, spectrum, and pharmacokinetics.
Adapted from  Domagala (1994).
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1965; Deitz et al, 1966; Crumplin & Smith, 1975 & 1976; Gellert et al, 1976), have led to the 
discovery of DNA gyrase, a unique enzyme that regulates and controls the tertiary structure of DNA 
(Menzel & Gellert, 1983). Further to this, several important molecular and bacteriological studies 
have demonstrated that these agents influence many biological processes in the bacterial cell which 
involve DNA.
This was the starting point for the development of the newer 4-quinolones. The work of the last
..: ■:;3'
f
decade has concentrated exclusively on the production of 4-quinolone analogues that were both 
fluorine substituted'at C-6 and contained either an aminopyrrolidine or piperazine base-substituent at 
R-7 (Figure 1.2).
.The second generation quinolones as shown in Figure 1.3a, were developed and synthesised 
for greater antibacterial activity, broader spectrum of activity, improved pharmacological and 
pharmacokinetic properties, and introduced for the treatment of many bacterial infections (Hooper 
& Wolfson, 1985; Hooper & Wolfson, 1991). These newer 4-quinolones greatly exceed the 
antibacterial activity of nalidixic acid, and have brought many bacteria, previously refractory to 
nalidixic acid, within the range of their therapeutic range (Smith, 1986). The C-6 fluorine 
substitution contributes to enhanced potency with at least a 10-fold increase in gyrase inhibition and
:
a 5-100-fold decrease in MIC (Domagala, 1994). The R-7 aminopyrrolidine base of tosufloxacin, 
and the piperazine base of ciprofloxacin, lomefloxacin, ofloxacin, and sparfloxacin (Figure 1.3a) 
improve antibacterial activity, spectrum, and pharmacokinetics. The pyrrolidines offer higher 
activity against Gram-positive bacteria, whereas the piperazines display higher activity against 
Gram-negative bacteria (Sanchez et al, 1988). Alkyl substitution of the R-7 base, as in 
sparfloxacin, has been shown to further enhance activity against Gram-positive bacteria (Sanchez et 
al, 1988; Domagala, 1994). Increasing the number of fluorine residues through mono-, di-, and 
tri-, halogénation of the quinolone nucleus (Figure 1.3a) has been shown to increase the antibacterial 
activity against. Gram-positive bacteria and obligate anaerobes (Mitscher et al, .1990), which are 
normally both considered intrinsically resistant to the first generation 4-quinolones.
Ofloxacin is currently the only available fluorinated 4-quinolone with optical activity (Figure
32 j
\3b), and exists as one of two optical sterioisomers or enantiomers in a 1:1 racemic mixture. 
These sterioisomers are known as D-ofloxacin, which is currently available, and L-ofloxacin 
(levofloxacin) is advancing towards clinical introduction in 1996. The L-enantiomer is 
more active against Escherichia coll, Pseudomonas aeruginosa, and Staphylococcus aureus with 
an 8"to 250-folddecrease in MIC (Atarashi et al, 1987; Mitscher et al, 1987).
Figure 1.4 illustrates 4-quinolone analogues currently under investigation. They have been 
termed the third generation quinolones, and from which the 4-quinolones of the near future may 
well emerge.
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Figure 1.3a. The second generation 4-quinolones or fluorinated 4-quinolones.
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Figure 1.36. Ofloxacin (D & L forms).
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Figure 1.4. The third generation 4-quinolones.
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1.1.2. The in vitro activity of the 4-quinolones
A. Gram-negative genera
With the exception of nalidixic acid, the 4-quinolones are highly active against most genera that 
belonging to the enterobacteria, including E. coli, Klebsiella species, Serratia species, Proteus 
species, and those strains resistant to nalidixic acid (Phillips et al, 1988). The newer 4-quinolone 
agents are also active against Neisseria species, Morexella catarrhalis, and Haemophilus
influenzae, including those strains that produce beta-lactamase, Legionella pneumophila, and P. 
aeruginosa (Neu, 1989; Phillips et al, 1988; Wolfson & Hooper, 1989).
shown to be susceptible. 
Miscellaneous bacteria
I
B. Gram-positive species
The 4-quinolones are less active against both the Staphylococci and Streptococci (Eliopoulos & 
Eliopoulos, 1989, Neu, 1990), than against the aerobic Gram-negative rods. Ofloxacin is the most 
active against Staphylococcus aureus and coagulase-negative Staphylococcus species (Lewin & 
Smith, 1988). Although, ciprofloxacin and ofloxacin are more active than nalidixic acid and
1
J
norfloxacin against Streptococcus species, including S.faecalis and S. pneumoniae, there is
-however increasing resistance. The activity of the 4-quinolones is also quite variable against the 
Gram-positive rods.
.Obligate anaerobes
Nalidixic acid generally possesses very poor activity against the anaerobes. Although, the 
activity of the newer generation 4-quinolones against the anaerobes has been greatly enhanced, the 
Clostridia demonstrate varying susceptibility to the 4-quinolones, with the highest degree of activity 
observed against C. peifringens and C. butyricum. However, other species including C. ramosum,
C. difficle, and C. clositridiforme are less susceptible (Phillips et al, 1988). The 4-quinolones are
?
also active against some members of the Bacteroides species including P. ureolyticus and B,
fragilis. Mobiluncus, the Peptostreptococci, the Peptococci, and the Fusobacteria have also been
The newer 4-quinolones have been shown to exhibit activity against Mycoplasma pneumoniae
I
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but less so against M. hominis and Ureaplasma urealyticum. Both ofloxacin and ciprofloxacin are 
active against Chlamydia trachomatis and members of the Mycobacterium species including
M. tuberculosis.
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1.1.3. DNA Structure, Topology, and Topoisomerases 
DNA Structure and its intracellular organisation
with RNA polymerase and topoisomerase I in the RNA core (Figure 1.5).
I':K
,i
Since the first proposal of the Watson-Crick model of DNA structure, our understanding of how 
DNA structure encodes genetic information, allows mutation and recombination, and serves as a 
template for semiconservative replication and transcription (Watson & Crick, 1953; Watson et al,
1987) have become well established.
Bacterial chromosomal DNA is a large linear covalently closed circular, highly organised' 
molecule (Cairns, 1963). Subsequently, it was found the E. coli chromosome is a circular E)NA
molecule, approximately 1,300pm long (Cairns, 1963). An essential and ubiquitous property of 
bacterial DNA is its negative supercoiled state (Stonington & Pettijohn, 1971; Worcel & Burgi, 
1972; Wang, 1974; Sinden et al, 1980) with a density of about 1 supercoil per 200 base pairs 
(Worcel & Burgi, 1972). The homeostatic control and high dynamic state of cellular DNA are now 
thought to determine the degree of negative supercoiling of DNA (Menzel & Gellert, 1983).
The supercoiled state of double-stranded DNA is required for DNA replication, transcription, 
recombination, and gene expression (Drlica, 1984). The in vivo configuration of DNA in the 
bacterial chromosome is torsionally strained and organised into segregated supercoiled domains
(Worcel & Burgi, 1972; Sinden & Pettijohn, 1981) (Figure 1.5). Worcel (1974) described how the 
1,300pm E. coli chromosome is subdivided into approximately 65 domains of supercoiling (Figure
1.5). Each domain of double-stranded DNA is 20pm long and attached to an RNA core and the 
size of each domain is reduced by being negatively supercohed (Wang, 1974) around a cylindrical
core to form nucleosome-like structures (Griffith, 1976; Lydersen & Pettijohn, 1977; Eickbush &
Moudrianakis, 1978; Drlica & Rouviere-Yaniv, 1987) called compactosomes (Watson et al, 1987).
These structures are adhered to a central RNA core containing primarily RNA polymerase Figure
1.5). Compactosomes are complexed with the histone-like protein, HU, and are thought to be
associated with bacterial chromatin (Kellenberger, 1987; Rouviere-Yaniv et al, 1992). It has also
been shown that HU protein participates in the condensation and compaction of DNA with one 
.dimer of HU per 200 base pairs (Rouviere-Yaniv et al, 1977). HU protein is found in association
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Figure 1.5. Domains of DNA within the E, coli chromosome structure.
The l^OOpm E. coli chromosome is comprised of 65 DNA 
domains condensed with HU protein and bound to a central 
RNA polymerase core. This complex is compacted by the 
negative supercoiling activity of DNA gyrase to form a 
network of negative supertwisted or supercoiled domains of 
DNA bound to RNA polymerase. The 4-quinolones inhibit 
the supercoiling action of DNA gyrase and the compacted 
DNA-HU-RNA-RNA polymerase complex tends to a more 
relaxed state. Adapted from Smith (1986) with permission.
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Tills location of HU suggested a role in translation and transcription prior to site-specific 
recombination and replication (Drlica & Rouviere-Yaniv, 1987; KeUenberger, 1987). One model 
suggested that the action of HU involved its binding to both DNA (Rouviere-Yaniv, 1977) and the 
native 30S ribosomal subunit (Suryanarayana & Subramanian, 1978).
Thus, the physical organisation of prokaryotic intracellular DNA occurs at multiple levels 
(Schmid, 1988) and a major consequence of DNA domains is that chromosomal regions can possess 
different levels of negative superhelicity (Drlica, 1984). This provides a mechanism that involves
42
the spatial regulation of genes within a chromosomal domain (Schmid, 1988). 
DNA topology and topoisomerases
DNA topology
A fundamental topological problem arises in bacteria because the chromosome is approximately 
1300pm in length in E. coli, and yet the average size of a bacterium is 1 to 2pm long. For the 
chromosome to be accommodated into such a smaller cell, the circular DNA molecule must be 
condensed at least 1,000-fold. Furthermore, in this highly condensed state, the DNA molecule must 
be able to replicate, segregate (into daughter chromosomes), and allow transcription of individual 
genes.
Double-helical DNA is comprised of two single anti-parraUel strands intertwined around each 
other (Watson & Crick, 1953). A consequence of this intertwining is that the two strands 
become linked and in the E. coli chromosome, which contains approximately 4 million bp, the 
strands are intertwined or linked about 400,000 times. This generates a linking number of 400,000 
and measures the number of times one strand pierces the plane of the other. Thus, for each cycle of 
semiconservative replication, the two DNA strands must unwind 400,000 times through a swivel
I
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mechanism which untwists the DNA double helix during strand separation (Cairns, 1963). The 
topological state of covalently closed circular DNA is dependant on the twist or number of helical 
turns (the linking number) in the molecule in its native conformation, and the writhe or geometric 
contortion of the helical axis in space, of (he interwound single DNA strands (Fuller, 1971; Wang, 
1974; Gellert, 1981). Negative supercoils result from writhe having a negative twist and
mI
.intracellular DNA exists in a slightly underwound state with one helical turn, on average every 
10.4bp (Sinden et al, 1980; Gellert, 1981). For prokaryotic DNA, the problems of 
entanglement, strand unwinding, and supercoiling are solved, at least in part, by the DNA 
topoisomerases (Drlica, 1984; Gellert, 1981; Wang, 1985 & 1987).
DNA topoisomerases
The topological state of closed-circular DNA, and the level of bacterial DNA supercoiling is 
controlled by the DNA topoisomerases (Cozzarelli, 1980; Gellert, 1981; Wang, 1985), In
prokaryotes, the maintenance of duplex DNA in a negatively supercoiled state is important for
■replication, transcription, and recombination. It is therefore likely that DNA supecoiling is an
important aspect of chromosome structure (Wang, 1985; Bjomsti et al, 1986). The topoisomerase 
enzymes are now known to catalyse changes in the tertiary structure of DNA (Cozzarelli, 1980;
Gellert, 1981; Lui & Wang, 1987; Wang, 1985, 1987; Maxwell & Gellert, 1986).
Four bacterial DNA topoisomerases have been isolated from E. coli (Hooper & Wolfson, 1993),
Type I topoisomerases include topoisomerases I and III, type II topoisomerases include DNA gyrase 
and topoisomerase IV, and the special topoisomerases include enzymes that catalyse transposition or 
integration into and excision of bacteriophage DNA from the bacterial chromosome. Type I and 
type II topoisomerases differ in their strucmre and function. The first activity of a topoisomerase to 
be described was the relaxation of negatively supercohed closed circular DNA by prokaryotic 
topisomerase I (Wang, 1971). The prokaryotic type II topoisomerase, DNA gyrase, is the only 
topoisomerase able to introduce negative supercoils into DNA (Gellert et al, 1976).
.Type I topoisomerases make a transient single strand break in the double helix, followed by 
passage of the other strand through the break, whhe type II topoisomerases transiently cleave both 
strands of the double helix and pass another double helical segment through this break (Morrison & 
Cozzarelli, 1979; Cozzarelli, 1980; Gellert, 1981). Type I and Type II topoisomerases have been 
isolated from many species of bacteria, and eukaryotes, including human cells.
a
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Type I topoisomerases 
Bacterial DNA topoisomerase I
"t
Nearly twenty-five years ago, it was first identified that extracts of E. coli could relax negatively 
supercoiled DNA (Wang, 1971). E. coli type I DNA topoisomerase was found to be responsible 
for this relaxing activity through unit change in the linking number of the intertwined strands of 
DNA (Brown & Cozzarelli, 1979). This enzyme is a monomeric protein with a molecular weight 
of 1 lOkDa and is the product of the topN gene, which is located at 28 minutes on the genetic map of 
the E. coli chromosome (Stemglanz et al, 1981; Trucksis & Depew, 1981).
Type I DNA topoisomerases from both prokaryotic and eukaryotic sources relaxes negatively
supercoiled DNA through catalytic removal of negative supercoils from DNA, and highly negatively 
supercoiled DNA is initially relaxed with high efficiency, but the rate slows as the linking number of 
fully relaxed DNA is approached. It is also known that positively supercoiled DNA is unaffected 
by this enzyme (Wang, 1971).
The relaxation of negative supercoiled DNA involves a change in the linking number (or number 
of helical turns) through both the cleavage and rejoining of the DNA chain (Gellert, 1981).
Cleavage studies have shown topoisomerase I to possess a high affinity for segments of DNA 
composed of both a single- and double-stranded region, and that the cleavage site is located within 
the single-stranded region. Topoisomerase I can both cleave and rejoin DNA repeatedly, in an 
energy conserving process that involves conservation of the free energy state of the phosphodiester 
bond in DNA (Depew et al, 1978).
Eukaryotic topoisomerase I is found in association with nuclear chromatin and is of a smaller 
molecular weight at, 60-75kDa (Gellert, 1981). The eukaryotic enzyme differs from the 
prokaryotic enzyme in several ways. It is active in the absence of Mg^+ions and in the presence of 
chelators (Gellert, 1981; Gootz & Osheroff, 1993). Unlike prokaryotic topoisomerase I, eukaryotic 
topoisomerase I can relax both positively and negatively supercoiled DNA (Champoux & Dulbecco,
1972).
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Bacterial DNA topoisomerase III
A second type I topoisomerase, topoisomerase III, been identified in E. colL As with
(DiGate & Marians, 1992).
E. coli chromosome (DiGate & Marians, 1989). There is evidence that topoisomerase III may have
I
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topoisomerase I, topoisomerase HI is able to remove negative superhelical twists without tlie 
requirement for ATP (Srivenugopal et al, 1984). In addition to its binding with DNA, 
topoisomerase III binds to RNA, and can cleave both nucleic acids at identical nucleotide sequences
Topoisomerase III is the product of the topB gene located at 39 minutes on the genetic map of the
a role in DNA recombination (Wang et al, 1990). 
Type II topoisomerases 
Bacterial DNA gyrase
DNA gyrase (EC 5.99.1.3) was the first type II topoisomerase to be isolated from E. coli (Gellert 
et al, 1976), and plays a central role in the structure and function of the bacterial chromosome.
DNA gyrase is a large ATP-requiring multisubunit enzyme responsible for the catalytic conversion 
of relaxed double-stranded DNA into negatively supercoiled DNA (Gellert et al, 1976). The 
discovery of DNA gyrase was the culmination of work on two classes of DNA synthesis inhibitors, 
the 4-quinolones, nalidixic and oxolinic acids (Goss et al, 1964) and the coumarins, novobiocin and 
coumermycin (Gellert et al, 1976; Ryan, 1976).
DNA gyrase is a tetramer composed of two A subunits (GyrA), and two B subunits (GyrB)
(Sugino et al, 1977). The A and B subunits were identified on the basis of their selective inhibition 
with either temperature-sensitive mutations (Gellert et al, 1979; Kreuzer & Cozzarelli, 1979) or 
specific subunit antibiotics (Gellert et al, 1976 & 1977; Sugino et al, 1977; Orr et al, 1979). The 
GyrA subunit was identified with the 4-quinolones nalidixic and oxolinic acids (Gellert et al, 1977;
Sugino et al, 1977) and the GyrB subunit was identified using novobiocin and coumermycin (Gellert 
et al, 1976; Orr et al, 1979). The supercoiling reaction is inhibited by both these classes of 
antibiotic, with the 4-quinolones blocking both the cleavage and re-union processes (Gellert, 1981), 
and the coumarins inhibit the intrinsic ATP activity of the energy-coupling reaction (Mizuuchi et al,
i
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introducing two cuts staggered by 4 bp with the 5-end protruding (Milleret al, 1981 ; Lui et al.
for active gene expression in eukaryotes (North, 1985; Weintraub, 1985). However, unlike, 
bacterial DNA gyrase, the mammalian enzyme is composed of only two subunits, each with a
■"I
1978; Sugino et al, 1978; Sugino et al, 1980). The GyrA subunits, which are encoded by the 
gyrA gene (locus at 48 minutes on the E. coli chromosome), each contmn 874 amino acids with a 
mass of 97kDa, and the GyrB subunits, are encoded by the gyrB gene (locus at 82 minutes on the E.
coli chromosome), and each contain 804 amino acids with a mass of 90kDa (Mizuuchi et al, 1978).
IThe tetrameric structure of E. coli DNA gyrase has been confirmed by small-angle neutron scattering, and this yields an estimated molecular mass of 353kDa, which is consistent with the 
calculated mass of the holoenzyme (A2B2) at 374 kDa (Krueger et al, 1990). DNA gyrase binds to 
double-stranded DNA and the DNA supercoiling reaction is driven by a magnesium-dependant
Î
hydrolysis of ATP (Gellert et al, 1976; Sugino & Cozzarelli, 1980; Tse et al, 1980). GyrA 
mediates DNA strand breakage and reunion with the tyrosine residue at position 122 (Tyr-122), 
forming a transient covalent linkage with the broken 5 -end of the DNA strand (Horowitz & Wang, 
1987). GyrB mediates the ATPase activity of DNA gyrase (Lui & Wang, 1987; Morrison & 
Cozzarelli, 1979), and the N-terminal domain of GyrB (amino acids 2 through 220) is now known i
Î
to contain the ATP-binding site (Wigley et al, 1991).
When bacteria are exposed to DNA gyrase inhibitors there are two well recognised effects on 
DNA supercoiling. ( 1 ) The specfic inactivation of either subunit of DNA gyrase blocks the 
introduction of titrable supercoils (Gellert et al, 1976; Gellert et al, 1977), and (2) inhibition of 
either subunit leads to a loss of titrable supercoils from both bacterial chromosomal DNA (Drlica 
& Snyder, 1978; Manes et al, 1983) and plasmid DNA (Pettijohn & Pfenninger, 1980; Kano et al, 
1981; Lockshon & Morris, 1983). %
Human cells possess a topoisomerase II. It also cleaves and rejoins double-stranded DNA by
1983). There is increasing evidence that the mammalian enzyme generates DNA supercoils in those 
regions of chromatin where genes are actively being transcribed (Smith, 1988), and it is also thought 
this enzyme is one of the major structural components of the chromosomal domain that may be sites
Î,JSr
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can also catalytically remove positive supercoils (Gellert et al, 1981). Both DNA gyrase and
molecular weight of 172kDa (Smith, 1984), and can catenate, relax, and unknot DNA by a duplex 
strand passage mechanism (Sutcliffe et al, 1989).
.Mechanism of action of DNA gyrase
The mechanism of DNA supercoiling by DNA gyrase involves the catalytic conversion of relaxed
DNA into negatively supercoiled DNA. The process is initiated with the transient cleavage and
re-union of double-stranded DNA at specific gyrase binding sites. These specific recognition sites,
of 140bp, are found in segments of chromosomal DNA tliat are in contact with DNA gyrase (Synder
& Drlica, 1979; Kleven & Wang, 1980). Within the DNA - DNA gyrase complex, GyrA subunits
,
cleave both duplex strands (Gellert et al, 1977) that are staggered 4bp apart, and the 5 -ends of 
duplex DNA (with Tyr-122 residues exposed) protrude (Morrison & Cozzarelli, 1979). A single 
turn of 120- to 150-bp of DNA segment is then wrapped around DNA gyrase, with DNA entry and 
exit points in close proximity (Kirchhausen et al, 1985; Rau et al, 1987). Kirchhausen et al (1985) 
have suggested that the gyrase holoenzyme is a "heart-shaped structure" wth DNA wrapped between 
the upper "lobes".
'IHydrolysis of ATP induces a structural change within the complex where it is thought increased 
wrapping of DNA around gyrase occurs (Rau et al, 1987). The DNA is then negatively 
supercohed by the GyrB subunits in a reaction that utilises one molecule of ATP for each supercoil
formed (Gellert et al, 1977). The number of supercoils for each domain of DNA is approximately 
400 (Smith, 1984). The supercoiling process is completed when the negative supercoils are sealed 
into each chromosomal domain by the GyrA subunits (Gellert et al, 1977). DNA gyrase is
distributed along DNA at lOOkbp intervals, which corresponds to approximately 1 gyrase molecule
.
per domain of chromosomal DNA (Synder & Drlica, 1979).
In vitro DNA gyrase is also involved in the formation and resolution (catenation and decatenation) 
of covalently closed circular DNA molecules that are interlocked, like links in a chain (Kreuzer &
Cozzarelli, 1980; Mizuuchi et al, 1980; Krasnow & Cozzarelli,1982; Marians, 1987), and 
formation and removal of knots within the DNA double-helix (Mizuuchi et al, 1980). DNA gyrase
topoisomerase I are regulated at transcriptional level in response to the negative supercoiled state of
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DNA (Menzel & Gellert, 1983). Reduction in the level of DNA supercoiling stimulates gyrase
: :
expression through increased transcription of the gyrA and gyrB genes (Menzel & Gellert, 1983 &
1987), and suppresses transcription of the top A  gene (Tse-Dinh, 1985). These findings suggest 
that the supercoiled state of DNA is homeostatically regulated (Menzel & Gellert, 1983 & 1987).
DNA gyrase plays an essential role in DNA replication and is involved in the initiation (Marians et 
al, 1977), of elongation (Gellert et at, 1976), and termination (DiNardo et al, 1982). The 
use of DNA gyrase inhibitors has shown, at least indirectly, that DNA gyrase is also involved in 
transcription, because an increase in negative supercoiling can increase the expression of the 
maltose, lactose, and galactose opérons (Sanzey, 1979; Sm theta l, 1978; Smith, 1981; Yang et 
al, 1979). DNA gyrase may also be involved in DNA recombination (Mizuuchi et al, 1978;
Ohtani et al, 1982; Von Wright & Bridges, 1981; Wu et al, 1983; ), and DNA repair (Hays &
Boehmer, 1978; Phillips et al, 1987). The transposition of Tn5 may also be dependent on the 
degree of DNA supercoiling of recipient DNA, and is affected by a reduction in gyrase activity 
by both coumarin inhibitors or gyrA mutations (Isberg & Syvanen, 1982).
Bacterial topoisomerase IV
Topoisomerase IV is a membrane-associated enzyme (comprised of the 145kDa combined protein 
products of parC and parE), that catalyses ATP-dependent relaxation of negatively and positively 
supercoiled DNAs, and unknotting of unnicked duplex DNA, and is thought to be involved in
■ ,'.i
chromosome partitioning and in removal of DNA supercoüs (Kato et al, 1990 & 1992). Unlike
DNA gyrase, topoisomeraseÜ^has not shown any DNA supercoiling activity (Hooper &
'Wolfson, 1993).
I
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1.1.4. The mechanism of action of the 4-quinolones
The quinolone antibacterials are now known to have distinct and remarkable effects on both DNA 
gyrase and the bacterial cell. Most of the effects of exposure to quinolones were first determined
:
from earlier studies with nalidixic acid and oxolinic acid prior to the discovery of DNA gyrase.
Nalidixic acid (NAL) was found to selectively inhibit DNA synthesis, produce DNA degradation, 
and induce cellular filamentation (Goss et al, 1964 & 1965, Deitz et al, 1966; Cook et al, 1966).
NAL is rapidly bactericidal (Goss et al, 1965), and it was found that both chloramphenicol, which 
inhibits protein systhesis, and dinitrophenol, which uncouples oxidative phosphorylation, reduced its
bactericidal activity on E. colt (Deitz et al, 1966). These findings demonstrated that competent 
protein and RNA synthesis were necessary for the bactericidal activity of NAL (Cook et al, 1966; 
Deitz et al, 1966; Crumplin & Smith, 1975). It has also been shown that although NAL inhibits 
overall DNA synthesis (Crumplin & Smith, 1976), the major effect of NAL was to produce 
unsealed nicks in newly synthesised DNA which led to the irreversible degradation of DNA through 
induced exonuclease action (Crumplin & Smith, 1975 & 1976; Hill & Fangman, 1973) and 
ultimately cell death.
Currently, the overall mechanisms of bacterial killing by the 4-quinolones are at present not 
fully understood and further studies wUl be necessary to determine precisely which mechanisms are 
responsible for the bactericidal activity of these drugs.
DNA gyrase - the 4-quinolone target
Since the discovery that DNA gyrase is the type II topoisomerase responsible for the 
introduction of DNA supercoiling (Gellert et at, 1976), it has become established through genetic 
and biochemical studies, the E. colt GyrA (nalA) subunit is the primary target for NAL and oxolinic 
acid (Gellert et al, 1977; Sugino et al, 1977). Recently, similar studies have shown the GyrA 
subunit in other bacterial species, including Bacillus subtilis (Sugino & Bott, 1980), Enterococcus 
faecalis (Nakanishi et al, 1991), Staphylococcus aureus (Okuda et al, 1991), Campylobacter 
jejuni (Gootz & Martin, 1991), Serratia marcescens (Masecar & Robillard, 1991), Pseudomonas
I
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aeruginosa (Inoue et al, 1987; Masecar et al, 1990), Haemophilus influenzae (Setlow et al, 1985),
et al, 1992). Ng et al (1992) have demonstrated that in the region of the parC and parE genes, a
and Citrobacter freimdii (Aoyama et al, 1988) to be the target of 4-quinolone action. It has also 
been shown the bactericidal activities of the newer 4-quinolones including ciprofloxacin (Hooper et 
al, 1987; Robillard & Scarpa, 1988), norfloxacin (Crumplin etal, 1984; Hirai etal, 1986a & 
1987; Hooper a/, 1986), and ofloxacin (Sato er a/, 1986a & 1986^ ?; Wolfson et a/, 1987) 
against DNA gyrase, are reduced by gyrA mutants. The GyrB (cou) subunit has also been shown 
to be a target of the 4-quinolones (Inoue et al, 1978; Nakamura et al, 1989; Smith, 1984; 
Yamagisha et al, 1981 & 1986). It has also been suggested that, to a lesser degree than DNA
gyrase, topoisomerase IV is susceptible to the in vitro and in vivo action of the 4-quinolones (Kato
a
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new 4-quinolone resistance locus nfxD exists, requiring the presence of the gyrA mutation. Studies 
on purified DNA gyrase have shown NAL, oxolinic acid, and other 4-quinolones to inhibit the 
activity of DNA gyrase, including the introduction of negative DNA supercoiling, formation and 
resolution (catenation and decatenation) of cccDNA molecules, formation and removal of knotting
' Ïwithin the duplex DNA molecule, and DNA dependent ATP hydrolysis (DrUca, 1984; Gellert,
1981; Wang, 1985 & 1987).
■Thus, the bactericidal action of the 4-quinolones action are thought to involve a cascade of 
cytopathic events (Crumplin et al, 1984; Drlica, 1984; Piddock & Wise, 1987; Reece & Maxwell,
■ÏVÏ
1991), which comprise (a) a primary component that specifically inhibits bacterial DNA gyrase and 
leads to both the inhibition of chromosomal DNA synthesis (Crumplin & Smith, 1975 & 1976) and 
an imbalance of bacterial metabolism (Crumplin et al, 1984), and (b) a secondary component 
resulting fi*om changes in the tertiary structure of chromosomal DNA, through gyrase-induced DNA 
cleavage, is thought to lead to the inducible production of the recB and recC exonucleases, and 
ultimately degradation of bacterial DNA (Crumplin & Smith, 1976; Crumplin et al, 1984; Menzel
& Gellert, 1983). Together, both these components constitute the major disruptive bactericidal 
effects of the 4-quinolones (Smith, 1984 & 1988). Shen et al (1989a) have proposed that, rather
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Bacterial DNA gyrase and eukaryotic topoisomerase II possess remarkable similarities in 
biochemical mechanisms and amino acid sequences. Therefore, it would be reasonable to question 
whether 4-quinoIone antibacterial agents demonstrate inhibitory activity against eukaryotic
s
than acting directly on DNA gyrase, the 4-quinolones are thought to bind to saturable sites on 
supercoiled DNA that involves a quinolone-DNA cooperative binding process. Tills binding has 
been suggested to be facilitated by DNA gyrase. Evidence also suggests that DNA gyrase induces 
a drug binding site on relaxed DNA in the presence of ATP to form a DNA gate (Shen et al,
1989a). The GyrA subunit cleaves the duplex strands that are 4bp staggered apart (Morrison & 
Cozarelli, 1979), and forms covalent bonds between Tyr-122 and the 5 -ends of the DNA chain 
(Horowitz & Wang, 1987). These exposed protruding 4bp staggered cuts form a DNA gate, which 
leads to the formation of a locally denatured DNA bubble that acts as the 4-quinolone binding site 
(Figure 1.6). The 4-quinolone molecules acquire high binding affinity through a cooperative 
binding mechanism with the separated 5 -ends of cleaved DNA (Shen et al, 19896). It is thought, 
the 4-quinolones self-associate cooperatively into a bioactive tetraplex in the DNA gate and bind 
with unpaired bases via hydrogen bonding (Shen et al, 19896). The cooperative 4-quinolone-DNA 
binding model (Figure 1.6) is in general agreement with the structure-activity relationships of the 
4-quinolones (Chu & Fernandes, 1989; Domgala et al, 1986; Mitscher et al, 1989 & 1990;
Rosen, 1990; Wenüand, 1990).
,x
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topoisomerase n. However, it is generally accepted that the eukaryotic enzyme is not sensitivie to
I
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inhibition by the 4-quinolones (Bergen, 1988; Hussy et al, 1986; Miller et al, 1981). This is 
probably due to the structural and functional differences between the bacterial and eukaryotic 
enzymes and would seem to provide an explanation of why the 4-quinolones are toxic to bacteria but 
not to humans.
The following are the well established cellular effects of the 4-quinolones on viable bacteria, 
including effects on bacterial metabolism, bacretial cell surface, and bacterial plasmids.
Bacterial metabolism
DNA synthesis is terminated rapidly during exposure to the 4-quinolones. At near growth
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Figure 1.6. 4-quinolone-DNA binding model for inhibition of DNA 
gyrase.
The 4-quinolone molecules form a tetraplex with Tc-tc 
stacking of the 4-quinolone rings bound to the DNA 
gate at the 5 -ends of cleaved DNA. The 4-quinolone 
high binding affinity occurs via hydrogen bonding 
(shown by dotted lines) with the exposed unpaired 
bases of DNA. Adapted from Shen et al (1989b) with 
permission.
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inhibitory concentrations of fleroxacin, large nucleoids in filamentous E, coli developed. This 
suggests chromosome decatenation is inhibited after a round of DNA replication (Georgopapadakou
,?.i
& Bertasso, 1991). High quinolone concentrations inhibit protein and RNA systhesis which leads 
to ceil filamentation (Crumplin et al, 1984; Diver & Wise, 1986; Dougherty & Saukkonen, 1985;
Elliott et al, 1987; Smith, 1984) possibly through inhibition of DNA synthesis and induction of the 
E. coli recA (SOS) DNA repair system (Donachie & Robinson, 1987; Phillips et al, 1987;
Piddock & Wise, 1987; Walker, 1984). There is also evidence that the quinolone concentration
required to inhibit the in vitro or in vivo level of supercoiling by gyrase with that required to inhibit
- !
cell growth demonstrates the in vitro level to exceed the in vivo by a factor of between 10 to 100
(Gellert et al, 1977; Domagala et al, 1986; Zweerink & Edison, 1986). This is paradoxical since 
it would be expected that the purified gyrase enzyme would be more and not less sensitive to the 
4-quinolones. This has been explained in part that the action of 4-quinolones on bacteria may 
involve additional mechanisms beyond inhibition of DNA gyrase (Kreuzer & Cozzarelli, 1979). 
This has lead to the hypothesis that an irreversible 4-quinolone-DNA gyrase complex forms a DNA
:
I
lesion that acts as a cellular poison (Kreuzer & Cozzarelli, 1979) and therefore initiates the 
cytopathic cascade of events that lead to cell death.
Many of the quinolones are structurally similar (Figures 1.1-1.4), and therefore share similar 
cellular effects. However, marked variation in antibacterial potencies have been well documented. 
These variations parallel differences in DNA gyrase inhibitory concentrations, as has been 
demonstrated for E. coli ( Domagala et al, 1986; Hooper et al, 1987) and Micrococcus luteus I
(Zweerink & Edison, 1986).
Bacterial cell surface 
.To reach the intracellular DNA gyrase target in the bacterial cell cytoplasm, the 4-quinolone 
.molecule must access, and traverse through both the outer and inner membranes (Bryan & Bedard, 
1991 ; Nikaido & Vaara, 1985; Hirai et al, 1986a). It has been proposed that the 4-quinolones 
penetrate the E. coli outer membrane by diffusion through OmpF and OrapC porin channels (Cohen 
et al, 1988; Hirai et al, 1986^). The hydrophilic 4-quinolones, ciprofloxacin, norfloxacin, and
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ofloxacin enter the bacterial cell via the porin channels, and the hydrophobic 4-quinolone, NAL 
penetrates not only through the porin channels but also through the phospholipid regions of the outer 
membrane. Lipopolysaccharide in the outer membrane has been shown to be a barrier to more 
hydrophobic 4-quinolones since mutants of S. typhimurium with LPS defects show increased 
susceptibility (Chapman & Georgopapadakou, 1988; Hirai et al, 1986ib; Timmers & Stemglanz, 
1978).
Exposure to subinhibitory concentrations of quinolones may alter the bacterial cell surface. It has 
been shown growth of an encapsulated strain of K. pneumoniae at subinhibitory concentrations of 
ciprofloxacin resulted in cell surface changes including, increased complement binding, changes to 
the outer membrane antigens, and heterogenous capsular distribution in filamenting cells (Williams, 
1987). Growth in the presence of subinhibitory concentrations of quinolones has resulted in 
reduced adherence of uropathogenic strains to uroepitheliai cells (Desnottes et al, 1990). Nal- 
induced morphological changes have also been observed and attributed to loss of membrane 
integrity leading to leakage of cytoplasmic constituents through plasmolysis (Dougherty 
& Saukkonen, 1985; Hooper ef a/, 1986).
Bacterial plasmids
Some plasmids have been shown to be eliminated from their hosts in the presence of subinhibitory 
quinolone concentrations (Michel-Briand a/, 1986; Platt & Black, 1987; Weisser & Wiedemann, 
1985 & 1986). However, the effect on plasmid elimination is highly dependent on the concentration 
of the quinolone used, the plasmid, and the bacterial host. Coumermycin and novobiocin have been 
shown to eliminate plasmids through GyrB subunit antagonism (Wolfson et al, 1982; Hooper et al, 
1984). The elimination of susceptible plasmids to curing indicates that at subinhibitory concentrations, 
plasmid DNA replication, partition, or copy number may be more sensitive to the effects of 
4-quinolone action than replication of chromosomal DNA (Wolfson et al, 1982; Weisser & 
Wiedemann, 1986). There is also evidence that certain R-plasmids, including RP4, increase the 
4-quinolone susceptibility of their host (Crumplin & Smith, 1981). The 4-quinolones have been 
shown to inhibit both the conjugative transfer of plasmids (Barbour, 1967, Burman, 1977; Gill &
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Iver, 1982; Hirai era/, 1984; Hooper era/, 1989; Michel-Briand Éff al, 1983; Nakamura gf al, 
1976; Weisser & Wiedemann, 1987), and the Hfr-mediated transfer of the bacterial chromosome 
Barbour, 1967; Bouck & Adelberg, 1970; Fenwick & Curtiss, 1973; Hane, 1971; HoUom & 
Pritchard, 1965; Hooper et al, 1989). Hooper et al (1989) also suggested that disruption of the 
transfer replication fork was the site for quinolone action. Transfer inhibition is not a unique effect 
of the quinolones since other antibiotics including both rifampicin and chloramphenicol have also 
demonstrated similar effects (Fenwick & Curtiss, 1973). It has also been suggested the in vivo 
lethal effect of the quinolones far exceeds plasmid elimination and transfer inhibition (Weisser & 
Wiedemnann, 1987).
Illegitimate recombination has been reported between pBR322 and bacteriophage X in the 
presence of oxolinic acid (Ikeda et al, 1982). Recombination was eliminated by coumermycin, and 
reduced by oxolinic acid when quinolone resistant gyrA mutants were used (Ikeda et al, 1984). It 
has also been suggested the recombination sites are similar to gyrase cleavage sites (Ikeda et al,
1984) and that GyrA-DNA cleaved sites mediate recombination (Ikeda & Shiozaki, 1984).
E, coli reck  (SOS) DNA repair systems
Damage to bacterial DNA has been shown to occur through quinolone induction of the reck 
DNA repair system in E. coll (Courtright et al, 1988; Gudas & Pardee, 1976; Phillips et al, 1987; 
Piddock & Wise, 1987). Induction of the reck  DNA repair system by 4-quinolones requires an 
active DNA replication fork (Gudas & Pardee, 1976) and the functional helicase (unwinding) 
activity of exonuclease V, the product of the recBC genes (Chaudhury & Smith, 1985). It has been 
suggested that the RecA protein is activated by DNA damage (Little & Mount, 1982). The 
most bactericidal concentrations of 4-quinolones have been found to be similar to concentrations 
that maximally induce the SOS system (Phillips et al, 1987). This suggests the SOS 
system may be involved in bacterial killing (Chow et al, 1988; Diver & Wise, 1986; Phillips et al, 
1987). However, recent studies have suggested the SOS system may not be a mediator of bacterial 
killing by the 4-quinolones (Lewin et al, 1989; Lewin & Smith, 1990). Therefore, the 
4-quinolones may either act on DNA gyrase or saturable sites at the replication fork to produce a
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lethal lesion which is converted by exonuclease V to an activating signal for RecA, and binding of
:multiple RecA molecules may promote error-prone DNA repair (Little & Mount, 1982; Sassanfar
■& Roberts, 1990).
Kinetics of 4-quinolone bactericidal activity
Although, the interaction with DNA gyrase appears to be a necessary prerequisite for the 
bactericidal activity of the 4-quinolones, our understanding of the molecular events leading to 
bacterial death remains incomplete. However, common characteristics of bacterial killing by the 
4-quinolones have emerged for £. coli (Crumplin gf al, 1984; Smith, 1984), S. marcescens Çucv/ïn 
et al, 1990), S. aureus and S. wameri (Lewin & Smith, 1988). Bacterial death is initially rapid but 
slows when the viable count is approximately 10^-fold lower than the initial inoculum (Cook et al, 
1966; Courtright et al, 1988; Crumplin et al, 1984; Deitz et al, 1966; Diver & Wise, 1986;
Elliott et al, 1987; Goss et al, 1964; Smith, 1984; Wolfson et al, 1989). These kinetics would 
suggest two components to bacterial killing. The less rapidly killed bacterial cells may represent 
persisters and do not appear to be resistant or less effectively killed mutants, since neither show 
resistance to growth inhibition or reduced killing on 4-quinolone re-exposure (Wolfson et al, 1989). 
The persistance mechanism to the 4-quinolones is as yet unknown. However, it has been suggested 
this subpopulation may be refractory to the lethal effects of the 4-quinolones, as has been 
documented for persistant cells exposed to {3-lactams (Hoffmann et al, 1972; Holzhoffer et al,
1985).
The viability of E. coli KL16 (ca 10^ bacteria/ml) when exposed to a range of concentrations of 
ciprofloxacin (CFX), nalidixic acid (NAL), norfloxacin (NOR), and ofloxacin (OFX), a
demonstrable biphasic response (Figure 1.7) is always observed (Diver & Wise, 1986; Smith,
• .
1984; WinsheU & Rosenkranz, 1970). The rate and magnitude of bacterial death is progressively
more bactericidal with increasing qiiinolone concentrations and this phase is due to the progressive 
inhibition of DNA synthesis (rate of inhibition for CIP>OFX>NOR>NAL). When the most 
bactericidal concentration is exceeded there is a progressive reduction in bactericidal activity for all 
4-quinolones, although, the reduction in bactericidal activity is much more pronounced for nalidixic
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acid and norfloxacin. Most bactericidal concentrations of 4-quinolones compare with those 
concentrations that inhibit bacterial DNA synthesis (Chow et al, 1988), but inhibition of DNA 
synthesis appears insufficient to effect bacterial death. This progressive reduction in bactericidal 
activity is through an antagonistic inhibition of RNA synthesis (Crumplin & Smith, 1975). The 
newer 4-quinolones ciprofloxacin and ofloxacin are less susceptible than nalidixic acid and 
norfloxacin to antagonism by rifampicin (Crumplin et al, 1984; Deitz et al, 1966; Smith,
1984; Zeiler, 1985; Zeiler & Grohe, 1984). Similarly, it has also been shown that 
chloramphenicol produces a much less marked antagonism by protein synthesis inhibition (Crumplin 
etal, 1984; Deitz ef a/, 1966; Smith, 1984; Zeiler, 1985; Zeiler & Grohe, 1984). Smith (1984) 
described this phenomenon and suggested the newer 4-quinolones ciprofloxacin and ofloxacin 
possess a second mechanism of killing in addition to a common mechanism possessed by all 
4-quinolones. A third bactericidal mechanism has been described for norfloxacin against non­
dividing E. coli under conditions of starvation (Ratcliffe & Smith, 1985).
Antagonism of both RNA synthesis and protein synthesis reduce the 4-quinolone bactericidal 
effect, but neither affect quinolone inhibition of DNA synthesis (Deitz et al, 1966; Piddock et al, 
1990; Winshell & Rosenkranz, 1970). Both antagonisms inhibit protein synthesis, and the letlial 
effects of the 4-quinolones may involve the synthesis of a protein required for lethality, possibly the 
RecA protein (Little & Mount, 1982; Smith, 1984). Both competent RNA and protein synthesis 
are therefore required for the bactericidal activity of the 4-quinolones.
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Figure 1.7, Biphasic response of E. coli KL16 to different 
concentrations of the 4-quinolones CFX, NAL, 
NOR, and OFX. Reprinted partly from Smith (1984) 
with permission.
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1.1.5. Bacterial resistance to the 4-quinolones
With the ever expanding worldwide clinical use of the 4-quinolones, resistance to these agents 
have been reported (Wolfson & Hooper, 1989), and the mechanisms of resistance has been the 
subject of many studies. Bacterial resistance to antimicrobial agents are usually mediated either via 
plasmid-encoded resistance or chromosomal mutation.
Currently, the 4-quinolones have been shown to be exempt from transferrable R-plasmid mediated 
resistance (Burman, 1977; Crumplin, 1987; Lewin eta/, 1990; Smith 1984; Crumplin, 1987). 
There have been two reports of plasmid-mediated nalidixic acid resistance in Shigella dysenteriae 
(Panhotra et al, 1985; Munshi et al, 1987). However, both have been questioned on the basis that 
nalidixic acid resistance could not be transferred and that it was therefore unknown if the generation
of nalidixic acid mutants was plasmid-mediated (Crumplin, 1987). It has been suggested that these :
plasmids do not carry a nal^ gene, but are mutator plasmids increasing the frequency of 
chromosomal mutations to nalidixic acid resistance (Levy et al, 1988; Lewin et al, 1990). There 
have been reports however, of a plasmid-mediated mechanism of resistance that may involve drug 
accumulation. The encoded 50 kDa Nor A protein product from the nor A  gene in S. aureus, has 
been identified to confer high-level resistance to hydrophilic fluoroquinolones through a process that 
appears to be membrane associated (Ubukata et al, 1989; Yoshida et al, 1990). When the nor A  
gene was cloned into pBR322, and transformed into E. coli HBlOl, it conferred resistance to the 
4-quinolones. The MICs for the hydrophilic 4-quinolones, ciprofloxacin, enoxacin, norfloxacin, 
and ofloxacin increased by 8-64 fold, and decreased 2-fold for the hydrophobic 4-quinolones 
nalidixic acid and sparfloxacin (Ubukata et al, 1989; Yoshida et al, 1990). Although this 
represents a mechanism whereby a plasmid can confer 4-quinolone resistance, it has yet to be 
established in clinical isolates (Amyes & Gemmell, 1992).
■
Chromosomally-mediated resistance to the 4-quinolones
Chromosomal resistance has been shown to occur through two mechanisms - either alteration in 
the target enzyme, DNA gyrase, or a permeability mutation that reduces drug accumulation (Hooper 
& Wolfson, 1987; Smith 1986).
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Alterations of the GyrA protein subunit in 4-quinolone resistance has been determined in a large |
number of species, and mutations in the gyrA have been shown to confer high-level resistance to all 
4-quinolones. These have been directly identified by genetic mapping or DNA sequencing in 
several bacteria that include E, coli (Cullen et al, 1989; Gellert et al, 1977; Hooper et al, 1986 &
1987; Sugino etal, 1977; Wolfson ar a/, 19S,7), P. aeruginosa (Him et al, 1987; Masecar gf a/,
1990; Robillard & Scarpa, 1988), S. marcescens (Fujimaki et al, 1989; Masecar & Robillard,
1991), and Klebsiella pneumoniae (Heisig & Wiedemann, 1991).
Most information on changes in the GyrA protein structure have been acquired from nucleotide
sequencing of 4-quinolone resistant gyrA mutants of E. coli. Nucleotide sequence analysis has 
demonstrated most 4-quinolone resistance to be conferred by single changes in amino acid sequence 
(point mutations) within a small region between amino acids 67 and 100 near the N-terminus of the 
A subunit (Cambau a/, 1992; CuUen gf a/, 1989; Hallet & Maxwell, 1991; Yoshida a/,
1990). All of these mutations are clustered in the amino-terminal region of the polypeptide |
sequence near Tyr-122 of the Gyr A subunit (Yoshida et al, 1990; Yoshida et al, 1988). Tyr-122
is also adjacent to the active site of DNA gyrase (Shen et al, l9S9b). The 5 -GyrA-Tyr -122-end 
is covalently bound to DNA when DNA gyrase breaks the phosphodiester bonds of DNA, and 
therefore mutations close to Tyr-122 lead to changes in the secondary and tertiary structure of 
GyrA. Resistance to the 4-quinolones is accompanied by changes in the affinities of the • |
4-quinolone for the DNA gyrase-DNA complex (Amy as & Gemmell, 1992), Shen et al (19896) 
have further suggested resistant DNA gyrase blocks the access of the 4-quinolones to the high 
affinity binding site. Most alterations in amino acid sequences involved changes in Ser-83 to Leu
'or Trp, resulting in a 128-fold increase in resistance to NAL, and 32-fold increase in resistance to 
the newer 4-quinolones (Cullen ef a/, 1989; Hallet & Maxwell, 1991; Oram & Fisher, 1991;
Yoshida et al, 1990). Mutations in the GyrB subunit have been shown to confer changes in 
4-quinolone susceptibiltiy in E. coli resistance loci nalC and nalD (Inoue et al, 1987; Yamagishi et 
al, 1981; Yamagishi et al, 1986). Both loci also encode point mutations, with nalC (Lys-447 to 
Glu) leading to hypersusceptibility to 4-quinolones with a piperzine substituent, and nalD (Asp-426
.J
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There have been recent reports o f E. coli with reduced susceptibility to the 4-quinolones, [3- 
iactams, tetracycline, and chloramphenicol (Hooper et a/, 1986; Hirai et al, 19866). This 
pleiotropic mutation has also been shown to be due to reduced ompV expression, and to be 
an allele o f mar A  (mapping at 34 min on E. coli chromosome), which encodes intrinsic 
multiple antibiotic resistance (George & Levy, 1983). Reduced ompp  expression has been 
obseived in mar A, norB, oficB mutants, and they are thought to be closely linked
(Hooper & Wolfson, 1993). This resistance mechanism has as yet still to be defined.
■1
to Asn) leading to small increases in 4-quinolone resistance (Yamagishi et al, 1986). The 
4-quinolone hypersusceptibility mutation results from an increase in negative charge of the GyrB 
subunit, increasing its attraction for the positively charged piperzine group (Yoshida et al, 1991).
The highest levels of 4-quinolone clinical resistance has been observed in gyrA mutants, and E. coli 
mutants selected with NAL (at 4xMIC) demonstrated equal numbers of gyrA and gyrB mutations 
(Nakamura et al, 1989). 4-quinolone resistance resulting from changes in E. coli topoisomerases I,
III, and IV have not been shown.
1986; Hooper et al, 1987). The small increase in resistance probably results from a compensatory
Chapman & Georgopapadakou, 1988; Hirai et al, 19866; Hooper et al, 1987). It has also been
Mutations that effect 4-quinolone permeability have been identified in several bacterial species 
including, E. coli. Salmonella, Pseudomonas, Klebsiella, and Serratia (Lewin et al, 1990; Piddock
et al, 1989). This mechanism appears to be associated with alterations in the outer membrane 
porin OmpF and OmpC, proteins encoded by the ompF and ompC genes, E, coli ompF mutants
have showed a 2-fold increase in resistance to many of the hydrophilic quinolones (Chapman et al,
■
1989; Chapman & Georgopapadakou, 1988; Cohen at a/, 1988; Hirai at a/, 19866; Hooper at a/,
.-i
increase in 4-quinolone efflux through the OmpC porin (Cohen at al, 1989). In contrast, ompC 
mutants have practically no detectable change in 4-quinolone resistance (Chapman et al, 1989;
shown that both inactivation of the ompF gene and mutation in regulatory genes controlling ompF
1expression conferred resistance to 4-quinolones and unrelated antibiotics that include tetracycline, 
chloramphenicol, and cefoxitin (Hooper at al, 1986 & 1989).
The clinical frequency and expression of mutational resistance to the 4-quinolones is still 
relatively rare, although there is evidence of increased frequency in P. aeruginosa and the 
multi-resistant staphylococci (Amyes & Gemmell, 1992). However, in some respects resistant 
mutants have been found to be slower growing, temperature sensitive, and auxotrophic (Crumplin & 
Odell, 1987; Hashmi & Smith, 1991).
The mutational resistance to the 4-quinolones for Gram-positive bacteria occurs at a higher 
frequency than Gram-negative bacteria both in vivo (Humphreys & Mulivill, 1985) and in vitro 
(Reeves et al, 1984; Limb et al, 1987). Gram-positive bacteria are less susceptible to
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4-quinoIones than Gram-negative bacteria, and no impermeability mutants have been 
identified in Gram-positive bacteria. As Gram-positive bacteria lack an outer membrane, this 
would therefore contribute to reduced susceptibility and lack of impermeability mutants (Smith,
,9»>.
I
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1.1.6. The subinhibitory action of antibacterials
In the clinical environment two aspects of subinhibitory concentrations play an important role in 
the treatment of infection. Firstly, non-compliance generates subinhibitory concentrations within 
tlie human body, and secondly, the post antibiotic effect may be of clinical importance between 
doses of an antibiotic when the drug concentration may fall below the MIC for an infecting 
organism. Cessation of antibiotic therapy will also generate a post antibiotic effect and is a 
characteristic of almost all antimicrobial agents. In this instance the post antibiotic effect is the 
phenomenon of persisting suppression of bacterial growth as a result of prior antimicrobial 
exposure. It is well established 4-quinolone therapy suppresses enterobacterial counts to 
undetectable levels within two to three days (Brumfitt et al, 1984; Reeves, 1986), and after therapy 
the re-emergence of the Enterobacteriaceae may take a few days (Brumfitt, 1986). The 
relevence of subinhibitory concentrations of antibiotics is clearly dependent on the in vivo 
reproduction of in vitro effects. To study the effects of how antibiotics influence cell functions, 
such as plasmid replication, plasmid elimination, plasmid mutation, and the transfer of transposons 
from chromosomal DNA to plasmid DNA, and pigmentation reversion in S. marcescens, the 
concentration of the antibiotic or the time during which the bacterial cell is exposed to it, must be 
less than the amount required to inhibit bacterial growth. Otherwise, levels approaching MIC and 
beyond would have bactericidal effects. The 4-quinolones are known to act on DNA replication, 
the stable maintenance of plasmids, transcription, and transposition (Isberg & Svyanen, 1985; 
Reece & Maxwell, 1991), and therefore antibiotics that act at the DNA level are more important at 
subinhibitory concentrations because they have the potential to alter genetic processes.
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1.2. Genetic change in bacteria
Genetic change in bacteria can result from a number of processes including, plasmids, mutation,
recombination, transposable genetic elements
1.2.1. Bacterial plasmids
Plasmids are extrachromosomal, intracellular self-replicating covalently closed circular double- 
stranded DNA replicons. They are ubiquitous within the bacterial kingdom (Sherratt et al, 1979) 
and by definition are characterised as being dispensible to their host cells except in specialised 
environments where plasmid-encoded genes including those for antibiotic resistance or degradative
metabolic pathways confer a selective advantage. Plasmids are major vehicles for the transfer of 
genes between bacteria and this transfer plays a vital role in the evolution of bacterial populations.
Plasmids range in size from several to greater than 400 kilobase pairs. The replication time for
plasmids is short compared to the bacterial generation time, and plasmid copy number is controlled 
by the frequency of initiation of replication, which is generally imder both chromosomal and plasmid 
control (Cohen et al, 1985; Kolter & Helinski, 1979; Timmis et al, 1986). Plasmids are 
categorised as either low copy plasmids (plasmids under stringent control) including Rl, RP4 and 
F, with approximately 1-6 plasmid copies per chromosome, or multicopy plasmids (plasmids under I
relaxed control) including R6K and ColEl, with approximately 10-60 plasmid copies per
-
chromosome. Although, natural plasmids may have either a high or low copy number, it now 
appears that for low copy plasmids, their copy number is under cellular control (Sherratt, 1982).
An important property of many plasmids is their ability to be transferred between donor and
recipient bacterial cells through conjugal transfer. Self-transmissible plasmids encode genes that 
promote their transfer (tra) among Gram-negative bacteria (Sherratt, 1986). Conjugation is a 
complex process specified only by large plasmids. Small non-conjugative plasmids cannot promote 
their own conjugal transfer, but they can be effectively mobilised by utilising the conjugation 
apparatus of a co-resident conjugative plasmid. Mobilisation is dependent on the small plasmid
.
possessing both an origin of replication (orft) and the means by which it can adopt the conjugation
I
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apparatus (Sherratt, 1982; Timmis et al, 1986). Conjugal transfer in Gram-negative bacteria 
appears to be the major means for dissemination of plasmids, whereas in Gram-positive bacteria, 
both conjugation and transduction have both been described (Clewel, 1981; Sherratt, 1982),
and protoplast fusion (Timmis et al, 1986), and conjugative transposons (Thompson, 1986). 
Bacteria] phenotypes encoded by plasmid genes
65
Moreover, alternative plasmid transfer mechanisms have been reported including transformation.
B
Plasmids provide a wealth of phenotypic characters for their bacterial hosts (Table 1.1). 
Bacterial pathogenesis
It is known that plasmid determinants enable their bacterial hosts to both colonise and thrive in 
changing environments (Timmis et al, 1986). Bacterial pathogenesis is enhanced when plasmid-
encoded cell surface adhesins permit enterotoxigenic strains of E. coli to adhere to and colonise 
specific target epithelial cells of the small bowel (Van der Waajj, 1992). Plasmids are also known 
to encode both bacterial enteroinvasion and multiplication in epithelial cells which lead to epithelial 
death and mucosal ulceration (Sansonetti, 1992).
Plasmids and bacterial evolution
Plasmids are important components in the growth and survival of many bacterial populations
(Bennet & Linton, 1986). Plasmid transmissibUity, whether by conjugation or transduction,
alter bacterial evolution by increasing the gene pool, and such genetic information benefits bacteria 
which may provide advantages over their competitors.
The evolutionary potential of plasmids are determined by their transmissibility (Anderson, 1968), 
their recombination properties (Richmond & Wiedemann, 1974), and their ability to incorporate 
bacterial transposons (Hedges & Jacob, 1974). It is also known R-plasmids may arise from 
transposition, from either another plasmid or from the chromosome, to a native cryptic plasmid 
(Roberts et al, 1977). Insertion of transposable elements, involving site-specific-illegitimate
1
Table 1.1. Examples of bacterial functions encoded by plasmids
-a
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Bacterial function Reference
Resistance to antibiotics
Ap, Cm, Km, and Sm Sharp et al (1973), McHugh et al (1975)
Heavy m etal resistance
Silver McHugh at fl/(1975)
Antimony III & Arsenate/Arsenite Silvers et al (1981)
Tellurium Summers & Silvers (1978)
Colicin biosyntheses Bacquero et al (1978), Hopwood (1978), 
Sidikaro & Nomura (1975)
Sugar fermentation Shipley at a /(1978)
Phage restriction Taylor & Grant (1970)
Virulence factors Elwell & Shipley (1980), Smith & 
Linggood (1971), Woodward at al (1989)
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recombination, into either a plasmid recipient or the chromosome generate DNA rearrangements, 
and thereby facilitate both plasmid and bacterial evolution. The evolution of plasmids is thought 
to involve two different types of process (Cohen et al, 1978). Macro-evolution is an evolutionary
process that results in the insertion, deletion, or rearrangement of large segments of plasmid DNA.
An example of this is the co-integrate R-plasmids. Micro-evolution is an evolutionary process that 
leads to the insertion, deletion, or substitution of very short segments of DNA. Both these changes 
can be detected through changes in restriction endonuclease fragmentation patterns of plasmid
DNA. These two processes suggest that plasmids evolve both mechanisms. Consequently, natural
plasmids have been subjected to both these processes over a long period of time during which they
have experienced structural changes to reach their stable state (Cohen et al, 1978).
Plasmid stability
One of the most important survival characteristics of naturally occurring plasmids is their ability 
to ensure that both daughter progeny at cell division contain at least one copy of the plasmid 
(Roberts et al, 1990). Naturally occurring plasmids are usually stably inherited under nonselective 
conditions, and the existence of a replication control mechanism ensures a constant number of I
plasmid copies per chromosome are available. This provides a pool of plasmids for segregation to 
each daughter cell (Thomas, 1988). Efficient control of plasmid replication is an important
prerequisite for plasmid stability. Plasmids that are present in only a few copies per cell must 
inherit functions for active partitioning (par) or stability {stb). par and stb loci have been identified 
in several plasmids including Rl (Gerdes & Molin, 1986), F (Mori et al, 1986), and NRl (Tabuchi 
et al, 1988), Both stability functions maintain the correct distribution of plasmid copies to 
daughter progeny (Gerlitz et al, 1990) and the multimer resolution system (mrs) maximises the 
number of segregating plasmid copies at cell del vision (Williams & Thomas, 1992).
if
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I1.2.2. Mutation
Mutations are produced by several types of changes in the base sequence of DNA. Gene 
mutations can arise spontaneously or they can be induced. Spontaneous mutations occur in all cells, 
and induced mutations are produced when an organism is treated with a mutagen (Cairns et al,
1988; Cairns at a/, 1990; Davis, 1989; Drake & Baltz, 1976).
Spontaneous mutations arise through DNA replication errors: transition, transversion, frame- 
shift mutations, deletions, lesions, depurination and deamination. Induced mutagenesis can increase 
the frequency of mutations through base changes, incorporation of base analogues, specific base 
mispairing, and replication bypass after induction of racA SOS system (Ames, 1979; Hanawalt et
:al, 1979; Hunter at a/, 1986; Lindahl, 1982; Lindahl at a/, 1977; Sancar&Rupp, 1983; Sinha,
1987; Singer & Kusmierek, 1982). Spontaneous mutations in E. coli and S. marcescens are 
thought to be the result of illegitimate recombination (Sherrat, 1981; Platt at al, 1983).
Spontaneous mutation rates of E. coli is of the order 10~^ ® per base per replication, and 
spontaneous mutations that lead to gene inactivation occur at about 10“^  to 10"  ^per gene per cell 
generation (Drake, 1969; Moses & Summers, 1988). Mutations in various genes involved in SOS 
repair can reduce the rates of both spontaneous and DNA damage induced mutagenesis (Miller &
Kokjohn, 1990; Simonson at a/, 1990; Smith & Eisenstadt, 1989: Walker, 1984). Replication 
errors and spontaneous lesions are known to generate most of the base substitution and frame-shift 
mutations. Resistance to the newer 4-quinolones as result of spontaneous single-step mutation have 
been shown to occur less frequently than nalidixic acid, at 10“^  to 10"  ^^  (Chin & Neu, 1980 &
1984; Cullmann at a/, 1985; Sanders at a/, 1984).
Recombination
Homologous and site-specific recombination produce new gene combinations and several E. coli 
enzymes including those encoded by the racABC genes have been implicated (Bryant at al, 1985; 
Cunningham et al, 1979; Kowalczykowski, 1987; Nies et al, 1986). It has also been described 
that homologous, illegitimate recombination (see section 1.2.3) play an important role In plasmid
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evoluüon(Grindley& Reed, 1985; Nies eï a), 1985 & 1986; Saedlerefa/, 1981; Sherratt, 1981;
Wasserman & Cozzarelli, 1986).
i
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1.2.3. Transposition
Prokaryotic transposable genetic elements include both transposons (Tn) and insertion sequences 
(IS). They are discrete mobile DNA elements capable of translocation, at low frequency, into 
multiple target sites within recipient DNA (Kleckner, 1981; Berg, 1989), without extensive DNA 
homology (Berg & Berg, 1983; Shapiro, 1983), and in the absence of the racA gene product 
(Kopecko & Cohen, 1975).
Transposable elements introduce foreign DNA into bacteria and the genetic rearrangements 
produced have biological importance both in terms of evolution and development. IS elements and 
transposons have contributed to the evolution of bacteria and their plasmids (Haiti & Sawyer,
1988).
The central property of transposable DNA elements is their ability to insert into recipient DNA 
sequences. Integration is thought to occur through a racA-independent non-homologous 
recombination process by an element-encoded transposase (Kopecko & Cohen, 1975). This 
process is distinct from racA-mediated homologous recombination (Hedges & Jacob, 1974). 
Although, transposons are known to insert at multiple sites within recipient DNA including 
bacteriophage DNA, chromosomal and extrachromosomal DNA (Calos & Miller, 1980), their 
insertion is not entirely random (Cohen & Shapiro, 1980). It is also known that certain regions of 
recipient DNA are 'hot spots' prone to transposon insertion (Tu & Cohen, 1980). These authors 
further found T ni could be inserted preferentially into racA-independent sites demonstrating 
sequence homology within inverted repeat (IR) termini. This suggests recognition of homologous 
DNA sequences may in some way pre-determine both frequency and site-specificity of transposon- 
associated recombination.
Most prokaryotic transposons promote transposition and DNA rearrangements at frequencies of 
10’'^  to 10"  ^per generation (Kleckner, 1981) and are normal constituents of many bacterial 
genomes, plasmids, and bacteriophages. However, the frequency of transposition of Tn7 to the 
chromosomal atfTn? sites occurs at 10"^ to 1.00, and 100-fold lower to other sites (Craig, 1989; 
Kubo & Craig, 1990). Transposition frequency in a specific bacterium is determined by the
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(Schmitt, 1986). IS elements contain no detectable genes unrelated to insertion functions, and are 
compactly organised, and contain one or more structural genes, regulatory information, and 
transposition determinants (Kleckner, 1981), Examples of IS elements include IS 1, IS 10, and 
ÏS59, which differ in size, the transposition proteins they encode, the sequences at their termini, and 
the structures they form by transposition (lida et al, 1983).
number of target sites and the efficiency of transposition. Transposons can also effect change in I
both the organisation and the expression of prokaryotic genomes at frequencies comparable to 
spontaneous mutation rates (Kleckner, 1989). These changes can result through several different 
pathways including, a direct effect of transposon-mediated insertion or promoted rearrangement, 
general recombination between two copies of an element present at different locations, and DNA 
sequences may act as facilitators where illegitimate recombination and mutation processes can 
produce new regulatory signals and/or new structural gene information.
Transposable elements have three structural features in common (Shapiro, 1983):
(a) inverted repeats (IRs) of 10-40bps at their ends which flank,
(b) a central core that contains genes required for transposition, and
(c) bounded by short 4-11 bp directed repeats (DRs) of target DNA found on both sides the inserted
■element.
Transposons encode additional genes in the central core that specify a wide variety of traits that 
include resistance to antibiotics (Hedge & Jacob, 1974; Kopecko & Cohen, 1975), heavy metal 
compounds, toxins (virulence factors), and the capacity to ferment sugars or metabolise 
hydrocarbons (Cohen & Shapiro, 1980).
Insertion sequences (IS elements)
Most of the IS elements (Figure 1.8a) range in size between 700 and ISOCbp, and their termini 
carry inverted repeats (IRs) of size 10-40bp (lida et al, 1983). Inverted repeats (IRs) serve as 
recognition sequences for transposases that catalyse the fusions of their termini with target DNA
■1‘¥‘:
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Class I (compound) transposons
Class I transposons (Figure 1.8A>) were previously described as IS-like elements or composite
elements (Berg et al, 1981; Foster et al, 1981; Isberg & Syvanen, 1981) and carry resistance
determinants flanked, on either side, with an IS element (Schmitt, 1986). The constituent IS 
elements can be either direct repeats (DRs) or inverted repeats (IRs) and these elements possess 
cognate transposases for transposition function (Berg et al, 1981; Grindley & Joyce, 1981; 
Schmitt, 1986). Class I elements generate both simple conservativetranspositions and cointegrate 
structures, with simple transpositions fivefold more frequent (Berg et al, 1981 ; lida et al, 1983; 
Berg et al\ 1988). Examples of Class I transposons include TnJ and TnlO.
Class II (complex) transposons
Class II transposons (Figure 1.8c) are typified by the Tni family which are so similar in 
structure and function that a common evolutionary origin has been proposed (Casadabran et al,
1981 ; Heffron et al, 1979). Most Class II transposons are flanked by 30-40bp inverted repeats 
(IRs) rather than IS elements. The genes for transposition are encoded within the central sequence 
of the element. Class II transposons are usually 4-5kb in length or more, and most encode 
antibiotic resistance determinants. The most studied in this group is the p-lactamase (bla)- 
producing-Tni. There are two subgroups in this family, determined by interchangeable 
transposition functions. Tn5, Tni, Tn2, and TnlOOO form one group, and the other group contains
Î
I
more than ten subgroup members, including Tn2i, Tn50I, and Tnl721 (Calos & Miller, 1980; 
Grinsted et al, 1990). Class II elements give rise to cointegrate intermediates during their 
replicative transposition (Ohtsubo et al, 1981)
Other classes of transposable elements
Class III (transposing bacteriophage) transposons
Members include the two related phages Mu and D108 (Faelen et al, 1978; Hull et al, 1978; 
Kamp & Kahmann, 1981; Reisibois et al, 1981; Toussaint & Reisbois, 1983). Both use 
replicative transposition as their mechanism of vegetati VAeplicatiqa-of the phage genome during
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lytic growth (Hull et al, 1978; Kamp & Kahmann, 1981). Two Mu genes, A and B have been 
shown to directly affect Mu-mediated transposition, and both are required for physical association 
between a Mu-containing plasmid and the target bacterial chromosome following Mu induction
■
(Chaconas etal, 1981; Coeiho et al, 1981). Phage Mu transposes repeatedly during lytic growth, 
and analyses of intracellular Mu DNAs revealed cointegrates with directed repeats (DRs) of Mu
sequences (Chaconas et al, 1981). Transposition of Mu is thought to involve both replicative 
cointegrate transposition and non-replicative conservative (simple) insertion (Craigie et al, 1988;
Mizuuchi & Craigie, 1986).
Class IV (unclassified elements) transposons
There are a few transposable elements that do not fit into any of the above classes. In Gram- 
negatve bacteria, only transposon Tn7 has significantly different properties from any of the other 
elements. Tn7 transposes at high frequency to a specific chromosomal site, and with a lower 
frequency to many different sites in plasmids (Barth & Datta, 1977; Lichtenstein & Brenner, 1981 
& 1982). It has also been shown that a relatively large region of Tn7 is occupied for the 
transposition genes (Craig, 1989). Members include Tn4 and Tn(5 (Berg et al, 1975; Datta et al,
1981; Kopecko, 1980; Kopecko^ta/, 1976).
:
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Figure 1.8. General structure for (a) IS elements, (b) Class I 
transposons, and (c) Class II transposons.
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(a) IS elements, examples include IS i (768bp), ISIO (1329bp, and IS50 (1543bp).
I J
I R IR
(b) Class I transposons, examples include Tn5 (5700bp) and TnJO (9300bp).
I I
R-genes
(c) Class II transposons, examples include Tn3 (4957bp).
F i
IR R-genes Tnp-genes IR
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Transposons or pairs of insertion sequences can provide a selective advantage through the 
transposition of DNA which may encode important genes that can provide resistance to antibiotics 
and heavy metals (Berg et al, 1989). These genetic elements can also act as biological switches 
(Cohen & Shapiro, 1980) by insertional mutation which may cause, genes to become dysfunctional 
(Cohen & Shapiro, 1980; Kleckner, 1981 & 1989), activation of cryptic genes (Parker & Hall, 
1990), chromosomal rearrangements by recombination between elements (Sayre & Miller, 1991), 
and deletions by imprecise or non-specific excision (Erlich, 1989). Transposons, after transposition 
to plasmids and subsequent conjugative transfer, also achieve greater mobility (Berg, 1977; Cohen 
& Shapiro, 1980).
Factors influencing the mobility of transposable elements
Several factors have been established as important for tlie regulation of range and firequency of 
transposon mobility within bacterial !DNA and includes target site-specificity between 
different transposons. Tn7 recognises a specific target DNA sequence or hot spot' located within 
the enterobacterial chromosome (Barth et al, 1976) at the attTnl site, about 84 minutes for E. coli, 
between the phoS and g/mS genes (Gay et al, 1986; Lichteinstein & Bremner, 1981 & 1982; 
McKown et al, 1988) as the preferred target site for transposition. The target site preference for 
the singular attachment site within the chromosome of E. coli, P. aeruginosa, and K. pneumoniae 
(Lichtenstein & Bremner, 1982; Smith & Jones, 1984) is so specific that when this site is available, 
virtually all transposition events (transposition rate lO"^ -1.0 to attTnT) are directed there 
(Lichtenstein & Bremner, 1981). However, if this site is not available, transposition occurs at a 
l(X)-fold lower frequency to other secondary sites (Barth & Grinter, 1977; Barth et al, 1978;
Craig, 1989; Kubo & Craig, 1990). The transposition of other transposons, for example, Tn5 
(Berg, 1989; Lupski et al, 1984) and TnlO (Hailing & Kleckner, 1982; Kleckner et al, 1977 & 
1982), also occur at preferred target sites (transposition rate for Tn5 is 10”^ , and for TniO is 10"7 
respectively). However, insertion is more random and is not as specific as the Tn7 insertion into 
the chromosomal 'hot spot’ (Hailing & Kleckner, 1982).
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Current genetic and biochemical evidence suggests three transposition mechanisms notably 
conseivative or simple transposition, replicative transposition, and a combination of both (Berg et, 
al, 1988; Craigie & Mizuuchi, 1985; Pato, 1989).
In conservative transposition, Class I transposons (Tn5 & Tn/O) are excised and move from the 
donor site to the recipient target site. The transposon is not duplicated, and the ends of the donor 
DNA excision site (the fate of which is not precisely known) are exposed and not rejoined and may
et a/, 1983). Further evidence suggests that reconstruction of the donor replicon, known as precise
(Craigie & Kleckner, 1987). The result o f consen^ative transposition is, aMiough one copy
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act as a signal for exonucleolytic degradation (Berg et al, 1988). Loss of the donor DNA is 
prevented when cells contain duplicates of the donor sequence. Alternatively, the exposed ends may
be repaired in some imprecise manner by non-specific processes unrelated to transposition (Szostak
i
wexcision, is not dependent on transposon-encoded functions, but is promoted by host functions
1
is consumed, the other survives, and the resulting cell lineage contains one element at the
original site and a second at a new site (Berg et al, 1988).
'
In replicative transposition. Class II transposons (Tn5) are duplicated. One copy remains within 
the original donor replicon, whereas a second copy is transferred to the new recipient target site via 
a co-integrate structure that results from fusion between donor and target sites (Shapiro, 1979). 
Tire co-integrate structure becomes resolved by reciprocal site-specific recombination between the 
directly repeated transposon copies to produce (a) a target replicon with the donor sequence that is 
genetically identical to the original donor molecule, and (b) a recipient replicon which contains a 
single copy of the transposable element (Shapiro, 1979; Berg et al, 1988).
The number of transposon copies for many transposons within a bacterial ceU is regulated. For
1
example, it is known that two different control mechanisihs regulate TnJO copy number (Kleckner,
1989). The amount of transposase protein is regulated through repressors, and méthylation of 
ISJOR by dam methylase (Sayre & Miller, 1991), This involves negative feedback mechanisms, 
which reduce TnlO transposition (Simons & Kleckner, 1983). An additional mechanism
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controlling transposition of some transposons including, Tn5 and Tn7, is transposition immunity, 
which is thought to be regulated by the number of transposon copies already present in the host 
(Sayre & Miller, 1991).
The molecular size of transposable elements can influence transposition rates. Transposition 
rates for chromosomal insertion, eg. TnlO and Tn9-like elements, decrease exponentially with 
increasing transposon length (Morisato et al, 1983; Way & Kleckner, 1985).
I
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1.2.4. DNA rearrangements
A wide variety of DNA rearrangements arise through gene mutation, transposition, and 
recombination, all of wliich can lead to changes in chromosome structure. Gene mutation as 
previously described is caused by several types of change in the base sequence of DNA, including 
base substitution and deletion. However, it has been recognised that many spontaneous mutations 
are due to DNA rearrangements that exclude single base changes (Cullum & Saedler, 1981). For 
example, insertion sequences (Reif & Saedler, 1977) and transposons generate a high frequency of 
deletions, inversions, and duplications in adjacent DNA sequences (Berg et al, 1989). Transposons 
can also give rise to deletions in which, part of the element is deleted together with varying lengths 
of surrounding DNA (Grindley & Reed, 1985). Therefore, such imprecise excision events are now 
recognised as deletions or inversions that emanate from the internal ends of the IR segments of the 
transposon (Grindley & Reed, 1985).
Two novel types of DNA elements termed intégrons and shufflons have been identified as 
promoting DNA rearrangements (Hall & Stokes, 1993; Komano et al, 1986 & 1987; Kubo et al,
1988). The Incla plasmid R64 shufflon consists of 4 DNA segments and is a clustered inversion 
region and the 4 DNA segments invert either independently of in groups (Komano et al, 1990). 
Movement of this shufflon has been shown to mediate DNA rearrangments (Komano et al, 1990). 
Intégrons represent a family of DNA elements that have evolved by site-specific integration of 
discrete genes, and have been shown to confer antibiotic resistance (Bissonnette et al, 1991).
Recombination has also been shown to promote DNA rearrangements. DNA rearrangements 
have also been shown to occur when co-integrate plasmids form through fusion and recombination 
of dual repiicons (Bennett et al, 1986) which may be IS-element- or Tn-element-mediated, or 
mediated via a rccA-independent site-specific recombination (Clerget, 1984; O'Connor & Malamy, 
1984).
Many rearrangements in botli plasmid and chromosomal DNA can be detected by REFP analysis, 
and provides a means for the assessment of DNA plasticity in both laboratory and epidemiological 
investigation (Browning et n/, 1995; Rankin et nZ, 1995; Platt gr al, 1988).
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increased during nutritional (teprivation (Groat et al, 1986). In E. coli 30-50 starvation-induced 
proteins have been identified (Siegele & Kolter, 1992). It is thought the increase in their synthesis
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1,3. The biology of bacteria in stationary growth phase
Under conditions of nutritional deprivation bacterial cells spend most of their existence in a state 
where rapid growth is not possible. This state closely resembles the stationary phase of growth in a 
culture (Roszak & Colwell, 1987), and it has been recognised that changes in gene expression 
occur on depletion of essential nutrients (Groat et al, 1986). Bacterial cells in stationary phase 
use several mechanisms to maintain their 'living state’ to survive prolonged periods of starvation 
(Matin et al, 1989; Tormo et al, 1990). It is also known that metabolically active, yet non-
.1
dividing cells are maintained by many bacteria (Roszak & Colwell, 1987).
Several studies suggest the development and unusual appearance of mutations during stationary 
phase in £■. C(9//(Cairns 1988; Hall, 1988; Ryangf aZ, 1963; Shapiro, 1984). When E,coli 
enters stationary phase, changes in gene expression are regulated at the level of transcription 
(Bohannon et al, 1991). Such cells undergo both morphological and physiological changes as well 
as the ability to induce transcription of specific genes upon the onset of stationary phase (Bohannon 
et al, 1991; Siegele & Kolter, 1992). A major regulator of the starvation response has been 
dentified in E. coli and is KatF, the product of the katF gene (Lange & Hengge-Aronis, 1991 ; 
McCann et al, 1991). It is required for the synthesis of many of the proteins induced by carbon 
starvation (Siegele & Kolter, 1992). Growth phase-dependent synthesis of add phosphatase 
(Dassa et al, 1982; Touati et al, 1986)), catalase (Loewen et al, 1985), exonuclease III (Sak et al,
1989) and microcins B17 and C7 (Diaz-Guerra et al, 1989; Hemandez-Chico et al, 1986)
may involve a specific activation of transcription at the onset of stationary phase. At present, their 
individual roles in the maintenance of the viabity remain uncertain. Thus, Hie activity of certain 
genes, not essential for growth in log phase but required for survival in the absence of growth,
■
uggests the presence of essential processes unique to stationary phase (Tormo et al, 1990).
Changes in tlie negative supehelical density of chromosomal DNA has been reported in starved
■
E. coli cells (Balke & Gralla, 1987), and RNA stability has been shown to decrease. Moreover, 
20-40% of total RNA is lost during the first several hours of starvation (Mandelstam, 1960). Both 
these changes are associated with an increase in spontaneous mutation rate (Cairns et al, 1988; 
Hall, 1990 & 1991 ; Tormo et al, 1990). It is also noteworthy that while bacterial cells are in 
stationary phase they may be sporadically replicating or repairing their DNA, because in a 
nutritionally deprived state the normal SOS repair enzymes are slow to function, and errors may 
persist in newly synthesised DNA (Foster, 1992; Ninio, 1991). In fact it has been shown that upon 
transcription and translation, the ceU replicates its DNA and such mutations can become permenant 
(Rebeck & Samson, 1991). Currently, we know very little about how mutational processes 
influence the physiology of bacterial cells in different nutritional states (Foster, 1992).
This study is therefore intended to focus primarily on the subinhibitory effects of ofloxacin on 
changes in genotypic and phenotypic characters involved in the processes of plasmid stability, 
mutation and transposition, of several members of the Enterobacteriaceae imder different growth 
conditions (and in particular stationary phase cells).
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CHAPTER 2
GENERAL M ATERIALS AND METHODS
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2.2. Maintenance and storage of organisms
Initially all strains (Table 2.1) were revived from -70% and subcultured onto CLED (Oxoid) agar
2.1 General bacterial strains and plasmids
The bacterial strains and plasmids used are shown in Table 2.1. which indicates the source and 
roles of individual strains.
■aI
g
to isolate pure singles colonies and confirm lac phenotype. Antibiotic sensitivity testing (see below) 
was performed to establish the presence of appropriate resistance determinants. With the exception 
of S. marcescens GRI2677-8, all other strains (Table 2.1) were subcultured on a weekly basis and
.
4 - iStored at 4% . S. marcescens GRI 2677-8, upon revival, is pigmented and reverts to the non- 
pigmented phenotype when subcultured on a daily basis. However, with storage at 4%  GRI 
2677-8 reverts to the pigmented phenotype.
2.3. Antibacterial agents and disc diffusion sensitivity testing 
Antibacterial agents
Ofloxacin (100% potent powder) was kindly provided by Hoechst Roussel. A stock solution of 
1280ug/ml was prepared by dissolving 12.8mg ofloxacin in 0.5mis of O.IM NaOH, diluted further
with sterile distilled water and added to solid or liquid media as appropriate.
The following antibacterial agents were obtained from Sigma and incorporated into CLED agar 
(Mast) to select for E. coli K12 transconjugants at the stated concentrations: kanamycin 
(SOpg/ml), rifampicin (50(ig/ml), tetracycline (30|ig/ml), and trimethoprim (150|ig/ml).
Sensitivity testing
Antibiotic disc diffusion sensitivity testing was performed using both standard methods (National 
Committee for Clinical Laboratory Standards, 1990a & 1990Z?) and the following Oxoid antibiotic 
discs: amikacin ( lOpg), ampicillin ( 1 Opg), carbenicillin (lOOpg), cefamandole (30pg), cephazolin
(30p,g), chloramphenicol (lOpg), colistin sulphate (25pg), gentamicin (lOjXg), kanamycin (30pg),
nalidixic acid (30pg), ofloxacin (Ipg), streptomycin (lOpg), sulphmethoxazole (25gg), tetracycline 
(lOpg), tobramycin (lOpg), and trimethoprim (1.25gg).
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Table 2.1. General bacterial strains and plasmids
(a) Strains & plasmids
Plasmid Profile 
(mol wt. in kb) Source/Reference Phenotype Experimental
Role
& coli K12 J62;:7«7 - D.C lac’Tp’*pSm*‘ R" recipient
E.co/iK12J52,RP4 54 D.C. lac+Ap^Km^Tcr R^ donor
E. coli K12 J53-2 - Meynell & Datta^ lac+riP* R" recipient
E. coli K12 J62-1 - Meynell & Datta^ lac'nal** R" recipient
E. coli K12 J62-2 - Meynell & Datta^ lac'nal® R" recipient
S. marcescens GRI 2677 - Platt era /(1983) Ap^Cz^TcFCb* pigmentedparent
S. marcescens GRI 2677-8 “ Piatt era /(1983) Apï'Czï’Tcï'Cbr non-
pigmented
variant
S. typhimurium NCTC73 87 Platt era /(1988) - REFP
reference*'^
(b) Plasmids Size (kb) Properties Phenotype
RP4 54 /ncP R-plasmid Ap*'Km*'Tc*’
pOG660 87 D.C. -
pOG669 139 Co-integrate R-plasmid** Ap^ ’Km’*
pOG670 52 IncX R-plasmid^ Ap**Km**
pSLT 87 SSP^ -
^(1966), ^indigenous plasnud provided reference REFPs, ^pSLT indistinguishable from pOG660 
on the basis of Pstl, Smal, and Avail fragmentation patterns, ^139kb co-integrate R-plasmid from 
bovine strain (1985) comprised of ^ 52kb IncX R-plasmid pOG670 and "^serotype-specific plasmid 
(SSP) of Salmonella typhimurium LT2, Department Collection, D.C.
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2.4. General media 
Oxoid Isosensitest Broth and Agar
Isosensitest broth was used to culture organisms overnight and Isosensitest agar was used
(Oxoid)]. The selective medium was designed to inhibit the growth of both donor and recipient 
organisms but permit the growth of transconjugants. Either nalidixic acid or rifampicin were used 
as appropriate to inhibit the donor and the antibiotic to which resistance was being transferred, was
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for disc diffusion sensitivity testing.
Nutrient agar (Oxoid)
Nutrient agar was used for growth of organisms for plasmid DNA extraction in the determination 
of plasmid profiles using crude lysates.
Brain Heart Infusion Broth (BHI, Oxoid)
Brain Heart Infusion broth was used for growtli of organisms for DNA extraction and purification 
for REFP analysis, and for conjugation experiments.
■■■■CLED agar (Mast)
.CLED agar (Mast) was used for growth, selection of pure colonies, and maintenance of
.orgamsms.
CLED agar (Oxoid)
CLED agar (Oxoid) was used for all investigations that involved S. marcescens GRI 2677-8.
2.5. R-plasmid transfer by conjugation
Modification of the broth method of Kraft et al (1983)was used to establish R-plasmid transfer
and characterise potential transconjugants. Donor and recipient strains were grown in BHI at 37%
overnight, mixed in the ratio of 1 ;5 and an equal volume of fresh BHI broth added. After
.incubation at 37%  for various periods from 30 minutes to 24 hours potential transconjugants were
harvested from various combination antibiotic selection CLED agar plates previously inoculated
'with lOpl mating mix volumes. Uridine (lOpg/ml) was added to media that contained 
trimethoprim (Amyes & Smith, 1978) to inhibit trimethoprim antagonists [as found in CLED agar
i î
,1
incorporated to inhibit the recipient. Transconjugants were purified and tested for homogeneity of 
resistance pattern by disc diffusion sensitivity tests. Plasmid transfer was confirmed by 
demonstration of plasmid DNA in the transconjugants by agarose gel electrophoresis.
2.6. Molecular Methods
Detection of plasmid DNA
Agarose gel electrophoresis was used for the detection of plasmids (2-2CX)kb in size), in crude 
lysates of E. coli.
Plasmid DNA was extracted and separated by agarose gel electrophoresis and the molecular 
weight determined using a modification of the method of Platt & Sommerville (1981). From an 
overnight culture on Nutrient agar (Oxoid), of 12 ~ 20 colonies were suspended in 300pl of tris- 
borate buffer (89mM tris, 89mM boric acid, 1.25mM disodium EDTA, pH 8.2) in 1.5ml Eppendorf 
tubes. 200pl of sodium dodecyl sulphate (SDS) (10% w/v in tris-borate buffer) was added and the 
tubes were mixed gently by inversion. After heating at 50%  for 5 minutes the crude lysates (clear 
and viscous in appearance) were centrifuged for 15 minutes (9980g) in an Eppendorf micro- 
centrifuge to remove cellular debris. A volume of lOOpl from the supernatant was loaded on to a 
0.7% vertical agarose (Sigma, type II in tris-borate buffer) gel (15xl0x0.5cm) together with 5pi 
bromophenol blue tracking dye (sucrose 25%, 8mM sodium acetate, 3.5mM SDS, and 0.7mM 
bromophenol blue). The gels were then sealed with molten agarose. Electrophoresis was carried 
out for 1 hour at constant voltage (1(X)V) followed by 4 hours at a constant voltage of 200V. The 
gels were then stained in TES buffer (50mM Tris, 50mM sodium chloride, 5mM sodium EDTA, pH 
8.0) that contain 0 .165pM (equivalent 6.5ug/ml) ethidium bromide for 15 minutes. Plasmid DNA 
was viewed with a ultraviolet transilluminator (365nm) and photographed on Polaroid type 665 film 
using a Polaroid MP4 land camera through Kodak filters 25,12, and 2E. The molecular weights of 
plasmids was determined by comparison with control plasmids of known molecular weight: 
strain 39R861 (154kb; 67kb; 37kb; 7kb), pOG669 (139kb), RP4 (54kb), pOG670 (52kb).
86
Restriction Endonuclease Fragmentation Pattern (REFP) analysis of plasmid DNA
:
1 - Kr
Digestion of plasmid DNA with appropriate restriction endonuclease generated fragmentation 
patterns that enabled the characterisation and general degree of relatedness of plasmid DNA to be 
determined. In this study, a simple REFP strategy (Platt et al, 1986) was employed to investigate 
similarities and differences between plasmids and their change(s) through variation.
Restriction endonuclease digestion of purified plasmid DNA was performed using the method of 
Platt et al (1986). The cells from a 10ml overnight BHI broth culture were harvested through 
centrifugation at 3000 rpm for 10 minutes and resuspended in4(X)|il TGE buffer (25mM Tris, ImM 
EDTA, 50mM glucose, pH 8.0). The suspension was centrifuged in an Eppendorf micro-centrifuge 
for 20 seconds, the supernate discarded, and 200pl TGE buffer containing 5mg/ml (freshly 
prepared) lysozyme (Sigma; E.C. 3.2.1.17) was added. After vortex mixing to evenly suspend the 
cells, the tubes were incubated on ice for 5 minutes. Cells were lysed by the addition of 400|tl 
alkaline/SDS solution (freshly prepared; 1ml 2 M NaOH, 1ml 10% SDS, and 8mis sterile water) 
was added to the tubes, mixed gently by inversion until the suspension was clear and viscous. The 
mbes were incubated on ice for 5 minutes and inverted on two further occasions. 300|ll 3M sodium 
acetate was added and the tubes were mixed gently by inversion until a white precipitate formed, 
then mixed vigorously, and incubated on ice for 5 minutes. After further mixing the tubes were 
micro-centrifuged for 2 minutes, the supernate transferred to a fresh tube and 0.5ml phenol/ 
Chloroform mixture (250g phenol, 250mls chloroform, and 50mls TGE buffer) was added, mixed, 
and centrifuged for 2 minutes. The upper aqueous layer was transferred to a fresh tube and 0.5mis 
isopropanol was added. The tubes were mixed and incubated at room temperature for 1 hour. The 
tubes were then micro-centrifuged for 5 minutes, the pellet resuspended in lOOpl TE buffer (lOmM 
Tris, ImM EDTA, pH 8.0), and the incubated at room temperature for 10 minutes. 100|ri 7.5M 
ammonium acetate was added followed by 600|il ice cold 100% ethanol, and incubated at -20% 
overnight. After a 2 minute micro-centrifugation, the pellet was resuspended in 160pl TE buffer 
and 18pl heat inactivated ribonuclease A (Sigma, E.C. 3.1.27.5) was added, mixed, and the tubes 
incubated at 37%  for 30 minutes. 20pl 2.5 M sodium chloride was added, mixed, and the 
phenol/chloroform extraction, isopropanol and ice cold ethanol precipitation, and -20% overnight 
incubation steps were repeated. The purified DNA pellet was resuspended in 45pi TE buffer and
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15 pi samples were taken for restriction endonuclease digestion. The following restriction 
endonucleases were used: Avail, EcaRI, HindUl, Pstl, and Smal (Gibco BRL). The restriction 
digestion mixture contained 15|il plasmid DNA (control contained 2|xl phage lambda DNA), 2ul I:
endonuclease (equivalent 20units), 5|il xlO buffer (specific to endonuclease used), and sterile 
distilled water to a final volume of 50pl. After incubation of 1 to 4 hours at 37% (30% for SmaV)
:5 pi bromophenol blue tracking dye was added to each tube and the total contents loaded on to a 
0.8% horizontal agarose gel (15xl5x0.3cm) composed of tris-borate buffer containing 0.3pg/ml
■ethidium bromide. Following overnight electrophoresis with constant 18mA current (in tris-borate 
buffer containing 0.3pa/ml ethidium bromide), the gel was photographed as described in the 
previous section. Lane 1 of the gel contained a restriction digest of lambda phage DNA with Pstl 
which provided calibration for determination of molecular weight of plasmid DNA restriction
fragments.
The following strategy was employed to characterise plasmids through quantitative assessment of 
their fragmentation pattem(s). A minimum of 12 restriction fragments from a combination of 2 
restriction endonucleases enables the characterisation of plasmid DNA (Platt et al, 1986). Pstl was 
the primary endonuclease used, and Smal was the secondary endonuclease used if Pstl produced 6- 
20 restriction fragments. If less than 6 restriction fragments were produced using Pstl, then the 
secondary endonuclease was Avail. Alternatively, if Pstl produced more than 20 restriction 
fragments, then the secondary endonuclease was Hindlll (EcoRl was used on a few occasions).
ÎThe use of a second endonuclease refined the descrimation of molecular relatedness.
2.7. Statistical analyses
Throughout this study non-parametric method significance tests were employed as these tests 
critically test the null hypothesis where data that may not be normally distributed. Calculation of 
standard deviation, standard error, chi-squared (% )^ test for two independent samples and 
proportions (Siegel, 1956; Wardlaw 1992). Yates' continuity correction was incorporated in 
contingency tables with df>l to improve the fit between observed and expected values. Goodness 
of fit Poisson distributions were determined where;
Î
I
P(x) =
where, P = the probability of occurrence of numbers of colonies with IPPs as a function of number 
of number of IPPs per colony, u -  average number of IPPs per colony, x! = 0, I, 2 ,3 , . . .  etc, 
e = base of natural logarithm, and
r k
%^  = S  2  (Ohserved - Predicted)^ . with df = (r-l)tk-l).
1=1 j= l Predicted
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CHAPTER 3
THE EFFECTS OF SUBINHIBITORY OFLOXACIN ON THE
TRANSPOSITION OF Tn7 FROM A CHROMOSOMAL SITE 
IN E. COLI K12 TO THE INCP  PLASMID RP4.
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3.1. INTRODUCTION
3.1.1. The transposon Tn7
Tn7 belongs to the Class IV family of unclassified transposable elements (Kleckner, 1981). It is 
a 14kb element which encodes resistance to trimethoprim and the aminoglycosides streptomycin and 
spectinoraycin (Barth et al, 1976). Tn7 differs from many transposable elements in that it can
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insert at high frequency into the E. coli chromosomal anTn7 site, and insertion has been shown to
be both orientation and site specific (Barth et al, 1976; Lichtenstein & Brenner, 1981 & 1982).
..When the attUn? site is not available, Tn7 transposes at a lower frequency to many different sites 
within plasmids (Barth & Grinter, 1977; Barth et al, 1978; Craig 1989). Tn7 transposition in 
vitro requires ATP and Tn7-encoded proteins (Bainton et al, 1991 & 1993; Waddell & Craig,
1988), and it is thought Tn7 transposes via a cut and paste mechanism with Tn7 excised firom donor 
DNA through staggered double-stranded breaks, and is then inserted into attTn? by the joining of 
the 3'-Tn7 transposon ends to the 5'-target DNA ends (Bainton et al, 1991; Hagemann & Craig 
1993). Tn7 confers transposition immunity analogous to the Tn3 family, possibly through a 
mechanism that senses the state of the carrier replicon (Hauer & Shapiro, 1984). Tn7 has terminal 
IRs, but does not appear to promote co-integrate formation, and there is no evidence to indicate that 
it encodes a resoivase (Craigie et al, 1985; Grindley & Reed, 1985; Shapiro, 1983)). Tn7 encodes 
five transposition genes (Figure 3.1), msABCDE (Rogers et al, 1986; Waddell & Craig, 1988).
tnsABC provide fonctions common to all Tn7 transposition events, and genes tnsD and tnsE are •■1thought to detemune the target site (Craig, 1991; Flores et al, 1992; Orle & Crmg, 1990; Rogers 
et al, 1986; Tang et al, 1991; Waddell & Craig, 1988). It has been suggested that the gene 
products of msD (TnsD) and tnsE (TnsE) are target DNA-binding proteins (Rogers et al, 1986;
'SWaddell & Craig, 1988). TnsD is a specific DNA-binding protein that recognises both attTtû and
pseudo-artTn7 sites and is also associated with high frequency transposition, and TnE is 
a non-specific DNA-binding protein that promotes low frequency transposition (Craig, 1989; Kubo 
& Craig, 1990). It has also been speculated that TnsC plays a central role in the selection of target
Figure 3.1. Physical and genetic map of the 14kb transposon 
Tn7.
The map is calibrated in kilobases. tnsABCDE are the transposition 
genes, dhfr,, encodes trimethoprim-resistant düiydrfolate reductase 
(TpO> aadAf encodes adenyl-transferase which inactivates streptomycin 
(Sm**) and spectinomycin. The numbers give the kb coordinates of the 
recognised restriction sites. The coordinates for the Kpnl and Pstl 
internal sites are 10.2kb and 13.5kb. RE & LE denote right and left 
ends respectively. Adapted from Gosti-Testu et al, 1983; Hauer &
Shapiro, 1984; Kubo & Craig, 1990; Lichtenstein & Brenner, 1981 &
1982).
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DNA during Tn7 transposition (Gamas & Craig, 1992).
3.1.2. The effect of 4-qiiinolones on transposition
Although the primary activity of DNA gyrase inhibitors leads to inhibition of DNA synthesis, 
secondary effects include inhibition of the transposition of several transposons.
The homeostatic control of negative supercoiled DNA by the DNA topoisomerases are known to 
play a central role in bacterial metabolism through their regulation of the tertiary structure of DNA 
(Menzel & Gellert, 1983). This is essential transcription, replication, recombination (Reece &
Maxwell, 1991; Wang, 1985), and transposition. Several lines of evidence have shown that the 
topoisomerases are involved in transposition. topA mutations exert pleiotropic effects on the 
frequency of Tni transposition (Stemglanz et al, 1981). Although, these authors have further 
suggested that DNA topoisomerase I may be directly involved in Tn5 transposition, they have also 
demonstrated the frequency of TnJ transposition is not top A  dependent. Similarly, Isberg &
Syvanen (1982) have shown in vivo transposition of Tn5 requires topoisomerase activity. They 
found the DNA gyrase inhibitor, coumermycin, inhibited Tn5 transposition. Both these 
observations support the hypothesis that the degree of negative DNA superhelicity is important in 
the mechanism of transposition, since both these topoisomerases have diametrically opposite effects 
on the supercoiling of covalentiy-closed-circular- double-stranded DNA. The capacity of the 
quinolones to influence and modify genetic processes including transposition, implies a potential to
influence resistance to unrelated antimicrobial agents (Mamber et al, 1992). Where antimicrobial
:therapy is optimised for a specific infected site, subinhibitory concentrations of the agent may occur 
elsewhere in the body (Lorian & De Freitas, 1979; Lorian, 1993). Non-compliance similarly 
generates subinhibitory concentrations. Subinhibitory concentrations are known to both generate 
and potentiate the post-antibiotic effect (PAE), which occurs following limited exposure to an 
antimicrobial agent (MacKenzie & Gould, 1993), and both have been indicated to have clinical 
significance (Tanaka et al, 1989). It is also known the PAE produced following exposure to
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4-quinolones, Is dependent on the time required for 4-quinolone-disassociation from receptor binding 
sites, and the subsequent diffusion out from the bacterial cell (Fuursted, 1987).
Exposure of the commensal flora to subinhibitory concentrations of 4-quinolones may potentiate 
alteration in the location and mobility of unrelated resistance determinants (MacKenzie & Gould, 
1993). The aim of this study was therefore to determine whether exposure to subinhibitory 
ofloxacin influenced the transposition of Tn7, from a chromosomal site in E. coli K12 to the 60kb 
conjugative IncF plasmid RP4. Previous work (Barth et al, 1976; Barth & Grinter, 1977) has 
demonstrated the transposition of Tn7 to multiple sites in RP4 and this system was therefore chosen i
as a model system in which to investigate the effect of subinhibitory ofloxacin on the transposition 
ofTnZ.
s
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3.2. M ATERIALS AND M ETHODS
3.2.1. Bacterial strains and plasmids
The bacterial strains used are listed in Table 3.1 and indicates the individual strains used in 
conjugative crosses.
3.2.2. Antibacterial Agents & MIC determination
The MIC of ofloxacin for E. coli J53-2,RP4 was determined using serial dilutions of ofloxacin in 
isosensitest agar (Oxoid) (Michel-Briand, et al, 1986; Weisser & Wiedemann, 1986). A single 
subinhibitory concentration of ofloxacin (0.25MIC) was studied.
The following antimicrobial agents were incorporated into CLED (Oxoid) agar. 50pg/ml 
rifampicin with ascorbic acid 5fig/ml was used to counterselect in conjugative transfer of RP4 to 
E. coli K12 J62::Tn7. 150|iig/ml trimethoprim (Tp) was used to select transconjugants containing 
Tn7. 1 Opg/ml uridine (Sigma) was added to CLED (Oxoid) agar containing trimethoprim to inhibit 
antagonists. 30pg/ml kanamycin (Km) or 30(xg/ml tetracycline (Tc) were used separately to select 
for RP4 transfer respectively.
3.2.3. Rationale of the study
RP4 was transferred to E. coli K12 J62::Tn7 that encoded a chromosomal copy of the transposon 
Tn7. A single transconjugant colony was grown in Brain Heart Infusion (BHI) broth, divided, and 
one half exposed to subinhibitory ofloxacin (0.25MIC) (Test population), and the unexposed 
population (Control) treated in parallel. At intervals up to 120 hours, samples were taken and used 
as a plasmid donor population in crosses with either Rif & Tp to select for plasmids that had 
acquired a copy of Tn7 (RP4::Tn7) by transposition from the E. coli K12 J62::Tn7 or Rif 8c Tc to 
determine the incidence of RP4 transfer. The incidence of transposition was calculated as a 
function of RP4::Tn7 mobility relative to RP4 mobility. Tn7 insertion was confirmed by an 
increase in the molecular weight of RP4 through plasmid profiles. The resultant RP4::Tn7 
transconjugants were analysed as described below.
96
Table 3.1. Bacteria! strains and plasmids for transposition
Strain/Plasmid Phenotype Experimental Role
£;.co/iK12J62::Tn7 lac’ pSm** Tc*" Recipient for RP4 and 
chromosomal Tn7 source
E. coli K12 J53,RP4 lac+ Ap** Km** Tc** RP4 Donor to E» coli K12 
J62::Tn7
E. coli K12 K12 J53-2 lac+Rif** Recipient for RP4:;Tn7
RP4 Ap** Km^Tcr Target plasmid for Tn7
I
.1
p, partial resistance, Ap, ampicillin, Km, kanamycin, Rif, rifampicin, Sm, streptomycin, Tc, 
tetracycline, and Tp, trimethoprim. E, coli K12 J62::Tn7 was kindly provided by Hillary 
Richards.
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The above design relied on the conjugative ability of RP4::Tn7. Therefore, transposition events 
that deleted transfer functions (trar) were selected against, and thereby passed undetected.
Moreover, insertion of Tn7 into the f;/A  & B genes (Figurski et al, 1982) would render the 
resultant host non-viable, and were similarly excluded.
3.2.4. Conjugation
and recipient cells. A mating time of 90 minutes at 37°C was used to minimise retransfer, and Rif 
& Tp CLED (Oxoid) agar selection plates were inoculated with 0.1ml volumes of BHI broth
established (Guiney & Lanka, 1989). Therefore, Tn7 insertion sites were determined by
RP4 was transferred from E. coli K12 J33,RP4 to E. coli K12 J62;:Tn7using Tp & Km 
selection. 1ml samples at times 0,4, 24,48,96, and 120 hours were taken from the donor culture 
E. coli K12 J62::Tn7,RP4 in the presence and absence of 0.25MIC ofloxacin. Ofloxacin from the 
test group was removed by washing the cells three times using sterile BHI broth. RP4::Tn7 was 
then transferred to the Rif resistant strain E. coli K12 J53-2. Using Rif & Tp selection, the 
lac'^strain E. coli K12 J53-2,RP4::Tn7 was isolated. After mixing, both the donor and recipient 
populations were centrifuged together for 5 minutes at 1500rpm to enhance contact between donor
culture samples from the mating mixtures prepared at times 0,4, 24,48,96, and 120 hours. 
Comparison of Ap*", Km*, Tc*, or Tp* transconjugants estimated the incidence of Tn7 transposition 
to RP4 as RP4;:Tn7 derivatives per RP4 transconjugant during the 120 hour exposure to 
subinhibitory ofloxacin.
3.2.5. Restriction Endonuclease Fragmentation Patterns (REFP) of RP4 DNA
The modified REFP method of Kraft et al (1986) was used, and RP4 DNA was extracted and 
digested with restriction endonucleases. REFP analysis enabled the location of Tn7 insertion in 
RP4 to be determined using Kpnl & Srml and Kpnî & Pstl double digests of purified plasmid RP4 
DNA.
3.2.6. Interpretation of REFPs
Tnl has been shown to possess several internal restriction sites (Figure 3.2), and include Kpnl 
(10.2kb) and Pstl (13,5kb), and the physical, genetic, and restriction map of RP4 is well
98
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comparison of Kpnl & Smal (Tn7 does not possess an internal Smal restriction site) and Kpnl &
Pstl REFPs with wild-type RP4 DNA. Insertion sites were deduced on the basis that any wild-type 
RP4 fragment deleted indicated Tn7 insertion, and similarly for each insertion the KpnUSmal double 
digest showed two new fragments, and each KpnUPstl double digest showed 3 (inclusive of the 
3.3kb internal Tn7 fragment).
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3.3. RESULTS
The MIC of ofloxacin for E. coli K12 J53-2,RP4::Tn7 was found to be 0,128ug/ml. A total of 
312 E. coli KI2 J53-2,RP4;:Tn7 transconjugants that acquired resistance to Tp (142 test group 
and 170 control group) were examined.
3.3.1. Changes in transposition of Tn7 with time
In the early phase of the experiment (4-48 hours) the number of RP4::Tn7 derivatives increased in 
both test and control groups (Table 3.2). However, the increase in colony count was lower in the 
subinhibitory ofloxacin group, with a lower number of RP4;:Tn7 derivatives isolated.
In both test and control groups, the number of RP4::Tn7 derivatives decreased during the 48-96 
hour phase (Table 3.2) when compared to the 4-48 hour phase. The decrease in the test group was 
greater when compared to the control group.
3.3.2. RP4 transfer
The number of RP4 transconjugants increased in both test and control groups during the 4-48 
hour phase (Table 3.2), although the initial numbers of RP4 transconjugants were lower in the test 
group. In addtion, although the test group demonstrated an increase, this increase when compared 
to the the control group was lower and indicates that subinhibitory ofloxacin reduced RP4 transfer.
The number of RP4 transconjugants decreased in both test and control groups during the 48-96 
hour phase(Table 3.2). The number of RP4 transconjugants in both groups at 72 hours were 
similar, and at 96 hours the number of RP4 transconjugants in the test group was lower compared to 
the control group.
With one exception, aU transconjugants acquired a single copy of Tn7. Tn7 insertion into RP4 in 
this single transconjugant was absent, and indicates insertion into the chromosome, since Tp 
resistance was still present. No insertions were observed in either the ampicillin or kanamycin 
resistance genes. Two control transconjugants were isolated with insertions in the tetracycline 
resistance gene and this represents less than 1% of those examined.
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Table 3.2. The incidence of transposition of Tn7 from a 
chromosomal site to RP4 after exposure to 
subinhibitory ofloxacin (0.25MIC) for 4 and 
96 hours.
Time (hours) No. of RP4::Tn7 No. of RP4 Incidence of
derivatives transconjugants transposition
C 4 83 65,000 1.28 X 10-3
T 4 159 25,000 636 X 10-3
C 24 557 250,000 2.23 X 10-3
T 24 222 125,000 1.78 X 10-3
C 48 1027 480,000 2.14 X 10-3
T 48 473 340,000 1.39 X 10-3
C 72 340 116,000 2.93 X 10-3
T 72 40 100,000 4.00 X 10-^
C 96 48 100,000 4.80 X 10-4
T 96 14 50,000 2.80 X 10-4
C denotes absence of subinhibitory ofloxacin, and T denotes exposure to subinhibitory 
ofloxacin (OJ25MIC).
This is a representative sample of two separate experiments.
I
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3.3.3. The incidence of transposition of Tn7 from a chromosomal site, and
determination of location of Tn7 insertion sites in RP4 by REFP analysis
The initial incidence of transposition in the test group was 6.36 x 10"3, and 1.2% x 10"3 in the 
control group. Over the 4 - 48 hour period, the incidence of transposition in the test group 
decreased from 6.36 x 10-3 to 1.39 x 10“3, and increased in the control group from 1.27 x 10“3 to 
2.14 X 10“3 . At 48 hours, the incidence of transposition in the control group was greater than the 
test group. The incidence of transposition, in the control group at 72 hours was observed to 
increase further, and in the test group there was a one log unit decrease.
Cumulatively, over the period 4 -7 2  hours, the incidence of transposition, increased in the control 
group and decreased in the test group. At 72 - 96 hours, the incidence of transposition in the test 
group remained at approximately 10“4, and in the control group a one log unit decrease was 
observed. At 96 hours the incidence of transposition was 1.7 times greater in the control group.
Digestion of wild-type RP4 DNA with Kpnl & Smal generated 7 restriction fragments o f ,
22.2kb, 8.8kb, 8.5kb, 7.2kb, 5.8kb, 5kb, and 2kb, and Kpnl & Pstl generated 5 restriction 
fragments 27.2kb, 14.2kb, 6.8kb, 6.2kb, 2.8kb (Figure 3.2). Athough, there are two Ikb Kpnl- 
Smal fragments and four Ikb KpnhPstl fragments, they were not always observed since the REFP 
gels were run a little longer to maximise resolution of larger fi:ugments.
Kpnl-Smal RP4 fragments
RP4::r«7 DNA from 312 E. coli K12 J53-2,RP4:;Tn7 transconjugants was digested with the 
restriction endonuclease combination Kpnl & Smal. Although insertion sites, for both groups, were 
widedly distributed among these fragments (Table 3.3a & 3.3b\ most insertions occurred within the 
22.2kb Kpnl-Smal fragment, with fewer than expected insertions within the 8.5kb, 7.2kb, 5.8kb, 
and 5kb Kpnl-Smal fragments (Table 3.3). There were no observed insertions in the 8.8kb, 2kb, or 
in any of the Ikb Kpnl-Smal fragments. The incidence of Tn7 insertion within all Kpnl-Smal 
fragments varied considerably with time, and differed between test and control (Table 3.3).
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Figure 3.2. Physical map of RP4 with kb coordinates for Kpnl^ Pstl  ^
and Smal restriction sites.
The REFP map also demonstrates the sizes ofKpnl-Kpnl, 
Kpnl-Pstl, Kpnl-Smal, Pstl-PstI, and Smal-Smal RP4 
fragments respectively. Adapted from Guiney & Lanka 
(1989).
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Table 33 . The effect of subinhibitory ofloxacin (0.25MIC) on 
the insertion of Tn7 in Kpn\-Sma\ RP4 fragments.
(fl) E. coli K12 J62::Tn7,RP4 culture not exposed to 
subinhibitory ofloxacin (control group) prior to 
transfer to E. coli K12 J53-2, and 170 E, coli K12 
J53-2,RP4:;Tn7 transconjugants analysed for 
changes in Tnl insertion, and
{b) E. coli K12 J62::Tn7,RP4 culture exposed to 
subinhibitory ofloxacin (test group) prior to 
transfer to E. coli K12 J53-2, and 142 E. coli K12 
J53-2,RP4::Tn7 transconjugants analysed for 
changes in Tn7 insertion.
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(a) NO EXPOSURE TO SUBINHIBITORY OFLOXACIN (0.25MIC)
Variation in the number of Tn7 insertions in each Kpnl-Sm al RP4 
fragment over 120 hours
TIM E (HOURS)
Kpnl-Smal 
Fragment (kb) 4 24 48 96 120 n
22.2 15 16 13 14 16 74
8.8 0 0 0 0 0 0
8.5 2 4 3 10 6 25
7.2 0 2 0 1 0 3
5.8 2 8 2 4 9 25
5.0 9 9 9 11 5 43
2.0 0 0 0 0 0 0
1.0 0 0 0 0 0 0
n 28 39 27 40 36 170
I
%
.
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*
n, denotes the total number of transconjugants tested
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ib )  EXPOSURE TO SUBINHIBITORY OFLOXACIN (0.25MIC)
Variation in the number of Tn7 insertions in each Kpnl-Sm al RP4 
fragment over 120 hours
TIM E (HOURS)
Kpnl-Smal 
fragment (kb) 4 24 48 96 120 n
22.2 11 30 23 25 22 111
8.8 0 0 0 0 0 0
8.5 5 2 0 0 2 9
7.2 0 1 0 0 0 1
5.8 1 2 1 5 1 10
5.0 2 4 2 0 3 11
2.0 0 0 0 0 0 0
1.0 0 0 0 0 0 0
n 19 39 26 30 28 142
n, denotes the total number of transconjugants tested
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Distribution of Tn7 insertions in RP4
Tables 2.3a & 3.3b show changes in the distribution of Tn7 insertion in each RP4 KpnVSmû 
fragment with time. With the exception of the observed change in TnZ insertion between 4-24
hours in the 22.2kb fragment in Table 3.3b, the overall insertion of Tn7 remained relatively contant 
between 4-120 hours for each fragment. This indicates that no new transposition events occurred
ofloxacin altered the number and sites of Tn7 insertion in RP4 (as described below). 
22.2kb Kpnl-Smal RP4 fragment
s
in stationary phase and subinhibitory ofloxacin was observed not to affect the overall transposition 
of Tn7. However, subinhibitory ofloxacin was observed to increase new Tn7 transposition events 
in the 22.2kb fragment between 4-24 hours (Table 3.3b). It was also observed that subinhibitory
3"
:Table 3.4 shows that subinhibitory ofloxacin significantly increased (p<0.001) the insertion of 
Tn7 (x^39 .9  with df=l for two independent proportions) in the 22.2kb Kpnl-Smal RP4 fragment
(exposed test group of 111/142 transconjugant colonies, and unexposed control group of 74/170 
transconjugant colonies).
8.8kb KpnUSmal RP4 fragment
No Tn7insertions were observed in this fragment (Tables 3.3a & 3.3^).
83kb Kpnl-Smal RP4 fragment
Tables 3.4 shows that subinhibitory ofloxacin significantly reduced (p<0.05) the insertion of Tn7 
(X^=4.7 with dfr=l for two independent proportions) in the 8.5kb Kpnl-Smal RP4 fragment 
(exposed test group of 9/142 transconjugant colonies, and unexposed control group of 25/170 
transconjugant colonies),
7.2kb Kpnl-Smal RP4 fragment
A low incidence of Tn7 insertions was observed in both groups (test group of 1/142 
transconjugant colonies, and control group of 3/170 transconjugant colonies) Tables 3.3a & 3.3b).
■II
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5.8kb Kpnl-Smal RP4 fragment
Ikb & 2kb Kpnl-Smal RP4 fragments
No Tn7 insertions in either fragment was observed (Tables 3.3a & 33b).
Therefore, subinhibitory ofloxacin was found to significantly alter the insertion of Tn7 in the 
22.2kb, 8.5kb, 5.8kb, and 5kb Kpnl-Smal RP4 fragments.
Tn7 transposition events in the 22.2kb KpnI-Smal RP4 fragment
In stationary phase, subinhibitory ofloxacin (0.25MIC) significantly increased (p<0.05) the 
insertion of Tn7 (% ^ 3.94 for two independent samples) during the first 24 hours in the 22.2kb 
Kpnl-Smal RP4 fragment (Table 3.3b). It was also observed that no new Tn7 transposition event 
were observed in this fragment in the unexposed control group (Table 3.3a).
Kpnl-Pstl RP4 fragments
RP4::Tn7 DNA from 60 E. coli K12 J53-2,RP4::Tn7 transconjugants at 96 hours was digested 
with the restriction endonuclease combination Kpnl & Pstl. Most insertions occurred within the 
14I2kb Kpnl-Pstl RP4 fragment (19/30 in the unexposed control group and 14/30 in the exposed 
test group), and the 27.2kb Kpnl-Pstl RP4 fragment (7/30 in the unexposed control group and 
12/30 in the exposed test group) (Table 3.5). There was a lower incidence of Tn7 insertion in the 
other Kpnl-Pstl RP4 fragments. Overall, subinhibitory ofloxacin (0.25MIC) significantly
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Table 3.4 shows that subinhibitory ofloxacin significantly reduced (p<0.05) the insertion of Tn7 
(X^=3.8 with df=l for two independent proportions) in the 5.8kb Kpnl-Smal fragment (exposed test 
group of 10/142 transconjugant colonies, and unexposed control group of 25/170 transconjugant 
colonies).
5kb Kpnl-Smal RP4 fragment
Tables 3.4 shows that subinhibitory ofloxacin significantly reduced (p<0.001) the insertion of Tn7 
(X^20.5 with df=l for two independent proportions) in the 5kb Kpnl-Smal fragment (exposed test 
group of 8/142 transconjugant colonies, and unexposed control group of 43/170 transconjugant 
colonies). I
Table 3.4. Tn7 insertion in the 22.2kb, 8.5kb, 5.8kb, and S.Okb 
Kpnl-Smal RP4 fragments.
Comparison of Tn7 insertion in the presence (test 
group) and absence (control group) of subinhibitory 
ofloxacin (0.25MIC) using a chi-squared test for 
Independent proportions.
GROUP N o.ofT n7  
insertions in 
fragment
No. of insertions 
not in fragment/^
TOTAL
STATISTICS 
(df) p'
22.2kb KpnI-Smal RP4 fragment
Control 74 96 170
Test 111 31 142 39.9 1 <0.001
8.5kb KpnI-Sma RP4 fragment
Control 25 145 170 «
Test 9 133 142 4.7 1 <0.05
5.8kb KpnI-Smal RP4 fragment
Control 25 145 170
Test 10 132 142 3.8 1 <0.05
SMkb KpnI-Smal RP4 fragment
Control 43 127 170
Test 8 134 142 20.5 1 <0.001
^denotes (Total number of insertions in all fragments - Number of insertions in fragment)
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Table 3,5. The effect o f subinhibitory ofloxacin (0.25MIC) on the 
fragments from a K pnl-P stl digest at 96 houi’s.
(a) E. coli K12 J62::Tn7,RP4 culture not exposed to 
subinhibitory ofloxacin (control group) prior to 
transfer to E. coli K12 J53-2, and 30 E, coli K12 
J53-2,RP4::Tn7 transconjugants analysed for 
changes in Tn7 insertion, and
(b) E. coli K12 J62::Tn7,RP4 exposed to subinhibitory 
ofloxacin (test group) prior to transfer to & coli K12 
J53-2, and 30 E, coli K12 J53-2,RP4::Tn7 
transconjugants analysed for changes in Tn7 insertion.
NO EXPOSURE AND EXPOSURE TO SUBINHIBITORY  
OFLOXACIN (0.25MIC)
V ariation  in  the n u m b er o f  T n 7  insertions in each K p n l-P s tl  R P 4  
fragm en ts at 96 hou rs
Kpnl-Pstl Fragment (kb) (a) Control Group (No 
exposure to ofloxacin)
(b) Test Group (Exposure 
to ofloxacin)
27.2 7 12
14.2 19 14
6.8 0 1
6.2 2 3
2.8 1 0
1.0 1 0
(n) 30 30
n, denotes the total number of transconjugants tested
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increased (p<0.05) the number of Tn7 insertions ( x -2.8 with df=l for two independent 
proportions) in the 27.2kb Kpnl-Pstl RP4 fragment (Table 3.5), and insertion of Tn7 in the other 
Kpnl-Pstl RP4 fragments were not found to be significantly different from the unexposed control 
group.
Cumulatively, most Tn7 insertions (a) occurred overall within the 22.2kb & 5kb Kpnl-Smal RP4 
fragments, and subinhibitory ofloxacin (0.25MÏC ) increased insertion in the 22.2kb fragment and
insertion sites.
decreased insertion in the 5kb fragment, and (b) most insertions occurred overall at 96 hours within
.the 27.2kb & 14.2kb Kpn-jt)}i^€RP4 fragments, and subinhibitory ofloxacin (0.25MÏC) increased
insertion in the 27.2kb fragment. Insertion into the 14.2kb K pnl-^^P P 4  fragment was observed
S
to decrease in the presence of subinhibitory ofloxacin (0.25MIC), but this was not found to be 
statistically significant. Comparison of Tn7 insertion into the Kpnl-Smal & Kpnl-Pstl RP4 
fragments at 96 hours demonstrated tlmt the 22.2.kb Kpnl-Smal fragment is foimd 
within the 27.2kb Kpnl-Pstl fragment, and the 5kb Kpnl-Smal fragment was also found within the 
14.2kb Kpnl- fragment.
3,3.4. REFP analysis of Tn7 insertion
' -njKpnl-Smal RP4 fragments
The combination of Kpnl & Smal, coupled with the prior knowledge that Tn7 possessed an
internal Kpnl site, and that certain regions of RP4 were excluded on the basis that Tn7 insertion into 
the tra and f//genes would render the plasmid non-conjugative or the host non-viable respectively 
(Figure 3.3), proved useful in establishing which Kpnl & Smal fragments contained potential Tn7
IThe Kpnl & Smal combination demonstrated the location of Tn7 insertion could be identified in
.any df the Kpnl & Smal fragments. Figure 3.4 shows REFPs of KpnT-Smal RP4 DNA digests 
with Tn7insertion at 24 hours in (a) RP4;:Tn7 derivatives 1-10 not exposed to subinhibitory 
ofloxacin, and (b) RP4::Tn7 derivatives 11-20 exposed to subinhibitory ofloxacin (0.25MIC).
...
60/0
/
/
-4 5 RP4
Figure 3.3. The genetic structure of RP4 (calibrated in kb).
Abbreviations: onV  (origin of vegetative 
replication, t f f A and B (transacting replication 
functions), tra 1 , 2 & 3  (regions required for 
conjugal transfer), oriT (origin of transfer), pri 
(DNA primase), dfr (dihydrofolate reductase,
Tp’O? àla (P-lactamase, ApH, tetA (tetracycline 
resistance determinant, Tc^, tetR (Repressor 
gene), aphA (aminoglycoside 3'-phospho- 
transferase, Km*)* The dotted lines signify the 
size of the tral&2 genes are as yet unknown.
Adapted from Guiney & Lanka (1989).
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Most lanes exhibit Tn7 insertion into the 14.2kb Apnl-^m/and 27.2kb Kpnl-Pstl fragments.
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(a) Figure 3,4a [unexposed E, coli K12 J53-2J%P4::TnZ derivative group (24hours)]
Lanes 5, 6, 8,10,11, 13, and 14 exhibit insertion of Tn7 into the 22.2kb Kpnl-Smal RP4 
fragment. Lanes 5 ,6, 8, and 13 are similar with a reduction in the size of the 22.2kb fragment.
Lane 11 shows the 22.2kb fragment also to be reduced with the resultant ISkb fragment as a 
doublet, and lane 14 shows the 22.2kb fragment to increase in size, and a smaller 7kb Tn7-Æpnl- 
Smal fragment results, and lane 10 also demonstrates an increase in size of the 22.2kb fragment, 
with a resultant doubet 5kb fragment. Lane 7 demonstrates Tn7 insertion into the 8.5kb Kpnl-Smal 
fr-agment with resultant 17.9kb and 4.6kb Tn7-Kpnl-Smal RP4 fragments, lane 9 demonstrates Tn7 
insertion into the 5kb Kpnl-Smal fragment with resultant 13.5kb and 5.5kb Tn7-Kpnl-Smal
fragments, lane 12 demonstrates Tn7 insertion into the 5.8kb Kpnl-Smal firagment with resultant 
lO.Skb and 9.6kb Tn7-Kpnl-Smal fragments.
b) Figure 3.46 [exposed E, coli K12 J53-2,RP4::Tn7 derivative group (24 hours)]
,Lanes 15, 16, 18, and 19, are similar and exhibit Tn7 insertion into the 22.2kb Kpnl-Smal
fragment. Lanes 17, 20, 24 also demonstrate Tn7 insertion into the 22.2kb fragment, and 
represent a decrease in the size of the 22.2kb fragment with resultant 18kb doublet fragment. Lane
%
21 also demonstrates an increase in the size of the 22.2kb with resultant 5.5kb Tn7-Kpnl-Smal 
fragment. Lane 21 demonstrates Tn7 insertion into 5kb fragment with resultant 12.5kb and
6.0kb UnL-Kpril-Smal fragments, and; Lane Z2 so demonstrates Tn7 insertion into the 5.0kb'
fragment with resultant Tn7-Kpnl-Smal fragments of 13.5kb and 5.2kb respectively. 
Kpnl-Pstl RP4 fragments
ITnl insertion was investigated in the Kpnl-Pstl RP4 fragments in the 96 hour samples. Figure 
3.5 shows REFPs of Kpnl-Pstl RP4 DNA digests with Tn7 insertion at 96 hours with (a) RP4::Tn7 
derivatives 21-30 not exposed to subinhibitory ofloxacin, and (6) RP4::Tn7 derivatives 31-40 
exposed to subinhibitory ofloxacin (0.25MIC)..
(a) Figure 3.5a [unexposed E. coli K12 J53-2dtP4::Tn7 derivative group (96 hours)]
| ‘
Figure 3.4. REFPs o f K pnl-Sm al RF4 fragments with Tn7 
insertion at 24 hours.
(а) RP4::Tn7 derivatives 1-10 not exposed to 
subinhibitory ofloxacin (0.25MIC), and
(б) RP4::Tn7 derivatives 11-20 exposed to 
subinhibitory ofloxacin (0.25MIC).
Lanes 1 & 11 show bacteriophage X DNA 
digested with Fstl.
Lanes 2 ,3 , 4 ,16 ,17 , and 18 show wild-type 
RP4 DNA digested with Kpnl, Smal, and 
both Kpnl & Smal respectively.
Lanes 5 to 14 show RP4;:Tn7 derivatives 
1-10, and Lanes 15 to 24 show RP4::Tn7 
derivatives 11-20.
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3.4a RP4;:Tn7 derivatives(l-10, not exposed to subinhibitory ofloxacin)
1 2 3 4 5 6 7 8 91011 12 1314
*4-»:
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3.46 RP4::Tn7 derivatives (11-20, exposed to subinhibitory ofloxacin)
11 12 13 14 15 16 17 18 19 20 21 22 23 24
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ÎMnes 4,7, and 9 all show Tn7 insertion into the 27.2kb Kpnl-Pstl fragment. Lanes 5 ,6 ,8 , 10, 
11, 12, 13 all show Tn7 insertion into the 14.2kb Kpnl-Pstl with resultant 13.5kb and 1 Ikb (both
expressed as a doublet fragment) Ti\7-Kpn-Pstl fragments, and a 3.6kb TnZ-ATpnl-P^fl fragment. 
The latter new fragment contains the internal Tn7 3.3kb Kpnl-Pstl fragment. Lane 5 demonstrates 
loss of the 14.2kb Tn7-Kpnl-Pstl fragment with resultant 21.9kb, 3.6kb and 2.8kb doublet Tn7- 
Kpnl-Pstl fragments. The latter fragments have been derived from the two small Tn7 fragments 
generated from the internal Kpnl and Pstl sites (3.3kb and 0.5kb respectively). The remaining 
11. Ikb fragment (resultant from the 14.2kb Kpnl-Pstl fragment) has been inserted with the
10.2kbTn7 fragment to form the larger 21.3kb Tïû-Kpril-Pstl fragment.
(b) Figure 3Sb [Test, exposed E. coli K12 J53-2,RP4::Tn7 derivative group (96 hours) I1'
Most lanes 17-26 exhibit Tn7 insertion into the 14.2kb .RTp/^-ii^wlfragment. Lanes 17, 19, 20,
:21, 22,25, and 26 all show the same restriction patterns with resultant new 14.5kb and 3.6kb Tn7- 
Kpnl-Pstl fragments. Lane 18 is likely to demonstrate Tn7 insertion into the 6.8kb Kpnl-Pstl 
fragment (eMdence o f low DNA content and partial digestion) ' with resultant
13. Ikb fragment (in 14.2kb fragment as a doublet), 4.Ikb, and 3.6kb Tn7-Kpnl-Pstl fragments. Î
Lane 23 demonstrates Tn7 insertion into the 6.2kb Kpnl-Pstl fragment with resultant 14kb (possible 
double fragment) and 4,7kb Tn7-Kpnl-Pstl fragments respectively. Lane 24 demonstrates DNA of 
insufficient concentration to be digested.
Since no new transposition events were observed between 24-96 hours, Figures 3.4 and 3.5 were 
compared, and Tn7 insertion sites were further discriminated. In particular, the Tn7 insertion sites
in the 5kb Kpnl-Smal fragment were found to overlap with the 14.2kb KpnhKpnltsigment, and 
similarly the 22.2kb Kpnl-Smal fragment overlaps with the 27.2kb Kpnl-Pstl fragment (Figures 3.2 
& 3.3). These overlap insertions were confirmed through comparison with Kpnl-Smal & Kpnl- 
Pstl REFPs for Tn7 insertions at 96 hours (Figures 3.5 & 3.6). The 14.2kb KpnWpnîüügmeni is 
the site of both the tra3 gene and the trfA operon (Figures 3.2 & 3.3), and insertion into tliese sites
I
,would render RP4 non-conjugative and the E. coli K12 J53-2 host non-viable. These sites also 
encompass approximately half the 14.2kb iCp/iijKpnl fragment (Figure 3.3). This large fragment
'i'
.In
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also possesses oriW (lOOObp), the origin of vegetative replication and is approximately 5kb
upstream from the f/f operon. Similarly, this fragment also contains the Tc*^  gene and very few 
insertions into this resistance determinant were observed. The 22.7kb Kpnl-Pstl and 22.2kb Kpnl- 
Smal fragments both contain the tral gene and the îtfB operon (Figures 3.2 & 3.3), and similarly
Insertion into these sites would render RP4 non-conjugative and the E. coli K12 J53-2 host non- 
viable.
Therefore, the fact that the 22.2kb & 5kb Kpnl-Smal fragments overlap the 27.2kb & 14.2kb 
Kpnl-Pstl fragments, and most Tn7 insertions occurred in these fragments, indicates these regions 
to be important sites for Tn7 insertion. Figure 3.(5demonstrates Tn7 insertion sites and potential
Tn7 insertion sites within the overlap regions of both the 14.2kb K p ^^pn l mô. 5kb Kpnl-Smal
'fragments respectively.
I
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Figure 3.5. REFPs of Kpnl-Pstl RP4 fragments with Tn7 
insertion at 96 hours.
(a) RP4:;Tn7 derivatives 21-30 not exposed to 
subinhibitory ofloxacin (0.25MIC), and (6) 
RP4::Tn7 derivatives 31-40 exposed to 
subinhibitory ofloxacin (0.25MIC).
Lanes 1 & 15 show bacteriophage X digested 
with Pstl.
Lanes 3 and 16 show wild-type RP4 DNA 
digested with Kpnl & Pstl.
Lanes 4 to 13 show RP4::Tn7 derivatives 21-30, 
and Lanes 17 to 26 show RP4::Tn7 derivatives 
31-40.
All RP4::Tn7 tracks show the internal Tn7 
Kpnl-Pstl fragment
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3.5a RP4::Tn7 derivatives (21-30, not exposed to subinhibitory ofloxacin)
3 4 5 6 7 8 9 10 11 12 13
m  mw  -w "## W m
A' •f :
-•Î
120
3.56 RP4::Tn7 derivatives (31-40, exposed to subinhibitory ofloxacin)
14 15 16 17 18 19 20 21 22 23 24 25 26
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Figure 3.6. Predicted overlap region for insertion of Tn7 in the 
14.2kb I^nhKpnlfrzgmeni (red-line) and the S.Okb 
Kpnl-Smal fragment (green-line).
Each fragment is bounded by the appropriate restriction sites. 
Abbreviations: oriV  (origin of vegetative replication), Tc** 
(tetracycline resistance gene), trfA (transacting replication gene 
of unknown bp size), tra3 (third conjugal tranfer gene of unknown 
size), Tn7^ insertion into tra l gene at 21kb (Guiney & Lanka, 
1989), tra l (second conjugal transfer gene of approximately 7kb 
extending beyond the 24kb site). The dotted lin es.... signify 
potential boundaries for tra?> and t r f \  and designate genes of 
unknown size. The curved arrows labelled 1 highlight the proposed 
3.5kb region for Tn7 insertion sites. The curved arrow labelled 2 
demonstrates other potential Tn7 insertion sites within the 14.2kb 
Kpnl-Pstl fragment between the oriW and tet genes.
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3.4. DISCUSSION
Tn7 differs from other transposons in that it transposes at a higher frequency to the specific 
attTn? site within the E. coli chromosome (Lichtenstein & Brenner, 1981 & 1982), and at a lower 
frequency to multiple sites in plasmids (Barth & Grinter, 1977; Barth et aU 1978). REFP analysis 
showed significant Tn7 transposition events into the 22.2kb, 8.5kb, 5.8kb, and 5kb Kpnl-Smal RP4 
fragments (Table 3.3). Tn7 insertions were also observed in the 27.2kb and 14.2kb Kpnl-KpnJ. 
fragments, which also contain the 22.2kb and 5kb Kpnl-Smal fragments.
The transposition of Tn7 to RP4 occurred between 4 and 24 hours in the control group and 
continued to increase, albeit marginally, up to and including 72 hours, afterwhich diminution was 
observed (Table 3.2). This assumes conjugation frequency of RP4:;Tn7 transfer is the same as 
RP4 transfer and suggests that the overall number of transposable events was either maintained 
against a background of logarithmic growtli (4-48 hours) as the number of RP4 transconjugants 
continued to increase, or the replication of E. coli J62::Tn7,RP4 cells matched those cells that died. 
In other words a net equilibrium had occurred. Subsequently, this was followed by a decrease in 
stationary phase (72-96 hours) with a constant decrease in the number of RP4 transconjugants.
The overall transposition of Tn7 decreased in the presence of subinhibitory ofloxacin (0.25MIC) 
during the 120 hour period, and decreased throughout relative to the transferable plasmid. The 
number of RP4;:Tn7 derivatives and RP4 transconjugants, and therefore Tn7 transposition and 
RP4 transfer were at a lower level when compared to the unexposed control group. This suggests 
subinhibitory ofloxacin reduced the conjugal transfer of RP4, as observed in Table 3.2. The former 
supports previous findings (Gill & Iyer, 1981; Weisser & Wiedemann, 1987), that subinhibitory 
4-quinolones reduce R-plasmid transfer in E. coli, and for RP4::Tn7 derivatives to be less 
transferable suggests Tn7 insertion into the pri, tra,znd genes reduces isolation. In addition to a 
reduced RP4 transfer, there was also a corresponding reduction in the incidence of Tn7 transposition 
in the presence of subinhibitory ofloxacin. The fact that reduction in Tn7 transposition mirrors the 
reduction in RP4 transfer also supports conjugation is reduced. The incidence of Tn7 transposition 
remained at approximately 10“  ^to 10""^  during both the logarithmic and stationary phases of growth 
(Table 3.2).
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between pri and Km^ (aphA) genes mapping at 39.5-40.5 minutes (Figure 3.3). Ofloxacin was also 
observed to significantly reduce Tn7 insertion in the 8.5kb, 5.8kb, and 5kb Kpnl-Smal fragments, 
mapping at 1-8.5, 31-37, and 8.5-13.5 minutes respectively.
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Ofloxacin significantly altered the insertion of Tn7 into several regions of RP4, notably the 
22.2kb, 8.5kb, 5.8kb, and 5kb ATp«I-5waI-RP4 DNA fragments (Tables 3.3 & 3.4). Tn7 was not 
found to randomly insert into RP4 and therefore produced a diverse population of molecular 
variants of RP4::T«7. Subinhibitory ofloxacin increased Tn7 insertions within the 22.2kb Kpnl- 
Smal RP4 fragment, and these may reside within one of three potential regions. The first of these is 
within a 2-3kb region between the tifB operon and the ortV site mapping at approximately 53-57 
minutes in the RP4 molecule. The second potential region for insertion is between tral and pri 
genes, mapping at approximately 44-47 minutes. The third potential region for insertion resides
I
i
The 4-quinolones are known to influence transcription through their inhibition of DNA gyrase
activity (Lui & Wang, 1987; Sanzey, 1979; Maxwell, 1992), which interferes with the homeostatic 
mechanism of negative supercoiling of E. coli DNA (Menzel & Gellert, 1983). It is also known the 
degree of DNA supercoiling affects the regulation of gene transcription (Sanzey, 1979) and
inhibition of DNA gyrase changes the tertiary structure of DNA (Menzel & Gellert 1983). This 
would also suggest that changes in the tertiary structure of DNA, may result through reduction in 
DNA supercoiling which may lead to relaxation of plasmid DNA and separation of loops of DNA 
with different superhelical density (Reece & Maxwell, 1991). This may be consistent with the 
insertion data presented here, since several Kpnl-Smal and Kpnl-Pstl fragments have been shown to
-contain specific regions for Tn7 insertion which, through changes in their superhelical density may
unfold the tertiary structure of such local regions of RP4. Therefore, any change in RP4 DNA 
tertiary structure may either alter or expose insertion sites for Tn7. Certainly, subinhibitory 
ofloxacin increased the number of Tn7 insertions in the 22.2kb, and reduced Tn7 insertions in the 
8.5kb, 5.8kb, and 5kb Kpnl-Smal RP4 fragments. It would be tempting to speculate that these 
changes in insertion may result from alteration in RP4 DNA superhelical density which may lead to 
an increase or decrease in exposed Tn7 insertion sites. This would suggest the topology of target 
RP4 DNA is important for transposition (Berg et al, 1988)
Most Tn7 insertions were observed in the 22.2kb Kpnl-Smal RP4 fragment, and subinhibitory 
ofloxacin significantly increased Tn7 insertion into this region. This region may therefore be more 
susceptible to change in DNA superhelical density, and perhaps this region was in a higher negative 
supercoiled state prior to treatment when compared to the remainder of the RP4 molecule. 
Subsequently, subinhibititory ofloxacin may have decreased the negative supercoiled state of this 
region thereby exposing the insertion sites to Tn7. The fact that Tn7 insertion into the other Kpnl- 
Smal fragments were lower suggests the degree of negative supercoiled state may be different 
throughout the RP4 molecule. The lack of Tn7 insertion into the 8.8kb Kpnl-Smal RP4 fragment 
was expected since both the traS and î?fA genes reside in this fragment (Figure 3.3). Insertion into 
this fragment would kill the host through expression of the kil-kor regulon and prevent replication 
and stable maintenance of RP4. The fact that no Tn7 insertions were observed in this fragment 
would also suggest the tral> and tr/A genes may be contiguous. Similarly, insertion into the pri 
gene in the 22.2kb Kpnl-Smal fragment would be fatal since pri is thought to co-regulate the trfB- 
korB operon which may play an important role in tlie stable inheritance of IncF plasmids including 
RP4 (Figurski et al, 1982). Therefore, any Tn7 insertion into either of these genes would prevent 
RP4::Tn7 containing isolates. The lower incidence of Tn7 insertion into the 7.2kb Kpnl-Smal RP4 
fragment could also be explained by the fact a large component of this Augment is taken up by the 
tral gene, and any insertion would also be fatal. No insertions were observed in either the 2kb or 
Ikb Kpnl-Smal, Smal-Smal, Kpnl-Pstl, and Pstl-Pstl fragments respectively. However, two 
transconjugants lost their Tc^ which suggests insertion into the Ikb Smal-Smal fragment (Figure 
3.2). Subinhibitory ofloxacin has altered the insertion of Tn7 in several RP4 regions and this 
may be consistent with previously observed reduced frequencies of TnJ transposition in strains of E, 
coli that lack DNA gyrase (Isberg & Syvanen, 1982; Sternglanz et al, 1982). This would suggest 
that DNA gyrase is involved in the transposition mechanism of Tn7, and subinhibitory ofloxacin 
position altered both location and mobility of unrelated resistance. Therefore, these findings may 
provide a potential role for 4-quinolones in the evolution of plasmids through changes in the multiple 
insertion sites for Tn7, and subsequent effects on expression of antimicrobial resistance.
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CHAPTER 4
STABILITY AND M OLECULAR VARIATION WITHIN THE 
CO-INTEGRATE R-PLASMID pOG669.
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4.1. INTRODUCTION
4.1.1. Stable maintenance of plasmids
Naturally occurring plasmids are typically categorised as either low copy plasmids (under 
stringent control) including Rl, RP4, F, and pOG669 with approximately 1-6 plasmid copies per 
chromosome, or multicopy plasmids (under relcuced control) including R6K and ColEl with 
approximately 10-40 plasmid copies per chromosome.
Recent molecular studies have shown several co-integrate R-plasmids to form through replicon 
fusion (Bennett et al, 1986; Platt et al, 1988). These co-integrate plasmids carry two origins of 
replication (Crosa et al, 1975), and both are likely to function independently of each other. 
Similarly, these plasmids may also express dual incompatibility, and if both plasmids are self- 
transmissible then the host range would be the sum of the range of each individual plasmid. 
Three mechanisms that lead to replicon fusion through illegitimate recombination have been 
proposed and include (a) IS element-mediated replicon fusion, (b) transposon-mediated replicon 
fusions, and (c) recA-independent site-specific recombination (Bennett et al, 1986).
Studies of the maintenance of naturally occurring plasmids within bacteria have provided a much 
greater understanding of the molecular mechanisms involved in plasmid replication (Kolter & 
Helenski, 1979; Nordstrom, 1985; Uhlin & Nordstrom, 1975). However, less is understood 
concerning the partition process of low copy number plasmids. Although, the existence of par 
genes has been identified in several low copy plasmids including R1 and RP4 (Gerdes et al, 1985 & 
1986), other low copy plasmids have evolved different partition systems to ensure their stable 
inheritance including the ccd, sop, and stb loci of plasmid F (Ogura & Hiraga, 1983a & 1983^).
Several stabilisation mechanisms include: the regulation of plasmid initiation and replication 
which affects the number of plasmid copies for random distribution (Kolter & Helinski, 1979;
Moiin et al, 1979; Roberts et al, 1990; Thomas, 1988). Partition ensures the physical separation, 
and distribution of plasmid copies to daughter cells at division (Austin, 1988; Boe et al, 1987;
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Molin et al, 1979; Nordstrom & Austin, 1989; Williams & Thomas, 1992), and monomerisation 
of plasmid multimers maximises the number of plasmid copies available for segregation (Cohen et 
a l , 1985; Gerlitzeta/, 1990; Nordstrom, 1985; Roberts e ra / , 1990; Williams & Thomas,
1992). Although, plasmid replication is known to depend upon host replication functions, there is
evidence that regulation of plasmid replication, partitioning, and monomerisation are dependent on
plasmid genes as in R l, RK2, RP4 and ColEl (Gerdes et al, 1986; Gerdes & Molin, 1986; Gerlitz 
et al, 1990; Ogura & Hiraga, 1983a & 1983/?).
The par genes have been identified as a site for DNA gyrase binding in pSClOl, and appear to be 
required for its stable inheritance (Meacock & Cohen, 1980; Wahle & Komberg, 1988). The level 
of DNA supercoiling also appears to be involved with partition (Gustafsson et al, 1983; Miller et 
al, 1990), and it has been suggested that the degree of negative supercoiling of plasmid DNA leads 
to the interaction of replicated plasmids with bacterially encoded proteins and/or sites, presumably 
located on cell membranes. This is thought to assist the subsequent distribution of replicated
iï:
plasmids to daughter progeny at cell division (Miller et al, 1990) and thereby maintain minimal 
variation in plasmid copy number (Biek & Cohen, 1989; Manen^fa/, 1990; Stenzele/a/, 1987).
ISeveral different stabilisation systems seem to have evolved for low copy number plasmids to 
ensure their stable inheritance within a population of cells, exemplified by the sop and ccd loci of 
plasmid F (Ogura & Hiraga, 1983a & 19836), the parA  and parB loci of plasmid Rl (Gerdes et al,
1986; Gerdes & Molin, 1986), and the par loci of plasmids pSClOl (Meacock & Cohen, 1980;
Miller et al, 1983) and PI (Austin & Abeles, 1983).
Plasmid F has been shown to possess two stabilisation mechanisms (encoded by the sop A, -B, -C 
region and ccd A, -B genes) that operate to ensure effective segregation of plasmid molecules (Ogura 
& Hiraga, 1983a & 19836). The first of these, the sop A, -B, -C region is analogous to the 
partition function although a parB region near oriT has also been identified (Boe at al, 1987), and 
secondly, the ccdA, -B genes rescue a single copy plasmid molecule in the cell at the point of cell 
division (Ogura & Hiraga, 1983a). Cell division is thought to be blocked until plasmid replication
i
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ensures segregation of 2 daughter replicons can take place (Ogura & Hiraga, 1983a & 19836; 
Gerdes et al, 1986). The par A  locus has been shown to be the site of partition in Rl (Gerdes & 
Molin, 1986), and the parB locus of Rl has also been shown to further stabilise plasmids (Gerdes 
et al, 1986). parB is also associated with a plasmid-encoded host cell killing mechanism where 
post-segregational killing of plasmid-free cells, results in the predominance of plasmid-containing 
cells (Gerdes et al, 1986; Jaffe et al, 1985; Roberts et al, 1994). The parB locus secures the 
maintenance of segregationaUy unstable plasmids through a mechanism that involves killing of cells 
that have become plasmid-ffee which have arisen from a plasmid-bearing line (Williams & Thomas, 
1992). This selective killing of plasmid-ffee hosts provides an important survival mechanism for 
naturally occurring plasmids and ensures that each daughter progeny contains at least 1 copy of the 
plasmid (Roberts et al, 1990). parB has also been shown to influence cell growth in conditions 
when the copy number approaches 1 (Gerdes et al, 1986). The parB killing mechanism has been 
demonstrated in Rl (Gerdes et al, 1986; Gerdes, 1988; Gerdes et al, 1990a & 19906), and the 
genes hok (Aast billing) and the unstable antisense sok (suppressor of billing) are required for the 
stabilising activity of parB. Under normal circumstances the hok lethal product and sok, the 
inhibitor of hok, are finely balanced. However, overexpression of the lethal hok product has been 
shown to lead to the rapid death of hosts when the plasmid is lost (and therefore cannot provide the 
inhibitor). Similarly, overexpression of the sok product inhibits the hok mediated killing and 
therefore protects plasmid-containing hosts (Gerdes et al, 1986; Roberts et al, 1990). A 
homologous system in plasmid F has been identified as flnt or stm (Golub & Panzer, 1988; Loh et 
al, 1988). The ccd system of plasmid F also operates similarly (Bernard & Couturier, 1991; 
Hiraga et al, 1986; Tam & Kline, 1989), as does the pern killer system of RlOO (Tsuchimoto et al, 
1988). The parB locus mediates the killing of plasmid-fi-ee cells at cell division, and the killing 
factor, the hok toxic product, is a small polypeptide which is not expressed in the plasmid- 
containing cell, due to an antisense RNA-mediated translational control loop. Rapid degradation of 
this control RNA induces translation of the lethal product in the plasmid-ffee cell (Gerdes et al.
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1990a & 19906).
4.1.2. Molecular variation within plasmids
Selection pressure acts on bacterial populations to favour the emergence of genetic variants and 
the effect of the genetic change may or may not be evident in the observable phenotype. Plasmids 
play an important role in bacterial reproduction and evolution (Helling et al, 1981) and any change 
through genetic variation may be the result of rearrangement through, transposition, deletion, and 
insertion of foreign DNA and contribute to molecular variation and subsequent evolution (Cohen et 
al, 1978). Furthermore, exposure to different selection pressures may increase the diversity of 
plasmids through changes in, plasmid mobility (Platt et al, 1987; Platt & Black, 1987), and 
molecular divergence, which may lead to DNA rearrangements (Cuilum & Saedler, 1981), and 
plasmid elimination (Platt & Black, 1987). DNA rearrangements contribute to the molecular 
variation in plasmids and molecular variants of the serotype-specific plasmid (SSP) of Salmonella 
typhimuriiim, pOG660, have been demonstrated by REFP analysis (Platt et al, 1988). One such 
variant, the R-plasmid pOG669, was first recognised during a veterinary outbreak of salmonellosis, 
and was also found to be a natural co-integrate of pOG660 and the R-plasmid pOG670, both from 
two different S. typhimuriiim isolates (Platt et al, 1988).
Previous characterisation of pOG669 as a co-integrate derived from analysis of REFPs 
after digestion with Pstl and Smal, and consistent with co-integrate formation, was the recognition 
of new restriction fragments that represented the co-integrate junctions. For Pstl these fragments 
were 4.7kb and 2, Ikb, and for Smal these fragments were 7kb and 2.2kb respectively.
Previous observations suggested that the pOG669 in a E. coli K12 nal^ host underwent deletion on 
storage (D. J. Platt, personal commimication). Therefore, the aim of this part of the study was to 
extend these observations and to investigate the subinhibitory effects of ofloxacin on the (1) stability 
of the co-integrate R-plasmid pOG669, and (2) on molecular variation, and (3) to investigate the 
role of deletion on both molecular variation and expression of antibiotic resistance of pOG669.
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4.2. M ATERIALS AND M ETHODS
î
I4.2.1. Bacterial strains and plasmids
The bacterial strains and plasmids used are listed in Table 4.1 together with a summary of their 
characteristics.
4.2.2. Revival of stored organisms
4.2.3. Rationale of the study
A single E. coli K12 J62-1, pOG669 colony was used to inoculate lOmls of isosensitest broth
(1) The E, coli K12 J62-1 [lac", pro", his~,trp", nal^] was used as the recipient strain for the 
R-plasmid pOG669.
(2) Salmonella typhimurium NCTC 73, pOG660 was obtained from the National Collection of 
Type Cultures, and was used to provide reference restriction endonuclease fragment patterns 
(Platt etal, 1988)
(3) & coli K12 J53-2 [pro", met", riff] was used as the recipient strain for the R-plasmid pOG670 
that specified Ap & Km resistance.
I-
Bacterial strains (Table 4.1) were revived from -70^C, subcultured onto CLED agar (Oxoid) and 
tlie appropriate phenotypes were confirmed together with antibiotic senstivity patterns by standard 
methods.
The stability of the natural co-integrate R-plasmid pOG669 was studied in E. coli K12 J62-1 
under different growth conditions either in the presence or absence of subinhibitory ofloxacin 
(0.25MIC). j;
(Oxoid) and incubated at 37°C overnight for 18 hours. From this E. coli K12 J62-1, pOG669 
culture, lOOjjJs was individually added to each o f six universal bottles containing lOinls fresh 
isosensitest broth with or without 0.25MIC ofloxacin, and labelled cultures A-F.
Culture A (designated SOF*^: stationary phase culture with 0.25MIC ofloxacin)
-'s.:
lOmls of isosensitest broth containing 0.5jxg/ml ofloxacin (equivalent to 0.25MIC) was maintained
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Table 4.1. Bacterial strains and plasmids for molecular variation study
Plasmid Profile Resistance
Host Organism (mol. wt In kb) Plasmid Designation Determinants Plasmid Origin
E, coli K12 
J62-1
J53-2
S. typhimurium 
NCTC73
139
52
POG669Û
pOG670^
ApKm
ApKm IncX R-plasmid
87 pOG660<^ Serotype specific 
plasmid (SSP)
••
%
^isolated from bovine strains in 1985, ^IncX R-plasmid isolated from bovine strains in 
1985, ^indigenous plasmid pOG660.
'.ïS:
«
J:
I
:
'■f
I
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%Culture E (designated RSOF+: repeated subculture with 0.25MIC ofloxacin)
at 37%  for 24 hours. This culture was repeatedly subcultured daily for the first week with 20pls 
taken and used to inoculate lOmls of fresh isosensitest broth and incubated at 37%.
■f
f
in stationary phase at 37%  for 8 weeks.
Culture B (designated SOF’: stationary phase culture without ofloxacin)
lOmls of isosensitest broth was maintained in stationary phase at 37%  for 8 weeks.
Culture C (designated MSOF+: maintenance subculture m th  025M1C ofloxacin)
lOmls of isosensitest broth containing 0.5pg/ml ofloxacin (equivalent to 0.25MIC) was maintained 
at 37%  through serial passage. After 48 hours the 10ml culture was centrifuged at 3K rpm for 5 
minutes, the cells were resuspended in lOmls fresh isosensitest broth containing 0.5pg/ml ofloxacin, 
and re-incubated at 37® C. This procedure was repeated every 48 hours for the duration of the 8 
week smdy.
■5;
:Culture D (designated MSOF": maintenance subculture without ofloxacin)
lOmIs of isosensitest broth was maintained at 37%  through serial passage. After 48 hours the 
10ml culture was centrifuged at 3K rpm for 5 minutes, the cells were resuspended in lOmls fresh 
isosensitest broth, and re-incubated at 37%. This procedure was repeated daily for tlie duration of 
the 8 week study.
V
lOmls of isosensitest broth containing 0.5|ig/ml ofloxacin (equivalent to 0.25MIC) was incubated
a
Ï
I
Culture F (designated RSOF“: repeated subculture without ofloxacin)
lOmls of isosensitest broth was incubated at 37%  for 24 hours. This culture was repeatedly 
subcultures daily for the first week with 20pls taken and used to inoculate lOmls of fresh sosensitest 
broth and incubated at 37®C.
4.2.4. Sampling
Samples were taken daily from the RSOF^ and RSOF" cultures, every second day from the
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Purified pOG669 DNA was initially digested with Pstl, and the number of fragments generated 
determined which additional restriction enzymes were likely to provide optimal fingerprints. Avail 
was the second enzyme used to fizrther characterise DNA rearrangements. The production of a 
wide range of restriction fragments enabled adequate specificity.
I  1
MSOF+ and MSOF" cultures, and weekly from the SOF^ and SOF" cultures. One loopful of 
each culture was spread onto CLED agar. From each CLED plate, 50 single colonies were tested 
for Ap & Km sensitivities. An additional 50 colonies were tested for Ap & Km sensitivities on 
days 3 and 5 for both the RSOF groups. Any colony that demonstrated variation in resistance 
pattem(s) was subjected to plasmid analysis as described below.
4.2.5. Plasmid profile analysis
When variation in either Ap & Km sensitivity was observed, the colony was subjected to plasmid 
profile analysis using a modified method of Platt & Sommerville (1981). pOG669 DNA was 
obtained from crude lysates, separated by agarose gel electrophoresis, and the molecular weight 
determined through comparison with plasmids of known molecular weight. This method
was used to identify any gross change in plasmid size and/or any evidence of plasmid elimination.
4.2.6. pOG669 DNA restriction endonuclease fragment patterns
All variants In Ap & Km sensitivities were subjected to DNA restriction endonuclease 
fragmentation patterns (REFP), as previously described (Platt et al, 1986). This technique enabled
detection of DNA rearrangement(s). The restriction endonucleases used were Pstl and Avail. I
I
4.2.7. Interpretation of REFPs
pOG669 possesses two co-integrate junctions (Platt et al, 1988), and the use of Pstl and Avail
:provided evidence of DNA rearrangments that occurred within pOG669. Furthermore, any 
rearrangements that occurred within or adjacent to the co-integrate junctions were readily identified.
Smal, Hindlll and EcoBl refined DNA discrimination further. DNA rearrangements were 
determined with comparison of restriction fragment patterns observed with wild-type pOG669
» .
f
a
1
' ï
1.
a
DNA. DNA rearrangements observed within pOG669 were also assessed in comparison with 
pOG660 and pOG670 REFPs.
Ï
Ï
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4.3. RESULTS
4.3.1. Variation of Ap & Km phenotype
A total of 2200 E. coli K12 J62-1, pOG669 colonies isolated from cultures A-F were tested for 
susceptibility to Ap & Km. The parental Ap^Km^ phenotype was shown in 1063 colonies. Three 
variant phenotypes were observed and included Ap^Km^ (421 colonies), Ap^Km^ [(36 colonies), 
kanamycin sensitive variant (KSV)]. The third variant was more complex. When disc sensivity 
tests were carried out on individual colonies, evidence of a mixed population was identified. This 
was observed where the region aroimd the Ap & Km discs showed a more sparse growth of colonies 
than the semiconfluent growth on the remainder of the plate. This is shown in Figures 4.1 & 4.2 
and is referred to as the mixed population variant (MPV), and these phenotypes were seen in 480 
colonies, and is described in more detail in 4.3.1(c).
Figure 4.3 shows phenotypic changes in all populations with time. The parental Ap^Km^ 
phenotype decreased from 1800 plasmid-containing colonies to just over 1063 colonies (the 400 
repeated subculture colonies were not included because they would increase the total number of 
plasmid-free colonies before week 2 when elimination occurred in the stationary phase and 
maintenance subculture). The number of plasmid-free colonies progressively increased from 0 to 
421, and the number of colonies that exhibited the MPV phenotype also progressively increased 
from 0 to 480. The number of KSV colonies increased, but at a much lower level (0 to36 colonies). 
The distribution of each phenotype within cultures A-F are described below.
(a) Ap®Km® phenotype
Overall, 421 E. coli K12 J62-1 colonies [wild-type parent contained pOG669] demonstrated 
sensitivity to both Ap & Km. Plasmid profiles confirmed in all instances that loss of both Ap & Km 
resistance was a result of loss of pOG669 (Table 4.2). This represented a frequency for plasmid 
loss of 421 in 2200; Plasmid loss was significantly greater (p<0.001) in the SOF+group (121/450 
colonies) compared to the SOF", group (94/450 colonies) (%^=20.7 with dfr=3 for two independent
137
Figure 4.1. Mixed population with E. coli K12 J62-1, pOG669- ApfKmr and E. coli K12 J62-1, pOG669-ApSKmS.
This mixed population variant was designated MPVl.
138
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% :
Figure 4.2. Mixed population with E. coli K12 J62-1, pOG669- AprKmS and E, coli K12 J62-1, pOG669-ApSKmS.
This mixed population variant was designated MPV2.
139
Figure 4.3. Population phenotype changes with time.
Total ApHCmï* (R+), ApSKmS (R ), MPV, and 
KSV colonies were counted.
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samples) (Figure 4.4a). In contrast, plasmid loss was significantly greater (p<0.01) in the MSOF" 
group (71/450 colonies) compared to the MSOF+group (45/450 colonies) (%^=11.2 with df=3 for 
two independent samples) (Figure AAb). Although, plasmid elimination increased with time for 
both stationary phase and maintenance subcultures, the number of colonies that exhibited plasmid 
loss was however greater in the stationary phase. Table 4.2 and Figures 4.5a, 4.5b, and 4.5c also 
show differences in the elimination of pOG669.
I. Stationary phase and maintenance subculture groups (Figures 4Sa & 4.5b)
(a) Cultures in stationary phase, in the presence and absence of subinhibitory ofloxacin, showed a 
progressive increase in plasmid elimination (Figure 4.4a). The increase between week 2 and week 
4 was higher in the SOF“group, when compared to the SOF^group. However, after week 4 the 
increase in plasmid elimination in the SOF^group was greater than in the SOF" group. The rate of 
plasmid elimination in the SOF^group continued to increase, whereas in the SOF" group plasmid 
loss continued at a constant rate. Thus, in stationary phase cultures, subinhibitory ofloxacin not 
only increased overall plasmid elimination, but also increased the rate of plasmid elimination.
(b) Cultures in maintenance subculture in the presence and absence of subinhibitory ofloxacin, 
the pattern of plasmid elimination was different. There was an overall increase in plasmid 
elimination in both groups (Figure 4.4b). In the MSOF^group, plasmid elimination was not 
observed to occur until week 4, and had increased by week 8, whereas in the MSOF'group, plasmid 
elimination was observed to occur at week 2, and increased more by week 8 than that observed in 
the MSOF^group. The rate of plasmid elimination in the MSOF" group continued to increase, 
whereas in the MSOF"group plasmid loss continued at a constant. Thus, in maintenance 
subcultures, subinhibitory ofloxacin reduced the rate of plasmid elimination.
Plasmid elimination was greater in stationary phase in the presence of subinhibitory ofloxacin 
(SOF^group) with 80% of the overall colonies tested having lost pOG669, and lower in the 
maintenance phase (MSOF^group) with 28% of the overall colonies tested having lost pOG669.
144
Figure 4.4. Plasmid elimination from E. coli K12 J62-1 colonies in 
stationary phasej maintenance, and repeated subculture.
The effects of subinhibitory ofloxacin (0.25MIC) was 
investigated in each phase. 50 colonies for each culture 
group per week were tested for Ap & Km susceptibility, 
and those colonies that showed Ap^Km®, were tested for 
plasmid profile.
(fl) Stationary phase: 121 SOF+coIonles and 94 SOF“ 
colonies showed pOG669 elimination, and
{b) Maintenance subculture: 45 MSOF+colonies and 71 
MSOF"colonies showed pOG669 elimination.
(c) Repeated subculture: 50 RSOF+colonies and 40 
RSOF"colonies showed pOG669 elimination.
■ - ■ with subinhibitory ofloxacin (0.25MIC) 
□ - □ without subinhibitory ofloxacin
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to that in stationary phase, by a reduction in plasmid elimination.
Although, plasmid elimination in the absence of ofloxacin (SOF'and MSOF"groups) demonstrated 
certain similarities in that end-stage elimination at week 8 was very similar. However, in 
maintenance subculture the effect of subinhibitory ofloxacin produced the opposite effect compared
i
II. Repeated subculture (RSOF+and RSOF") groups (Figure 4.4c)
In both groups, elimination of pOG669 was observed (Table 4.2), with 100% elimination in the 
50 RSOF^colonies after week I, and 80% elimination in the 50 RSOF"colonies after week 2, with 
the remaining 20% (equivalent to 10 colonies) showed Ap^Km® (on days 3 and 5,50 additional
colonies tested for Ap & Km susceptibility, showed approximate overall 50% plasmid elimination in 
repeated subculture for these days). The growth of these cultures was stopped after 7 days on tlie 
basis that almost complete elimination of pOG669 was observed. In a replicate experiment, 
complete elimination of pOG669 was observed from aU colonies in both groups after the 7 days.
(b) Ap^Km  ^phenotype (KSV)
36 kanamycin sensitive variants were isolated. 26 KSV colonies were isolated in stationary 
phase between weeks 2 and 8 (Table 4.3). 10 KSV colonies were isolated from the RSOF'group. 
Plasmid profile analysis showed all KSV isolates to harbour between 10 and 15kb reduction in size 
compared to wild-type pOG669. Thus, this phenotype was not a result of transposition of 
ampicillin resistance to the chromosome with the subsequent elimination of pOG669.
Overall, in stationary phase, subinhibitory ofloxacin increased the incidence of KSV 
(SOF+group 16 of 36, SOF'group 10 of 36). However, tliis was found not to be statistically
■
significant. 10 of 36 KSV were isolated from the RSOF~group, and represents a frequency for 
KSV in the RSOF'group as 10 in 200). No KSV were isolated from the RSGF"^group.
(c) Mixed population variant (MPV)
MPV colonies were first identified on Ap & Km susceptibility tests on isosensitest agar (Oxoid).
On isosensitest agar plates there was evidence of a mixed population around both Ap and Km discs
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Table 4,3. The distribution of Ap**KmS variants (KSV) isolated 
from stationary phase and repeated subculture in the 
presence or absence of subinhibitory ofloxacin 
0.25MIC),
Culture Group Week isolated Number of KSV colonies isolated
Stationary phase
SOF+ 2 3
SOF+ 4 5
SOF- 5 7
SOF+ 6 5
SOF+ 7 3
SOF- 8 3
Repeated subculture phase
RSOF" 1 10
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(Figures 4.1 & 4.2). Figure 4.1 shows a mixed population with E. coli K12 J62-1, pOG669- 
Ap^Km^ and E. coli K12, pOG669-ApSKm^, and Figure 4.2 shows a mixed population with E. coli 
K12 J62-1, pOG669-Ap^Km^ and E. coli K12 J62-1, pOG669-Ap®Km®. The development of 
mixed plasmid phenotypes, either as Ap^Km^ and ApSKm®, or Ap^Km^ and Ap^Km® produced two 
E. coli K12 J62-1 variant populations, MPVl and MPV2 respectively. Overall, it was observed 
that for MPV, 50% were plasmid-containing and 50% were plasmid-free.
This anomaly was an unexpected phenomenon since the original wild-type E. coli K12 J62-1
■contained the plasmid pOG669. Both MPVl and MPV2 populations could only have developed on 
CLED purity plates, since they were observed at the same time when changes in antibiotic resistance 
became apparent at week 2 (Figure 4.3). It is likely that cells at week 2, when sampled from the 
stationary phase cultures A & B, and maintenance phase cultures C & D onto CLED purity plates, 
were in an unusual state in that single colonies on CLED agar (Oxoid) were composed of half the 
cells plasmid-containing, and the other half were plasmid-free. These ceils then actively grew from
a state of nutrient deprivation to a state of active growth on fresh nutrients (CLED agar), and 
thereby generate 2 cell types in each colony. This represents either a change in genotypic or 
phenotypic character of both host and/or plasmid, and for the plasmid-free state to occur, pOG669 
must not have partitioned. 50 SOF"*"and SOF" inter-zonal colonies (IZC) (Figure 4.5) from week 5 
were further tested for Ap & Km susceptibility, and the population was curiously found to contain 
ail three phenotypes (Table 4.4). Notably, the generation of MPV from IZC colonies were de novo.
Table 4.4 also shows that for SOF+, the prevalence of Ap^Km^>Ap^Km^>MPV>KSV, and for 
SOF", the prevalence of Ap^Km^>Ap^Km^>MPV (no KSV colonies were detected). These results
show that in stationary phase subinhibitory ofloxacin reduced the number of resistant colonies, 
increased the number of plasmid-free colonies, and increased both MPV and KSV colonies. 
Confirmation of whether a genotypic or phenotypic change accounted for the generation of MPV 
colonies was detemuned with conjugative transfer of (a) transitional pOG669 (MPVl donor with
resident pOG669) into wild-type E. coli K12 J53-2 recipient, and re-transfer into transistional
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IZC
Figure 4.5. Inter-zonal E, coli K12 J62-1 colonies (IZC) within ampicillin (Ap) zone.
A mixed population of either M PVl or MPV2 was 
prevalent outside zone (A & B). Inside box, 1 of 50 
colonies was taken for further Ap & Km susceptibility (X).
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Table 4.4. The effect of subinhibitory ofloxacin (0.25MIC) onthe prevalence of Ap^Knii*, ApSKmS, MPV, and KSV colonies from single IZC in stationary phase.
PHENOTYPES (No. colonies tested)
i
. . . .
Culture Groupé Ap*Km** ApSKm^ MPV KSV
SOF+ 17 2 1 S 4
SOF- 29 17 4 ND
-§
^isolates from week 5 (SOF+and SOF" groups). ND, none detected. 
MSOF colonies not tested.
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E. coli K12 J62-1 recipient (pOG669 previously lost in plasmid elimination experiment as described 
below), and (b) wild-type pOG669 (£. coli K12 J53-2 donor) into transitional & coli K12 J62-1
recipient (pOG669 previously lost in plasmid elimination experiment as described below). No 
MPV colonies were detected in any of the transconjugants (on basis of no mixed population growth 
with Ap & Km susceptibility). This indicates the generation of MPV colonies is a phenotypic 
character.
480 MPV colonies were isolated. Their distribution over the sampling period is shown in Table 
4.5) and illustrated in Figures 4.6a & 4.6b. MPV were isolated more significantly .i from 
maintenance subcultures (294/450 colonies) as compared to stationary phase cultures (186/450 
colonies) (%^=53.0 with df=l for two independent proportions). This indicates that in dividing 
cells (MSOF groups) MPV are more prevalent and/or in non-dividing cells MPV are less 
prevalent. These differences therefore indicate preferential is involved with the generation of 
MPVs. Table 4.5 and Figures 4.6a & 4.6b also show differences in MPV occurrence. In both 
groups the effect of subinhibitory ofloxacin on the generation of MPV was not statistically
Msignificant (p>0.1) (Table 4.5). No MPV colonies were detected in either of the RSOF groups.
Although not statistically significant the overall pattern of MPV colony production was different 
between the SOF*  ^and SOF" groups (Table 4.5 and Figure 4.6a). Figure 4.6a also shows that for 
both groups the incidence of MPV colonies increased with time. At week 2 the number of MPV 
colonies in the SOF~ group was just over three-fold lower when compared to the SOF“^ group. From 
weeks 2 to 4 the number of MPV colonies increased six-fold in the SOF'group and marginally 
decreased in the SOF'^group. Thus, in stationary phase cultures, subinhibitory ofloxacin reduced 
the overall incidence of MPV production. In maintenance subcultures the number of MPV 
colonies increased in parallel in both groups with time (Figure 4.6b).
%
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Table 4.5. The distribution of mixed population variant (MPV) 
prevalence in E, coli K12 J62-1 colonies isolated 
from stationary phase and maintenance subculture 
in the presence or absence of subinhibitory 
ofloxacin (0.25MIC).
WEEKS
STATISTICS
Culture group 0 1 2 3 4 5 6 7 8 n X2 (df) p'
Stationary phase
SOF+ 0 0 11 10 8 10 14 16 16 85 4.1 (3) >0.1
SOF“ 0 0 3 9 17 17 18 19 18 101
Maintenance subculture
MSOF+ 0 0 1 16 21 23 25 26 27 139 1.8 (3) >0.1
MSOF- 0 0 2 16 25 27 28 28 29 155
155
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Figure 4.6. Incidence of mixed population variants (MPV) in E, co li  
K12 J62-1 colonies from stationary phase and maintenance 
subculture,
The effects of subinhibitory ofloxacin (0.25MIC was 
investigated in both groups. Each week 50 colonies 
were tested for Ap & Km susceptibility, and any 
colony that exhibited mixed population with pOG669 
expressing ApHCm^ & Ap®Km®, or ApHCm® &
Ap^KmS, were designated M PVl and MPV2 
respectively.
(fl) Stationary phase: 85 SOF+and 101 SOF* 
colonies showed occurrence of MPV, and
(b) Maintenance phase: 139 POF+ and 155 
PCF* colonies showed occurrence of MPV.
■ - ■ with subinhibitory ofloxacin (0.25MIC) 
□ - o  without subinhibitory ofloxacin
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%4.3,2. Co-integrate junctional DNA rearrangements and characterisation of 
kanamycin sensitive variants (KSV) by REFP analysis
Figure 4.7 shows Pstl, Avail, and Smal fragmentation patterns of the co-integrate plasmid 
pOG669, together with those of pOG670 and pSLT, from which it is derived. The co-integrate 
junctions observed through comparison of each plasmid with each endonuclease are marked by
arrows. pOG669 possesses 2 Pstl junctional fragments of 4.7kb and 2.1kb, 2 Smal junctional 
fragments of 7kb and 2.2kb, and to date, only 1 Avail junctional fragment of 3.9kb has been
resolved. The fragmentation patterns in Figure 4.7 provided reference fragmentation patterns for 
pOG669, pOG670, and pOG660. This enabled identification of DNA rearrangements that occur
,
within or close to co-junctional fragments, and in which component of pOG669 (either pOG670 
and/or pSLT).
The plasmids in the KSVs were characterised further using REFP analysis and are shown in 
Figures 4.S-4.9 for Pstl, and Avail respectively. pOG669 DNA from E. coli K12 J62-1, [pOG669 
- Ap^Km® variants (KSV) was extracted, purified, and digested with the previously described 
restriction endonucleases, and changes in fragmentation pattern were observed when compared to 
wild-type pOG669 DNA.
S:
1. Pstl fragmentation patterns (Figures 4.8 & 4.10)
:(a) 4 fragment deletions of 4.7kb, 4.1 kb, 2.3kb, and 1. 8kb were deleted in all of the KSV colonies.
(b) 3 additional deletions were observed in KSV colonies 1, 3 ,5 ,7 , and 8 respectively.
( i) deletion of a 6.8kb fragment, which was observed as a doublet fragment in wild-type 
pOG669 DNA, and 
( ii) deletions of 1.6kb and 1.4kb fragments was also observed in these variants.
(iii) KSV 3 also shows deletion in the 9.5kb fragment. - -
2. Avail fragmentation patterns (Figures 4.9 & 4.10)
(a) 2 fragments of 4.1 kb and 3.6kb were deleted in all of the KSV colonies.
i::
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Figure 4.7. pOG669, pOG670, and pOG660 digested with Pstly 
Smaly and Avail.
Tracks 1 and 2, Bacteriophage X digested with Pstl 
and Smal, Tracks 3,6, and 9, show pOG670 digested 
with Pstl, Smal, and Avail, Tracks 4, 7, and 10, show 
pOG669 digested with Pstl, Smal, and Avail 
respectively. Tracks 5,8, and 11, show pOG660 
digested with Pstl, Smal, and Avail respectively.
The arrows illustrate the junctional fragments with 
Pstl (4.7kb and 2.1kb), Smal (7kb and 2.2kb), and 
Avan (3.9kb).
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Figure 4.8. Kanamycin sensitive variants (KSV) 1 to 7 digested 
with Pstl.
Track 1, Bacteriophage X digested with Pstl, Track 2, 
shows wild-type pOG669 digested with Pstl, Tracks 3 
to 9, show KSV 1 to 7 digested with Pstl. KSV 8 
digested with Pstl is shown in Figure 4.9 Track 12.
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Figure 4.9. Kanamycin sensitive variants (KSV) 1 to 8 digested 
with Avail.
Tracks 1 and 2, Bacteriophage A. digested with Pstl and 
Avan, Track 3, shows wild-type pOG669 digested with 
Avan, Tracks 4 to 11, show KSV 1-8 digested with 
Avan. Track 12, shows KSV 8 digested with Pstl.
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Figure 4.10. Computer generated REFP library for 
E. coli K12 J62-l,pOG669 kanamycin 
sensitive variants (KSV) 1 to 36 using 
Pstl, and Avail.
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(b) 2 additional fragment deletions were observed in KSV 1, 3,5, 7, and 8 respectively.
( i) deletion of a 3.1 kb fragment, which is the largest fragment of tliree grouped fragments as 
as observed in wild-type pOG669 DNA, and 
(ii) deletion of the 2.8kb fragment was also observed in these variants.
KSV colonies 9-36
The Pstl and Avail fragmentation patterns observed for this group of KSV colonies are shown in 
Figure 4,10. KSV 9-27 were isolated from statioTiary phase cultures, and KSV 28-36 were 
isolated from repeated subcultures. All were similar to fragmentation patterns of KSV colonies 
1-8 (Figure 4.8), in that they possessed the Pstl and Avail common deletions, and several of the 
lower fragment deletions (Table 4.6 & Figure 4.10). Table 4.6 summarises the DNA 
rearrangements observed for all KSVs and 3 patterns (I-III) of DNA rearrangements have occurred.. 
The 4.7kb and 1.8kb Pstl fragments deleted in all KSVs correspond to the junctional fragments of 
the co-integrate. Since both junctions (separated by at least 50kb) were deleted in all KSVs, the 
generation of this variant is associated with at least two genetic events. Furthermore, since no 
variant was isolated with a single junction deleted, it must be the second event that leads to loss of 
kanamycin resistance. The fact two common junctional deletions were observed, and that the other 
two common deletions exist within the pOG660 component (as compared with the pOG660 REFP 
in Figure 4.7), provides direct evidence that generation of kanamycin susceptibility resides adjacent 
to the junctional fragment within the p(Xj670 component. The additional fragment deletions of 
4.1kb, 2.3kb, and 1.6kb all occurred within the pOG660 component of pOG669. The 6.8kb 
deletion, observed in 18 of the 36 KSV (50%) colonies, was also found to reside in the pOG660 
component, and the 1.6kb and 1.4kb deletions were observed in 11 of the 36 KSV (30%) colonies. 
Avail fragmentation patterns from both Figures 4.7 and 4.9 show that the only common fragment 
deletion, as observed in all KSV, occurred within the junctional fragment. The second common 
4.1 kb fragment deletion was found to reside in the R-plasmid pOG670 component of pOG669, and 
the remaining observed 3.1kb and 2.8kb fragment deletions were also found to reside in the
165
Table 4.6. Patterns (I-III) of DNA rearrangements for kanamycin 
sensitive variants (KSV).
Pattern KSVs Pstl deletions (kb) Avan deletions (kb)
I 1,5,7,8,11,12,15,17,19,22,24,25,29,32,36 6.8;4.7;4.1;23;1.8;1.6;1.4 4.1;3.6
II 2,4,6,9,10,13,14,16,18,20,21,23,26,27,28,
30,31,33,34,35
4.7;4.1;2.3;1.8 4.1;3.6
III 3 9.5;4.7;4.1;2.3;le8;1.6;1.4 4.1;3.6
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pOG660 component (Figures 4.7 & 4.9), The 3. Ikb deletion was found in 22 of the 36 KSV, and 
the 2,8kb deletion was also found in 22 of the 36 KSV.
4.3.3. Characterisation of resistant E. coli K12 J62-1 mixed population variants 
(MPV) by REFP analysis
As previously described, mixed population variants were derived as three subpopulations 
descendant from the wild-type parent strain. Figures 4.1 and 4.2 clearly demonstrate the existence 
of three populations of E. coli K12 J62-1, pOG669 - Ap^Km^ , E.coli K12 J62-1, pOG669 - 
Ap^KmS, and E. coli K12 J62-1 - Ap®Km .^ Figure 4.11 shows MPV Pstl and Avail REFPs to be 
identical to wild-type pOG669. Therefore, this indicates the generation of MPV does not appear to 
involve DNA rearrangements.
167
4.11. Computer generated REFP for mixed population variants 
(MPV) 1-20 using P5 /I and Avail.
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more susceptible to the elimination effects of ofloxacin under these conditions. Conversely, the 
reduced elimination observed in maintenance subculture suggests host cells may be in a less 
stressed state and therefore less susceptible.
I
I
,a.4.4. DISCUSSION
Relatively little is understood about the molecular mechanisms involved in plasmid stability, and
even less is understood about the mechanisms that contribute to plasmid instability. However, it is 
established that many naturally occurring plasmids are susceptible to both spontaneous 
fragmentation and recombination (Clowes, 1972; Cohen et al, 1976; Nisioka et al, 1970). These 
processes have led to bacteria containing a wide range of derivative plasmids (Richmond & 
Wiedeman, 1974) and may also be responsible for the envelopment of natural co-integrate plasmids.
Maximal loss of pOG669 was observed in repeated subcultures. Subinhibitory ofloxacin 
eliminated the R-plasmid pOG669 from cultures in stationary phase, and reduced the elimination of 
pOG669 in maintenance subculture. The effect in stationary phase (nutrient deprivation) may be 
consistent with host cells being in a highly stressed state and that non-dividing cells may therefore be
I
.3
It is known the stable maintenance of naturally occurring plasmids within a bacterial population is
dependent upon several mechanisms including replication {rep), partitioning (par), and adequate 
selection pressures (Gerdes et al, 1986). There is also evidence that both rep and par depend on 
the level of negative DNA supercoiling (Miller et al, 1990), and that inhibition of both DNA 
replication (rep) and distribution of plasmid copies (par) into viable progeny, wiU destabilise any 
existing plasmid population (Austin & Nordstrom, 1990). Although, plasmid loss was observed in 
cells that were either in stationary phase or in maintenance subculture, nevertheless subinhibitory 
ofloxacin affected both groups differently. In stationary phase, subinhibitory ofloxacin increased 
plasmid loss, and in maintenance subculture, subinhibitory ofloxacin reduced plasmid loss. 421 
out of 2200 cells (19%) exhibited plasmid loss, and 480 out of 2200 cells (21%) exhibited 
generation of MPV, and 36 out of 2200 cells (2%) exhibited generation of KSV. The remaining
:
I
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1263 out of 2200 cells (48%) were fully resistant and therefore still plasmid-containing. Therefore, 
this higher level of plasmid-containing cells may be associated with the nal^ mediated Induction of 
the recK system in £. coli which is known to block cell division and thereby prevent plasmid
'elimination (Drlica, 1984; Hooper et al, 1984). The results presented here are consistent with 
these, since E. coli K12 J62-1 is nal^, and thereby induce the recA system followed by inhibition of 
DNA gyrase mediated cleavage. There is also evidence that nal^ reduces the ability of bacteria to 
maintain R-plasmids (Smith, 1984 & 1986).
An explanation for the higher and lower incidence of plasmid elimination, as observed in both 
stationary phase (SOF*^) and maintenance subculture (MSOF'*'), may either involve (a) changes in 
partition par (Miller et al, 1990) thereby effecting the number of plasmid copies available for 
distribution into daughter progeny, and/or (b) a threshold level for stable maintenance of plasmid 
DNA load (Platt & Black, 1987; Platt & Chesham, 1986).
(a) Partition (par)
As the par locus of pSClOl has been shown to contain a strong E. coli DNA gyrase binding site 
(Wahle & Komberg, 1988), there is evidence that this binding site overlaps par (Tucker et al,
1984). Furthermore, similar par loci have been shown to operate in several plasmids including F 
(Austin & Wierzbicki, 1983; Ogura & Hiraga, 1983a), R1 and RP4 (Gerdes et al, 1985 & 1986;
Gerdes & Molin, 1986), and NRl (Tabuchi et al, 1988). Therefore, it is possible the par loci in 
most plasmids may contain this strong DNA gyrase binding site, and this could be a candidate for 
the site of action for subinhibitory ofloxacin on pOG669 in stationary phase where the number of 
pOG669 copies may be reduced. There is also recent evidence that the products of parC (ParC) 
and parE (ParE), which partially derive the recently identified bacterial topoisimerase IV (Kato et 
al, 1988, 1990 &1992), are involved with partition in association with the bacterial cell membrane 
(Kato et al, 1992). Both of which are now thought to have a role in negative DNA supercoiling 
(Hooper & Wolfson, 1993). These lines of evidence would suggest that the observed effects of 
subinhibitory ofloxacin on plasmid elimination may result from an effect on plasmid copy partition
't:
;at the bacterial membrane, and on plasmid replication, possibly through changes in plasmid DNA 
supercoiling. However, in maintenance subculture, the number of pOG669 copies would not be 
expected to be reduced, and therefore, in these conditions subinhibitory ofloxacin may have reduced 
the elimination of pOG669 on the basis that not all copies of pOG669 are eliminated
(b) Threshold level for the stable maintenance of plasmid DNA load
therefore the reduction in plasmid elimination is lower. In repeated subculture virtual 100% 
elimination was observed, and this may be attributed to the instability mechanisms of pOG669 being 
accelerated during active logarithmic growth. This would be consistent with a notion that lethal 
DNA rearrangements lead to plasmid elimination. Recent evidence has suggested that bacteria in
A high frequency of DNA rearrangement leading to plasmid instability has been shown to alter the 
upper threshold limit to the number of plasmids a strain can stably maintain (Platt & Chesham, 
1986; Platt & Black, 1987). Thus, a threshold level may be available to the cell for the stable 
maintenance of acquired plasmids. However, as pOG669 is a low copy plasmid and as several
copies contribute to the plasmid DNA load of the cell, then this threshold may become reduced in 
the presence of subinhibitory ofloxacin, leading to DNA rearrangements, a reduction in plasmid 
copy number, and subsequent plasmid elimination. In addition, the stable maintenance of pOG669 
in stationary phase may become reduced through the direct reduction of the threshold level thereby 
reducing plasmid copy number. In maintenance phase the plasmid copy number is higher, and
stationary phase produce starvation-induced proteins (Siegele & Kolter, 1992), some of which 
include the exonucleases (Sak et al, 1989). Therefore, the starvation response in stationary phase 
may activate an error-prone SOS DNA repair process (Foster, 1992; Ninio, 1991) which leads to 
exonucleolytic-induced-DNA-rearrangements. These rearrangements may be responsible for 
spontaneous mutation (Hall, 1990 & 1991; Tormo et al, 1990), which may lead to pOG669 
instability and its subsequent reduction in plasmid copy number.
The generation of MPV was an unexpected phenomenon since the original wild-type E. coli K12
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J62-1, pOG669 strain was fully plasmid-containing, and during the experiment there was clear 
evidence that mixed populations had occurred. This change in mixed plasmid status, either 
Ap^Km^/Ap^Km®, or Ap^Km^/Ap^Km® resulted in the development of the two mixed population 
variants MPVl and MPV2 which could only have developed after the cultures were sampled 
directly onto CLED agar for purity and selection. Perhaps the cells became even more stressed 
during the transition from stationary phase and maintenance subculture to an active phase on new 
nutrients. It is conceivable that during plasmid replication, and in particular the partition of 
daughter progeny, only 1 molecule of pOG669 was transferred to every second daughter cell. In 
other words, for every two daughter cells, one was plasmid-containing and the other plasmid-free. 
Notably the incidence of MPV was significantly greater in the maintenance subculture compared to 
stationary phase, and in both cases when subinhibitory ofloxacin was present, there was a marginal 
reduction in the number of MPV colonies. This suggests ofloxacin may not be involved in tlie 
generation of MPV. The increase in MPV generation was mirrored by an increase in 
plasmid elimination and this was observed in both stationary phase and maintenance subculture. 
This suggests that the stability of pOG669 had changed and perhaps both these observations are 
linked. Common molecular rearrangements in KSV was also demonstrated, and this lead to loss of 
kanamycin resistance. Therefore, both these findings would suggest that two different mechanisms 
are in operation, with one leading to a highly unstable pOG669 (MPV), and the other a derivative of 
pOG669 (KSV).
Miller et al (1990) demonstrated that plasmids with minimal par region deletions were converted 
into unstable plasmids, and this may be consistent in the MPV,pOG669 colonies. Subinhibitory 
ofloxacin through reduction of DNA supercoiling, may therefore increase the rate of their loss. 
Furthermore, since spontaneous mutations have been shown to contribute to plasmid loss (Heller et 
al, 1981), and as plasmid loss was observed in MPV in both stationary phase and maintenance 
subculture, may reflect the absolute instability of pOG669,
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REFP analysis demonstrated several different molecular rearrangements in the form of fragment 
deletions pOG669 DNA in the KSV and several common junctional fragment deletions including 
two deletions, and one Avail deletion were observed. Therefore, one or more of these deletions 
must be associated with the concomitant loss of kanamycin resistance as observed in all KSV. This 
was found to occur within the pOG670 component of pOG669 and this is consistent, since the 
pOG670 component carries the Km resistance determinant. Of the KSV that were isolated, most 
were from the SOF+group, and most of the overall KSV molecular rearrangements (85% of total) 
resided within the pOG660 component of pCXj669. Therefore, this would suggest the pOG660 
component is responsible for the instability mechanism(s) of pOG669.
The generation of both KSV and MPV are likely to have occurred as a result of at least two 
mutational mechanisms. It is tempting to speculate that these deletions generate, MPV with 
defective par, and KSV through junctional deletions. In addition to this, preliminary studies have 
demonstrated pOG669 to be stable in E. coU K12 J53-2, and similarly, evidence has shown 
pOG669 to be unstable in E. coli K12 J62-1. These findings would suggest that tlie nal^ phenotype 
of E. coli K12 J62-1 may play an additional role to par. This is consistent since inhibition of the 
nal^ mediated recA system would generate plasmid-free cells (Drlica, 1984; Hooper et al, 1984),
It is unknown if other naturally occurring co-integrate plasmids behave in a similar fashion, 
although it would be tempting to speculate this, since the very nature of the co-integration 
mechanisms have been established (Bennet et al, 1986). Similarly, constructed co-integrates as a
result of illegitimate recombination would be expected to mintic those constructed in the natural
environment (Bennet et al, 1986; Platt et al, 1988).
This part of the study would suggest instability of pOG669 leads to the generation of molecular 
variants through molecular rearrangements, and may therefore influence the evolutionary potential 
of low copy plasmids. The generation of both KSV and MPV would signifiy this. However, the 
fact that the pOG670 component was mostly conserved would further suggest that only small ' I
regions of plasmid DNA are subject to change. Subinhibitory ofloxacin increased pOG669 
elimination and the number of KSV, and both would add to a hypothesis that 4-quinolones influence 
plasmid evolution.
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CHAPTER 5
THE SERRATIA MARCESCENS MUTANT GRI 2677-8
I
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5.1. INTRODUCTION
5The Gram-negative bacillus, Serratia marcescens, is a member of the family Enterobacteriaceae, 
and belongs to the Klebsiella-Enterobacter-Serratia tribe (Ewing et al, 1959; Ewing et al, 1962).
S. marcescens is an organism of modest pathogenicity (Grimont & Grimont, 1978), often associated 
with infection in the compromised host, after recent surgery and/or previous antimicrobial therapy 
(Platt & Sommerville, 1981). Serratia species are typical opportunistic pathogens and have gained
increasing nosocomial significance, ftirther complicated by the emergence of multiple drug resistant
strains.
■,:5They are intrinsically resistant to some antimicrobial agents including ampicillin and tetracycline, 
and additional resistance may be either plasmid-mediated (Hedges, 1980; Platt & Sommerville, 
1981) or the result of chromosomal mutation (Traub & Kleber, 1977; Traub & Fukushima, 1979).
Pigmented strains are occasionally isolated from patients (Wilkowski et al, 1970), although the 
majority of clinical isolates are non-pigmented (Blazevic, 1980; Clayton & von Graevenitz, 1966). 
Historically, strains of S. marcescens have been recognised for their blood red-pigment appearance 
(Bizio, 1823), and production of the blood red-pigment, prodigiosin, is a common characteristic of 
many strains of S. marcescens.
5.1.1. Biosynthesis of prodigiosin
Strains of S. marcescens produce prodigiosin via a bifurcated pathway in which two 
precursors, 2-methyl-3-amylpyrrole (MAP) and 4-methoxy-2,2'-bipyrrole-5-carboxaldehyde MBC) 
are enzymatically condensed to form the tripyrrole prodigiosin (Morrison, 1966; Williams & Hearn, 
1967). S. marcescens mutants 933 and WF have contributed to the elucidation of the biosynthetic 
pathway. Each mutant had alternative branches of the pathway blocked and therefore produced a 
single precursor. When both mutants were grown on the same plate bi-directional cross-feeding of 
precursors occurred, and prodigiosin was formed at the interface of the both mutants. Identification 
of the bipyrrole intermediate structure, MBC, produced by mutant 933 was an important step in 
determination of the structure of prodigiosin (Santer & Vogel, 1956). Wasserman et al (1960) 
identified the intermediate structure to be MBC, and Rapoport & Holden (1960 & 1962) confirmed
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the structure by synthesis. The final step in the pathway was the identification of MAP which was 
established through the use of gas chromotography, mass spectroscopy, and nuclear magnetic 
resonance (Deol et al, 1972).
The genetic control of prodigiosin synthesis is complex with at least nine enzymes required for its 
biosynthesis (Williams, 1973), and it has been suggested that genes controlling prodigiosin 
biosynthesis may be clustered (Williams & Qadri, 1980). However, it is not known, either what 
size the gene cluster is, or whether the pigmentation genes are contiguous (Dauenhauer et al, 1984).
5.1.2. Intracellular location and physiological role of prodigiosin
Synthesis of prodigiosin occurs in the late stages of growth and is therefore thought of as a 
secondary metabolite. It is also thought to be complexed with the sugar-containing outer membrane 
glycoproteins (Cruz-Camarillo & Sanchez-Zuniga, 1968) in close association with the cell envelope 
(Williams & Qadri, 1980). More recently it has been proposed that prodigiosin is present as 
protein-pigment complexes within the inner ceil membrane (Kobayashi & Ichikawa, 1989) and 
accumulates as periplasmic prodigiosin (Kobayashi & Ichikawa, 1991). Furthermore, the 
accumulation of prodigiosin increases during active bacterial growth (Geron et al, 1988). The 
enzyme responsible for the last step in the formation of prodigiosin is also thought to be periplasmic 
(Matsuyama et al, 1986) since two extracellular enzymes are thought to be released from pigmented 
Serratia via two different mechanisms (Kobayashi & Ichikawa, 1991). The physiological role of 
prodigiosin is poorly understood and even now the precise function of prodigiosin remains unknown.
The pigment is thought not to be essential, since white mutants of 5. marcescens have been shown 
to grow in vitro as well as pigmented strains (Williams, 1973). Nevertheless there is evidence that 
prodigiosin possesses antimicrobial activity (Gerber, 1975; Williams & Hearn, 1967; Williams &
Qadri, 1980) which may enhance survival in nature.
Many pigmented strains of 5. marcescens spontaneously mutate to non-pigmented variants when 
subcultured (Bunting 1940 & 1946), and several of these variants revert to the pigmented phenotype
1
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with high frequency. Spontaneous mutation also generates cross-resistance among some 
aminoglycosides (Traub & Fukushima, 1979), and unrelated agents that include nalidixic acid, 
trimethoprim, and chloramphenicol (Traub & Kleber, 1977).
S. marcescens GRI 2677 is a pigmented plasmid-free clinical isolate, and S. marcescens GRI
2677-8 is a spontaneously non-pigmented nutritionally defective, (but not auxotrophic) antibiotic 
resistant mutant. In contrast to the parent strain (GRI 2677), it is resistant to carbenicillin and 
aminoglycosides. GRI 2677-8 reverts at high frequency to the parental phenotype and it has been 
suggested this may involve DNA rearrangement(s) by illegitimate recombination (Platt et al, 1983). 
Revenants accumulate in cultures stored at both room temperature and 4% , and subcultures of 
an overnight broth culture contain a high proportion (10 - 20%) of pigmented colonies.
After extended incubation individual non-pigmented colonies develop discrete intracolonial 
pigmented papillae (EPF) (Platt et al, 1983). These IPPs become progressively evident with 
increasing colony age, up to 6 days. The number detected per colony ranges from 0 - 8 on CLED 
agar (Oxoid), but increases on media enriched with additional peptone (Platt & Brown, unpublished 
observations). Washed suspensions of GRI 2677-8 plated at intervals over a 21 day period show 
progressive reversion of the population (Platt et al, 1983).
The aim of this part of the study was to extend earlier observations, and to determine the effects of 
subinhibitory ofloxacin firstly on the reversion of a starved population, and secondly on IPP 
formation in relation to colonial growth rate.
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5.2. MATERIALS AND METHODS
5.2.1. Bacterial strains and media
strain, p±, p±, and p" (non-pigmented).
Isosensitest broth (Oxoid) was used to culture GRI 2677-8 during population reversion. 
Isosensitest agar (Oxoid) was used for disc diffusion sensitivity testing, and the following antibiotic-
incorporated into the medium. This was inoculated with 100|l i 1 of an 8 hour culture of GRI 2677-8 
diluted to 10"^ to give approximately fifty colonies per plate each separated by at least 1cm. This 
criterion eliminated competition for nutrients as a source of size variation in resultant colonies. The
1
3S. marcescens GRI 2677-8 was stored in glycerol-peptone at -70%, and revived by plating onto 
CLED agar (Oxoid), and incubated at 30%. CLED agar (Oxoid) was used for (a) growth and 
maintenance of cultures and (b) to distinguish the non-pigmented phenotype from the parental 
pigmented phenotype.
To purge initially revived cultures of pigmented revenants, daily subcultures of non-pigmented 
variants for three consecutive days were performed. CLED agar was also used for the assessment
of pigmented variants during population reversion. These variants were classified, as previously 
described by Platt et al (1983), into groups of decreasing pigmentation: p+ (pigmented parent
=t..
. . . 7
impregnated discs (Oxoid) : ampicillin ( 1 Opg), carbenicillin ( 100|ig), cephazolin (30p.g), 
cefamandole (30|ig), colistin sulphate (25|ig), tetracycline (lOpg), gentamicin (lOfrg), tobramycin 
(lOpg), amikacin (lOpg), streptomycin (lOpg), kanamycin (30pg), trimethoprim (1.25pg), 
sulphmethoxazole (25|ig), chloramphenicol (lOpg), nalidixic acid (30pg), and ofloxacin (Ipg) were 
used.
5.2.2. Colony reversion assay and determination of the mean colony radial growth 
rate of GRI 2677-8 colonies
The colony reversion assay was carried out in bioassay plates 243 mm^ (Gibco/NUNC) that 
contained 300mls CLED agar (Oxoid). Subinhibitory (0.1 MIC and 0.25MIC) ofloxacin was
plates were incubated for 3 days at 30%  followed by a further 2 days at room temperature. For
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formulation of 5g/l peptone in CLED agar (Oxoid) was supplemented to 12.5gA and 15g/l to reduce
0.25MIC ofloxacin, but also to observe real effects of subinhibitory ofloxacin on both the reversion
However, such a result could have been accounted for by either cryptic growth or the higher growth
reversion assay also carried out using washed cell suspensions in distilled water (Platt et al, 1983). 
Since, 4-quinolones have been shown to act on stationary as well as growing populations (Ratcliffe 
& Smith, 1984; Zeller & Grohe, 1984; Zeiler, 1985), the subinhibitory effects were studied under
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ieach colony, the number of intracolonial pigmented papillae of each colony was determined. As
IPP formation may be growth rate dependent and it was therefore not be possible to assess the effect 
of subinhibitory ofloxacin on a single medium. To overcome this disparity, the standard
the net inhibitory effect of ofloxacin on growth rate. This provided not only a means to achieve 
matched growth rate for the comparison of IPP production in the presence of either 0.1 MIC or
i.
process and mean colony radial growth rate. The mean colony radius was determined by measuring f
the diameter (mm) of fifty GRI 2677-8 colonies at intervals 15, 20, 25, 30, 35, 40,50, and 60 hours 
using a Leebrook microbiological zone reader (Leebrook Scientific Instrument Company Limited) 
giving a linear magnification of 7.5:1 (Platt & Sommerville, 1984).
5.2.3. Rationai of population reversion study
In previous studies the population reversion effect was first observed in stationary broth cultures.
rate of the revertant as compared with GRI 2677-8. To exclude these possibilities the population
* 
■Ïboth conditions. Initially, 65mls of isosensitest broth (Oxoid) was inoculated with one pure GRI
2677-8 colony and incubated at 30%  for 8 hours. An eight hour incubation was deemed sufficient 
to allow the GRI 2677-8 culture to enter the logarithmic phase of growth, and at this stage contain a 
minimum number of revertants. The appearance of the culture was turbid, indicating sufficient cell 
numbers were present (as observed in previous experiments with dilution plate analysis). From this
"■'B65ml GRI 2677-8 culture, lOmls were individually aliquoted into one of four separate universal
'7;
bottles labelled culture A to D.
i:
revertants were carried out.
Culture A {starved stationary phase population)
lOmls of the original culture was centrifuged at 3000 rpm and the cells were washed, and 
resuspended in lOmls sterile distilled water.
Culture B {starved stationary phase population with 0.25MIC ofloxacin)
lOtnls of original culture was centrifuged at 3000 rpm and the cells were washed, and resuspended 
in lOmis sterile distilled water that contained 0.125|ig/ml ofloxacin (equivalent to 0.25MIC).
Culture C {stationary phase pogxAsdioii)
lOmls of original culture.
Culture D {stationary phase population with 0.25MIC ofloxacin)
lOmls of original culture containing O.125|0,g/ml ofloxacin (equivalent to 0.25MIC).
Each culture was incubated at 30%  for 25 days and the total count, number of non-pigmented
(p") variants, and the total number of pigmented (p" )^ revertants (including p+, p±, and p± 
revertants) were detemuned by dilution plate viable counts at 5 day intervals. Antibiotic sensitivity
patterns for 30 single colonies of non-pigmented (p" ) variants and pigmented (p+, p±, p±)
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5.3. RESULTS
The red-pigmented appearance of GRI 2677 was enhanced on CLED agar (Oxoid) and tills 
provided reproducible discrimination of pigmented variants. Figure 5.1 shows IPPs demonstrating 
reversion of non-pigmented GRI 2677-8 to the pigmented phenotype after three to five
days incubation at 30%. On revival of GRI 2677-8 fi’om storage, the initial ratio of occurrence of 
pigmented (p+) and non-pigmented (p") phenotypes was observed as 4:1. This ratio decreased to 
less than 1:1000 by daily subculture for 3 days.
5.3.1. The effect of subinhibitory ofloxacin (O.IMIC & 0.25MIC) on colony radial 
growth rate, numbers, and distribution of IPPs in GRI 2677-8 colonies
The radial growth of colonies was linear between 15 and 60 hours and Figures 5.2-5.4 also show 
that both 0.1 and 0.25MIC ofloxacin reduced growth rate. Table 5.1 and Figures 5.2-5.4 show the 
radial growth of GRI 2677-8 colonies to increase with increasing peptone concentration. Table 5.2 
and Figure 5.5 show similar colonial and radial growth rates. When the peptone concentration was 
increased, the colony radial growth rate (Kr) increased (Table 5.2), but inhibition by either O.IMIC 
or 0.25MIC subinhibitory ofloxacin was also evident. However, when standard peptone 
concentration of 5 g/1 was compared with a peptone concentration of 12.5 g/1 that contained 
0.1 MIC ofloxacin, and a peptone concentration of 15 g/1 that contained 0.25MIC ofloxacin, the 
colony radial growth rate (Kr) was closely matched (Figure 5.5). Therefore, these concentrations 
of peptone allowed the effect of subinhibitory ofloxacin on IPP formation to be determined 
independent of growth rate.
The radial growth rate of GRI 2677-8 on CLED with standard formulation of 5g/l peptone was 
very similar when compared to either CLED containing 12.5 g/1 peptone and O.IMIC ofloxacin 
or CLED containing 15g/l peptone and 0.25MIC ofloxacin (Figure 5.5 and Table 5.2). The 
population distributions as shown in Table 5.3 and Figure 5.6 demonstrate subinhibitory ofloxacin 
effected a reduction of IPPs per colony. O.IMIC ofloxacin significantly reduced (p<0.05) the 
reversion process through reduction of the number IPPs per colony (%^=8.27 with df=3 for two 
independent samples, Table 5.4). 0.25MIC ofloxacin was also shown to significantly decrease 
(p<0.001) the reversion process through reduction of the number of IPPs per colony (%^=279.3 with
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Figure 5.1. Colonies o f 5. m arcescens GRI 2677-8 that d em ^ stra te  intracoloniai pigmented papillae
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Table 5.1. The effect o f variation in peptone concentration in the presence and absence or subinhibitory ofloxacin (0.25M IC) on m ean colony radius (mm) of GRI 2677-8 colonies.
(a) [peptone 5g/l], (b) [peptone 12.5g/l with O.IMIC 
ofloxacin], and (c) [peptone 15g/l wifii 0.25MIC ofloxacin].
[peptone 5g/l] [peptone 12.5g/l] [peptone 15g/l]
Time (hours) (a) (b) (c) (a) (b) (c) (a) (b) (C)
15 0.13 0.10 0.08 0.25 0.20 0.17 0.28 0.25 0.22
20 0.42 0.33 0.32 0.53 0.47 0.40 0.60 0.53 0.47
25 0.65 0.52 0.43 0.77 0.73 0.57 0.87 0.80 0.70
30 0.92 0.72 0.62 1.03 0.95 0.78 1.17 1.05 0.93
35 1.13 0.95 0.80 1.33 1.23 1.00 1.47 1.33 1.20
40 1.38 1.13 0.95 1.57 1.47 1.18 1.73 1.60 1.45
50 1.90 1.53 1.33 2.10 1.97 1.63 2.30 2.13 1.93
60 2.33 1.90 1.70 2.63 2.50 2.07 2.90 2.68 2.40
%
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Each mean colony radius was determined from measurements of fifty colonies. The standard error for each measurement was <2%.
185
i
I
££
■ af ï
hours
Figure 5.2. Radial growth of S. marcescens GRI 2677-8 colonies on CLED agar (Oxoid) with peptone concentration of 5g/l.
• [peptone 5g/!]; ▼, ■ [peptone 5g/l] withO.IMIC, and 0.25MIC ofloxacin respectively.
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Figure 5.3. Radiai wowth of S. marcescens GRI 2677-8 colonies on CLED agar (Oxoid) with peptone concentration of 12.5g/l.
•  [peptone 12.5g/I]; T , ■ [peptone 12,5g/ï] with 
O.IMIC, and 0.25MIC ofloxacin respectively.
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Figure 5,4. R adial^ow th of 5. marcescens GRI 2677-8 colonies on CLED agar (Oxoid) with peptone concentration oflSgd .
• [peptone 15g/l]; ▼, ■ [peptone 15g/I] withO.IMIC, and 0.25MIC ofloxacin respectively.
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Table 5.2. The effect of variation in peptone concentration in the presence and absence or subinhibitory ofloxacin (0.25MIC) on colonial growth rate (Kr) of GRI 2677-8 colonies.
!
(a) [peptone 5g/l], (b) [peptone 12.5g/I with O.IMIC 
ofloxacin], and (c) [peptone 15g/l witii 0.25MIC ofloxacin].
Kr (pm  hour-1)
[peptone g/1] (a) (b) (0
5.0 48.9 40 36
12,5 53 51 42
15.0 58 54 48.4
s
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Figure 5,5. Comparison of radial growth of GRI 2677-8 colonies on CLED agar (Oxoid) with variation in peptone concentration.
■ [peptone 5g/i]; ♦ [peptone 12.5g/I] withO.IMIC ofloxacin, and a [peptone 15g/l]with 0.25MIC ofloxacin respectively.
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Table 5.3. Comparison of observed number of S. marcescens GRI ^ 677-8 colonies with IPP per colony, with the number of IPP per colon;y with values predicted from a Poisson Distribution, (a) 5g/l peptone group, 12.5g/l peptone group, and (c) 15g/l group, with and without subinhibitory ofloxacin.
For statistical purposes the numbers of IPP per 
colony were separated into cells. [Statistical 
Cells I, II, m ,  and IV represented the number 
of colonies with IPP as 0 -1 ,2 ,3 , and 4-9 IPP per colony respectively (see Table 5.4).
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Figure 5.6. Variation in population distribution of numbers of S. marcescens GRI 2677-8 colonies with IPP per colony with the numbers of IPPs per GRI 2677-8 colony.
The peptone concentration was also varied with
(a) [peptone 5g/l], (b) [peptonel2.5g/l] with 
O.IMIC ofloxacin, and (c) [peptone 15g/I] with 0.25MIC ofloxacin.
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df=3 for two independent samples, Table 5.4).
5.3.2. Characterisation of intracoloniai reversion
Figure 5.6 shows the distribution of the number of GR I2677-8 colonies with pigmented papillae 
as a function of the number of pigmented papillae per colony. When the distribution for GRI 
2677-8 colonies on CLED with standard formulation of 5g/l peptone was compared with colonies 
grown on CLED with either 12.5g/l peptone that contained 0.1 MIC ofloxacin or 15g/l peptone that 
contained 0.25MIC ofloxacin, there was an observed stiift to colonies with decreased reversion 
(Figure 5.6 and Table 5.3). Furthermore, when similar growth is taken into account, as observed 
in Figure 5.5, subinhibitory ofloxacin (0.1 MIC) significantly reduced reversion, and an increase in 
subinhibitory ofloxacin to 0.25MIC reduced reversion further with a shift to colonies with fewer
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IPPs. The results from Table 5.3 indicate the ffeqency distributions for colonies (grown on CLED 
with peptone concentrations 5g/l, 12.5g/1 that contained 0.1 MIC ofloxacin, and 15g/l that contained 
0.25 MIC ofloxacin) with different numbers of IPPs are represented by 'goodness-of-fit' Poisson 
Distributions (Table 5.3). Of the 9 distributions tested using 'goodness of fit' Poisson, 6 differed 
significantly (Table 5.3), and 3 did not. This indicates that the reversion process is not necessarily 
random, and therefore not a typical mutational process.
.1
I
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Table 5.4. The effect of subinhibitory ofloxacin (0.25MIC) on the reversion of the non-pigmented (p") variant to the parental pigmented Cp^ ) revertant, independent of growth rate.
Comparison of normal peptone concentration of 5g/l 
in CLED agar (Oxoid) with peptone concentrations 
of 12.5g/l with O.IMIC ofloxacin, and 15g/l with 
0.25MIC ofloxacin respectively, using a Chi-squared test.
STATISTICAL CELLS
[peptone g/1] I II III IV i } (df) ’P’
5 4 18 44 14 ■B -
12.5 + O.IMIC 8 24 34 14 8.27 (3) <0.05
15.0 + 0.25MIC 36 22 16 6 279.30 (3) <0,001
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5.3.3. Observed variation in parental pigmented phenotypes and antibiotic 
sensitivity patterns of GRI 2677-8 3:f"
Although GRI 2677-8 nomtally reverted to the parental pigmentation phenotype, several 
pigmented variants were isolated during the population reversion study. Table 5.5 shows two 
variant sub-populations, pale-pink (p i) and bright-pink (p i) phenotypes, of the parental red- 
pigmented phenotype (p"**) were isolated. Table 5.5 also shows that a greater number of bright-pink 
pigmented variants occurred in stationary phase (nutritionally undeprived), with or without 
0.25MIC ofloxacin. Cumulatively, the number of pale-pink variants occurred more frequently with 
time. Furthermore, by day 25, there were more pale-pink variants in the culture without ofloxacin.
Antibiotic sensitivity patterns for the non-pigmented variant and pigmented revertant of GRI
2677-8 were different (Table 5.6). The critical zones (Table 5.6) were taken from GRI 2677 p"^ ,
and any value less than the respective antibiotic zone is still significantly resistant when compared to 
the usual revertant. Therefore, reversion to the parental pigmented phenotype was associated with
•■S
loss of resistance to carbeniciUin and cefamandole, increased sensitivity to sulphmethoxazole, the
aminoglycosides, trimethoprim, and chloramphenicol. There was no change in the sensitivity to 
nalidixic acid, ofloxacin, rifampicin, and colistin sulphate.
In contrast to Table 5.6, Table 5.7 shows there are further differences in antibiotic patterns for 
both p± and p i  pigmented variants. The reversion of pigmentation involved four pigmented 
phenotypes, non-pigmented (p“), pale-pink (p i  ), bright-pink (p i ), and parental red-pigmented 
(p+).
i
if|-
Table 5.5. The number of parental pigmented variant colonies isolated from G R f2677-8 colonies during population reversion in stationary phase (SP) and starved stationary phase (SS) culture conditions in the presence and absence of subinhibitoryofloxacin (0.25MIC) respectively.
Days SP SS SP (0.25MIC) SS (0.25MIC)
0 5p±/362 lp ±  & lp±/505 3p±/405 4p±&lp±/367
5 0/750 4p±/240 2p±/112 8p±/622
10 0/420 5p±/680 lp±/950 12p±/194
15 0/260 18p±&3p±/300 0/430 21p±/850
20 0/ 90 29p±/100 0/ 35 17p±/52
25 0/ 58 32p±/80 0/ 31 2p±&7pi^46
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Table 5.6. Antibiotic sensitivity patterns (mm) for the non-pigmented (p"> variant and the parental pigmented Tp )^ revertant of GRI 2677-8.
Antibiotic (p“) variant (p+) revertant
AmpicilUn R R
CarbeniciUin R 15 (13.00)
Cephazolin R R
Cefamandole R 11 ( 9.50)
Nalidixic acid 15 (13.50) 15 (13.25)
Ofloxacin 15 (13.00) 14 (12.75)
Colistin sulphate 10 ( 8.00) 10 ( 8.00)
Rifampicin 5 ( 6.00) 6 ( 4.50)
Tetracycline R R
Sulphmethoxazole <5 ( 7.00) 9 ( 7.25)
Chloramphenicol 6 ( 7.50) 14 (11.75)
Trimethoprim 7 ( 8.25) 11 ( 9.25)
Tobramycin <5 ( 7.00) 14 (12.00)
Amikacin <5 ( 7.00) 13 (11.00)
Kanamycin <5 ( 7.00) 14 (12.00)
Streptomycin 6 ( 7.25) 17 (15.75)
Gentamicin 6 ( 7.50) 15 (13.75)
( ) critical zone size shown for those agents to which parent and revertant differed in
sensitivity: calculated as (x - 3SD: revertant) and (x + SD: variant)
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Table 5.7. Antibiotic sensitivity patterns (mm) for the p± and 
p± pigmented partial revertants of GRI 2677-8.
Antibiotic (p±) variant (bright-pink) (p±) variant (pale-pink)
I
Ampicillin R R
CarbeniciUin 11 (I) 12 (I)
Cephazolin R R
Cefamandole R (NR) R
Nalidixic acid 15 14
Ofloxacin 13 15
Colistin sulphate 10 10
Rifampicin 7 7
Tetracycline R R
Sulphmethoxazole <5 (NR) <5 (NR)
Chloramphenicol 7 (NR) 6 (NR)
Trimethoprim 8 (NR) 8 (NR)
Tobramycin 11 (I) 11 (I)
Amikacin 9 (I) 10 (I)
Kanamycin 11 (I) 13 (R)
Streptomycin 10 (I) 12 (I)
Gentamicin 12 (I) 13 (R)
R = no zone. I = intermediate sensitivity (partial reversion) and p+ phenotypes, and 
NR -  no reversion of resistance ie. retention of the variant phenotype (see critical 
zones in Table 5.6)
-A
202
bright-pink intermediate phenotypes, and indicates that partial reversion did not affect all
203
Those intermediate in pigmentation also showed partial reversion with respect to ^-lactam and 
aminoglycoside resistance (Tables 5.6 & 5.7). However, the partial resistance of the p” variant to 
sulphmethoxazole, trimethoprim, and chloramphenicol was maintained in both the pale-pink and
i
I
components of the combined phenotype equally. These results indicate the mechanism of reversion
is complex and that the generation of intermediate revertants appeared to be influenced by 
subinhibitory ofloxacin (0.25 MIC).
5.3.4. The effects of subinhibitory of subinhibitory ofloxacin (0.25MIC) on the 
growth kinetics of 5. marcescens GRI 2677-8 during population reversion 
under different growth conditions
(a) Culture A (starved stationary phase population without 0.25MIC ofloxacin)
When a starved stationary phase culture of GRI 2677-8 was incubated at 30%  for 25 days, the 
following changes in total count, number of non-pigmented variants, and number of pigmented 
revertants were observed (Figure 5.1a), For purpose of analysis, Figure 5.1a was divided into three
separate time periods: 0-15 days, 15-20 days, and 20-25 days respectively. During the first 15
days the total count and the number of non-pigmented variants both decreased by 1 log unit. 
However, the number of pigmented revertants increased by 0.45 log units. This period shows the 
decrease in total count is mirrored by the decrease in the number of non-pigmented variants and is 
attributed to a combination of loss of viability and reversion of p" variants to the p*^  parental 
phenotype. Between days 15 & 20 there was a decrease of 0.1 log units in the total count, and a 
decrease of 1 log unit in the number of non-pigmented variants, and a decrease of 0.15 log units in
the number of pigmented revertants. The total number of non-pigmented variants decreased below 
the total number of pigmented revertants. Furthermore, the decrease in the number of non-
pigmented cellsjndicates the.reversion rate reached a maximum during this period, together with an 
increase in cell death. The total count, the number of non-pigmented variants, and the number of
i .
Figure 5.7. Viability counts of population reversion of starvedstationary phase culture of S. marcescens GRI 2677-8 incubated at for 25 days in distilled water in the presence and absence of subinhibitory ofloxacin To.25MIC).
(û) without 0.25MIC ofloxacin, and (b) with 0.25MIC 
ofloxacin. •  Total count; □ non-pigmented (p*) 
resistant variant; T  pigmented (p+) sensitive revertant
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Days
I
*
,!■;I
1
■i
I
I
Î#1
206
207
pigmented revertants decreased at similar rates between days 20 & 25. However, the decrease in 
the number of non-pigmented variants appeared to reach a plateau where reversion to the parental 
pigmented phenotype had slowed.
Cumulatively, the total count decreased by less than 2 log units, the number of variants decreased 
by more than 2 log units, and the number of revertants increased by 0.75 log units over 25 days.
(b) Culture B {starved stationary phase population with 0J15 MIC ofloxacin)
When starved stationary phase culture of GRI 2677-8 was incubated at 30°C for 25 days in the 
presence of subinhibitory ofloxacin (0.25MIC), the following changes in total count, number of non- 
pigmented variants, and the pigmented revertants were observed (Figure 5.76). During the first 15 
days the total count and the number of non-pigmented variants both decreased by 1 log unit. The 
number of non-pigmented variants decreased more sharply during the first 5 days. However, the 
number of pigmented revertants increased by 0.8 log units during the first 5 days, followed by a 
slow decrease of 0.2 log units during the next 5 days, and further followed by a 1 log unit decrease. 
This period was demonstrated by an overall decrease in reversion. Between days 15 & 20 the total 
count and the number of non-pigmented variants both marginally decreased, and the number of 
pigmented revertants decreased further by 0.9 log units. This was consistent by a further reduction 
in reversion. The total count and the number of non-pigmented variants decreased by 1 log unit, 
and the number of pigmented revertants reached a plateau between days 20 to 25.
#
Cumulatively, the total count decreased by 2 log units, the number of variants decreased by 3 log 
units, and the number of revertants initially increased by 0.8 log units and then decreased by 2 log I
:units.The effect of 0 J55MIC ofloxacin on a starved stationary phase culture of GRI 2677-8
Comparison of cultures A and B show subinhibitory ofloxacin to influence the reversion process 
by an initial increase, followed by a 2 log unit decrease in the number of pigmented revertants. 
Although the reversion process was accelerated, the attained peaks of the number of pigmented
i"
revertants were similar, and thereby demonstrated little effect. Therefore, in starved stationary 
phase subinhibitory ofloxacin clearly reduced reversion. However, under starvation conditions 
subinhibitory ofloxacin (0.25MIC) appeared to accelerate the death of revertants.
(c) Culture C {stationary phase population without 0JÏ5MIC ofloxacin)
When a stationary phase culture of GRI 2677-8 was incubated at 30°C for 25 days, the 
following changes in total count, number of non-pigmented variants, and number of pigmented 
revertants were observed (Figure 5.8a). For the purpose of analysis, Figure 5.8a was divided into 
two separate time periods: 0-5 days and 5-25 days respectively. During the first 5 days, the total 
count increased by 0.7 log units, the number of non-pigmented variants decreased by 0.1 log units, 
and the number of pigmented revertants increased by 2.7 log units. Stationary phase (in this 
stationary phase, nutrients deprivation was not initially present as it was a broth culture) enhanced 
pigmentation which generated the increase in reversion from the non-pigmented to the respective 
parental pigmented phenotype. A noticeable feature of Figure 5.8a was at day 5 there were more 
pigmented revertants than non-pigmented variants, where the former contributed to the increase in 
total count. Between days 5 & 25,the total count decreased by 1.4 log units, the number of non- 
pigmented variants decreased by 1 log unit, and the number of pigmented revertants decreased by 
1.7 log units. Throughout this period there were more ceils with the parental pigmented phenotype. 
The pattern of decrease for total count, number of non-pigmented and pigmented cells were similar. 
The decline indicates the culture had entered the death phase through lack of nutrients.
Cumulatively, the total count initially increased by 0.7 log units and then decreased by 1.4 log 
units, the number of variants decreased by 1 log unit, and the number of revertants initially 
increased by 2.7 log units and then decreased by 1.7 log units.
(d) Culture D culture wt/A 0J5MIC ofloxacin)
When a stationary phase culture of GRI 2677-8 was incubated at 30°C for 25 days in the 
presence of subinhibitory ofloxacin (0.25MIC), the following changes in total count, number of non- 
pigmented variants, and the number of pigmented revertants were observed (Figure 5.86). During
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Figure 5.8. Viability counts of population reversion of stationary phase culture of S, marcescens GRI 2677-8 incubated at 30^C for 25 days in isosensitest broth (Oxoid) in the presence and absence of subinhibitory ofloxacin (0.25MIC).
(a) without 0.25MIC onoxadn, and (6) with 0.25MIC 
ofloxacin. • Total count; □ non-pigmented (p“) 
resistant variant; ▼ pigmented (p+) sensitive revertant.
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the first 5 days the total count increased by 0.3 log units, the number of non-pigmented variants 
decreased by 0.1 log units, and the number of pigmented revertants increased by 1.7 log units. 
Between days 5 & 25 the total count decreased by 1.2 log units, the number of non-pigmented 
variants decreased by 1 log unit, and the number of pigmented revertants decreased by 1.5 log units. 
Comparison with Figure 5.8a, demonstrates the total number of revertants at day 5 was 1 log unit 
lower, which is consistent with ofloxacin inhibiting ofloxacin in a stationary phase culture. The 
rate of decline for all groups were sirailarand the culture had entered the death phase through lack of 
nutrients. Cumulatively, the total count initially increased by 0.5 log units and then decreased by 
1.75 log units, the number of variants initially increased by 0.5 log units and then decreased by 1.75 
log units, and the number of revertants initially increased by 1.5 log units and then decreased by 1 
log unit.
The effect of 0 JiSMIC ofloxacin on a stationary phase culture of GRI 2677-8
Comparison of cultures C and D show that subinhibitory ofloxacin reduced reversion by 
approximately 1 log unit. Ofloxacin also inhibited peak reversion, and this demonstrated its effect 
on reversion in stationary phase.
Comparison of the effects of 0.25MIC ofloxacin under starved stationary phase and stationary 
phase conditions
Although, both starved stationary phase and stationary phase show initial increases in 
reversion, the increase in stationary phase was however approximately twice that observed in 
starved stationary phase. This was followed by a decrease in revemon in both cultures.
However, in starved stationary phase, the decrease in reversion was twice that observed in 
stationary phase. These results indicate that the reversion mechanism in starved non-dividing S. 
marcescens GRI 2677-8 cells is more susceptible to the effects of subinhibitory ofloxacin.
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5.4. DISCUSSION
The spontaneous carbenicillin-resistant non-pigmented (p“ ) variant of S. marcescens GRI 2677-8 
reverted with high frequency to the carbenicillin-sensitive pigmented phenotype. Spontaneous 
reversion produced a diversity of pigmented variants, and included the red-pigmented (p+), bright- 
pink (pi), pale-pink (p±), and non-pigmented (p") phenotypes, and this accords with previous 
findings (Eisenberg, 1914; Bunting, 1946; Labrum & Bunting, 1953; Flattera/, 1983).
Spontaneous reversion to the parental pigmented phenotype gave rise to a loss of resistance to the 
(3-lactams carbeniciUin and cefamandole, sulphmethoxazole, the aminoglycosides, and unrelated 
antimicrobial agents including trimethoprim and chloramphenicol (Table 5.6). These antimicrobial 
agents are all structurally unrelated and possess different mechanisms of action. Resistance to 
these agents is thought to occur via decreased uptake through changes within the cell envelope 
(Traub &Fukushima, 1979). Both pigmentation and production of a chromosomaUy-mediated 
inducible (3-lactamase have also been shown to be associated with the cell envelope (Platt et aU 
1983).
Population reversion to the parental pigmented phenotype generated the pigmented variants pale- 
pink (p i) and bright-pink (pi), and comparison of their antibiotic patterns (Tables 5.6 & 5.7) show 
the pale-pink and bright-pink to be intermediate-phenotypes between the non-pigmented and 
pigmented phenotypes. The change in resistance to both carbeniciUin and the aminoglycosides was 
observed to occur between the non-pigmented and pale-pink stage, and changes in resistance to 
sulphmethoxazole occurred between the bright-pink and red-pigmented stage. Reversion to 
cefamandole sensitivity also occurred between the bright-pink and parental pigmented stage. 
Therefore, the 4 stages in the pigmentation process would suggest complex multistate mutational 
mechanisms may be involved. The first mutation involves changes in resistance to both 
carbeniciUin and the aminoglycosides, and is coupled to a change in pigmentation (non-pigmented to 
pale-pink). The second mutation involved loss in resistance to sulphmethoxazole, and further loss
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their regulation may be involved. It is therefore proposed that the likely candidate is a Regulator of 
Antibiotic resistance and Pigmentation (RAP). This structural mutation also changes the
I
S:
of resistance to chloramphenicol and trimethoprim, and is also coupled to a change in pigmentation 
(change from bright-pink to red-pigmented). The third change involved loss of cefamandole 
resistance and is also coupled to a change in pigmentation (non-pigmented to parental red- 
pigmented). Loss in carbeniciUin resistance was progressive with increased sensitivity from the p ' 
phenotype, througli the intermediate phenotypes, to the p+ phenotype. Similarly, the increase in
aminoglycoside sensitivity was also progressive for these changes in pigmented phenotype. These 
observations are therefore consistent with both antibiotic resistance and pigmentation being co- 
regulated, since pigmentation resulted in loss of carbenicUUn resistance, increased sensitivity to aU 
ttie aminoglycosides, and unrelated agents that included chloramphenicol, sulphmethoxazole, and
trimethoprim. It is noteworthy that S. marcescens is known to possess intrinsic permeabiUty 
barriers to the p-lactams, and changes in the permeabiUty barrier would account for these 
changes in resistance patterns. Therefore, the observed change in both pigmentation and antibiotic 
resistance during reversion would therefore suggest that this spontaneous mutation maybe 
associated with structural changes in the cell envelope. This spontaneous mutation may occm* in a
regulator of thepigmentation enzymes, which themselves may be membrane-bound. One of the 
pigmentation enzymes that may be involved is the periplasmic condensing enzyme, which combines 
the MAP and MBC precursors to form prodigiosin. This is consistent since 2 mutations may 
account for the two intermediate changes in pigmentation. Thus, the observed changes in both
pigmentation and antibiotic resistance presented here are in accordance with previous studies, since 
pigmentation and p-lactamase have been shown to be associated with the ceU envelope (Platt et al, 
1983; Sykes & Matthew, 1976; Traub & Fukushima, 1979; Williams & Qadxi, 1980).
The genetics and molecular basis of reversion is thought to involve a back-mutational event (Platt 
& Sommerville, 1981; Platt et al, 1983), and as the pigment, prodigiosin, is bound to a glycoprotein
complex within the cell envelope, then a structural mutation in either the pigmentation (pig) genes or
- ::i
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1 Changes in (3-lactam and chloramphenicol resistance may be explained by a mutation in 
the mar locus. Similarly, the resultant changes in membrane permeability (through reduced 
ompY expression) may also influence periplasmic pigmentation. Further work wdl be 
required to investigate these possibilities.
permeability of the (3-lactams, aminoglycosides, and other unrelated antibiotics through the cell
envelope, and is therefore implicated with the changes in pigmentation, and (3-lactam,
1
aminoglycoside, and other antibiotic resistance.
5The population distributions of numbers of EPF per colony varied between Poisson & Non- 
Poisson distributions. In growth matched GRI 2677-8 colonies, the increase in peptone 
concentration in the 5g/l and 12.5g/l + O.IMIC subinhibitory ofloxacin demonstrated no significant 
difference from a Poisson distribution in the frequency of colonies with IPP. However, the 15g/l + 
0.25MIC subinhibitory ofloxacin group differed significantly from a Poisson distribution. This 
suggests the Poisson distributions accord with probabilities for random events following a mutation, 
and that Non-Poisson are non-random. Similarly, an increase in peptone concentration,
independent of the effects of subinhibitory ofloxacin, demonstrated Poisson at standardised peptone 
and Non-Poisson with increased peptone. These findings suggest either two RAP  regulators RAPA 
& RAPE), or a single RAP  regulator with two levels of control is involved with the Poisson and 
Non-Poisson distributions of colonies with IPP.
DNA rearrangement by illegitimate recombination has also been described as a possible
mechanism for the occurrence of spontaneous reversion mutation (Platt et al, 1983). This liigh 
degree of genetic instability suggests DNA rearrangements result from a change in DNA structure 
through either transposons, inversions, or deletions of DNA involving an illegitimate recombination 
events (Shapiro, 1983). DNA inversion as observed with tranposition may result from the invertion 
of a piece of DNA which alternates the position, and thus expression of both the pigmentation and 
resistance. However, the generation of intermediate phenotypes would contradict this eventuality, 
since two mutational mechanisms are strongly suggested. Platt et al (1983) demonstrated the 
reversion pocess during growth involves a back-mutation, and since the reversion process (with the
exception of the [peptone 15g/l + 0.25MÏC ofloxacin) generally fits a Poisson distribution, the
-findings presented here would further suggest the spontaneous reversion occurs via a back-mutation.
The reversion rate appears to be more susceptible to the effects of subinhibitory ofloxacin in starved
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stationary phase, and this would suggest that in starved GRI 2677-8 cells, the reversion mechanism 
is different to that of cells in stationary phase.
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Viability counts during spontaneous reversion of starved stationary phase and stationary phase 
cultures of S. marcescens GRI 2677-8 (in the presence and absence of 0.25MIC ofloxacin) showed 
population reversion in a starved stationary phase culture accords with previous findings (Platt et 
al, 1983). In starved stationary phase, subinhibitory ofloxacin (0.25MIC) produced a step-wise 
change in reversion, with an initial increase in reversion followed by a significant decrease (Figure 
5.1b). Population reversion in a stationary phase culture similarly demonstrated a step-wise change 
in reversion (Figure 5.8/?). However, the increase and subsequent decrease was much more 
pronounced in the starved stationary phase culture. Both these results suggest that subinhibitory 
ofloxacin 0.25 MIC) affects the reversion process by two mechanisms (a) a initial potentiation of 
reversion followed by (b) suppression of reversion. The pronounced suppression of reversion in
starved non-dividing cells provides further evidence that synthesis of prodigiosin occurs in the late
ystages of growth. This further suggests that both growth and reversion are closely associated. The 
results presented here substantiate this, since subinhibitory ofloxacin significantly reduced 
(p<0.001) the number of IPP per colony and therefore intracoloniai reversion in growth matched 
colonies. In addition, since the growth conditions were adjusted to obtain independence of reversion 
from growth rate, IPPs in the presence of subinhibitory ofloxacin must result from a direct effect on 
the reversion mechanism. Furthermore, since the initial mutation is pleotropic, this would also 
suggest the RAP  regulators for antibiotic resistance and pigmentation are the most plausible 
candidates. The mutagenic potential of 4-quinolones have been described (Hirai et al, 1986a; 
Phillips, 1987; Hooper a/, 1992; Mamber a/, 1993). Quinolones interact with DNA gyrase 
and DNA in a manner that results in the induction of the recA SOS DNA repair system. This repair 
system is error prone and may therefore increase the frequency of bacterial mutations (Phillips,
1987). Although, the potential for mutagenicity is low, nevertheless there is evidence that links 
4-quinolones as weak mutagens (Phillips, 1987). It has been reported that the bacterial DNA-
reactive and mutagenic properties of subinhibitory concentrations of quinolones promote increased 
resistance to several structurally unrelated antimicrobial agents (Mamber et al, 1993). In this 
context, ofloxacin could be classified as a weak mutagen on the basis of its interference with 
pigmentation, thereby suggesting a direct genetic effect.
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CHAPTER 6
GENERAL DISCUSSION
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This study focused on the effects of subinhibitory ofloxacin on three different genetic processes
219
among the Enterobacteria. These included (1) the insertion of Tn7 into the IncV R-plasmid RP4,
(2) the stability of the R-plasmid pOG669, and (3) the spontaneous reversion mutation of Serratia
| ,marcescens GRI 2677-8, The overall conclusion was that subinhibitory ofloxacin altered each of
these genetic processes. In each of the systems studied the genetic events took place in the 
absence of ofloxacin, and this allowed the effects of ofloxacin to be evaluated statistically. This
;,y
approach highlighted quantitative differences in the effects of ofloxacin. Nevertheless, a number of 
results obtained in one system appear anomalous when compared to another. For example, 
subiniubitory ofloxacin suppressed reversion in Serratia marcescens GRI 2677-8, increased 
instability of pOG669, and altered the site of Tn7 insertion. It might be argued that ofloxacin 
indirectly alters the degree of negative supercoiling throughout, but that the systems of transposition 
mutation and rearrangement have evolved in an environment where DNA supercoiling is constant or iS
at least host-controlled. Alteration of this results in different native cellular processes responding in 
different ways. Perhaps ofloxacin is equivalent to a chaotropic agent? One of the benefits of 
examining 3 different processes is that it gives an overview. Thus anomalies not recognised in a 
more foccussed approach become evident and allow the formulation of more precise experimental 
questions for future investigation.
Subinhibitory ofloxacin significantly altered the pattern of Tn7 insertion into multiple sites in the 
IncP R-plasmid RP4, and regions of RP4 were therefore found to be either more or less susceptible 
to insertion of Tn7. However, in stationary phase, no new Tn7 transposition , events occurred 
and subinhibitory ofloxacin had no effect. Similarly, the transposition immunity of Tn7 was not 
affected. This suggested the mechanism of transposition for Tn7 required active chromosomal and 
RP4 DNA replication during active growth.
Previous studies have shown that topisomerase I and DNA gyrase are involved in the mechanism 
of transposition of TnJ (Stemglanz et al, 1981; Isberg & Syvanen, 1982), and that both these 
enzymes homeostatically control DNA supercoiling (Menzel & Gellert, 1983). Therefore, the
degree of negative DNA supercoiling may be important for the mechanism of transposition. 
Similarly, the level of DNA superhelicity may be required in stable maintenance of plasmids, and 
gene expression of pigmentation and antibiotic resistance in S. marcescens.
The insertion of Tn7 occurred in several regions of the RP4 molecule, and subinhibitory ofloxacin 
altered insertion into these regions. Most notable was the increase in insertion into the 22.2kb 
Kpnl-Smal fragment, and the decrease in insertion into the 5kb Kpnl-Smal fragments. For 
subinhibitory ofloxacin to have exerted changes in insertion, a structural change in the tertiary 
structure of RP4 would explain these regions to be of different superhelical density. Therefore, 
alteration in the degree of supercoiling would affect the number of available insertion sites within 
regions of RP4 DNA, The increase in insertion of Tn7 in the 22.2kb fragment suggested 
subinhibitory ofloxacin to increase the exposure of Tn7 insertion sites to Tn7, and the decrease in 
insertion in the 5kb fragment further suggested a reduction in the number of available sites. 
Ofloxacin specifically inhibits DNA gyrase, and a result of this inhibition, would be to alter the 
homeostatic balance of negative supercoiling. It is plausible that these regions may contain DNA 
gyrase binding sites, and their inhibition would contribute to a change in supercoiling, and therefore 
alter the exposure of Tn7 insertion sites through structural changes within RP4 DNA. This would 
suggest the topology of target DNA is an important prerequisite for Tn7 insertion. Further 
investigation would be required to examine this possibility.
Subinhibitory ofloxacin significantly eliminated the co-integrate R-plasmid pOG669 in stationary 
phase, and significantly reduced elimination in maintenance subculture, in E coll K12 J62-1. 
Complete pOG669 elimination occurred in repeated subculture. These three different 
environments altered the stable maintenance of pOG669 with elimination increasing from 
RSOF>SOF>MSOF. In maintenance subculture the higher level of pOG669 stability may be 
associated with nal^-mediated induction of the recA system which reduces plasmid elimination 
(Drlica, 1984; Hooper et al, 1984). The elimination of pOG669 in both stationary phase and 
repeated subculture suggests that an error in plasmid partition may be responsible. In repeated
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subculture the rate pOG669 elimination was much greater and this further suggests the rapid loss of 
pOG669 occurs through an abrupt change in plasmid stability. However, in stationary phase 
subinhibitory ofloxacin increased both elimination and molecular variation of pOG669. This 
clearly confirms ofloxacin to have a mechanism of action on non-dividing E. colL Further evidence
of pOG669 instability was demonstrated with the production of two variants. Kanamycin sensitive 
variants (KSV) resulted from a junctional deletion that produced loss of Km^, and mixed population
variants (MPVl and MPV2) resulted in marked plasmid instability that produced two mixed 
populations. MPV must have occurred through a error-prone process that resulted in reduced 
partition of pOG669 into the two populations. Most KSVs were isolated in stationary phase and 
several DNA rearrangements were observed, which apart from loss of kanamycin resistance 
(pOG670) were mostly associated with the pOG660 component of the co-integrate.
pOG669 was clearly unstable in stationary phase with both elimination and the generation of 
variants occurring, and pOG669 elimination occurred most in repeated subculture. Subinhibitory 
ofloxacin increased the elimination of pOG669 through a recognised mechanism when the GyrA 
subunits of DNA gyrase are inhibited, and the resultant unsealed breaks act as signals for the 
induction of exonucleases leading to rearrangements of pOG669 DNA (Crumplin & Smith, 1975). 
Therefore, an explanation for this instability may involve the production of starvation-induced 
proteins and include exonucleases, which are activated through the SOS DNA repair system. This
error-prone repair system may lead to either the loss of pOG669 or the generation MPV and KSV. 
The generation of both MPV and KSV were independent of subinhibitory ofloxacin effects, and they 
themselves arise through junctional instability in non-dividing cells.
Spontaneous reversion in stationary phase and starved-stationary phase (non-dividing cells) from 
the non-pigmented variant to the parental pigmented revenant was reduced in the presence of 
subinhibitory ofloxacin. The reversion process involved the reversion of the non-pigmented
phenotype , with the formation of several intermediate phenotypes, to the parental pigmented 
phenotype. This was coupled to change in antibiotic resistance. Both pigmentation and antibiotic
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transposon-mediated resistance.
pathogenic may change. For example, during antibiotic therapy, sites in the body that are 
peripheral to the site of infection, maybe exposed to sub-MIC levels through, for example, different
222
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#resistance are co-regulated either by two regulators, RAPA and RAPE, or a regulator RAP that has
.1two levels of control. The spontaneous reversion involves a structural back-mutation in the cell Is
■'.'1envelope (Platt et aU 1983), which may involve a change in the superhelicity of DNA. A change in 
the degree of negative supercoiling may alter gene expression as observed with both changes in s'i"
antibiotic reistance and pigmentation. In aH three processes, subinhibitory ofloxacin was found to 
alter the expression, location, and mobility of unrelated resistance determinants. In the clinical
environment these findings are important since a drug at subinhibitory concentrations that alters
' ■ i l
several genetic processes including antibiotic resistance may have important implications. It is well 
recognised that the 4-quinolones eliminate susceptible plasmids (Wiesser & Wiedemann, 1986) and 
in this respect pOG669 is susceptible. pOG669 is both ampicillin and kanamycin resistant, and 
when both are lost through plasmid elimination, the plasmid pool for antibiotic resistance is reduced. #
An interesting feature of this elimination is that pOG669 is a natural co-integrate R-plasmid that 
has fused an R-plasmid (pOG670) with pOG660, that had originated in Salmonella typhimurium. 
pOG660 encodes for virulence, and pOG670 encodes Ap & Km resistances. Therefore, when
fpOG669 is eliminated, not one, but two plasmids are lost, both of which code for potential problems 
in the clinical environment. Tn7 also encodes antibiotic resistances (Tp & Sm) and subinhibitory 
ofloxacin altered both the location and mobility of these resistances. Therefore, here we have a
ssubinhibitory antibiotic that has the potential to alter the transmission of plasmid-mediated and ■ f |
However, there is the possibility of changing the pattern of an infection through sub-MIC effects 
on the normal commensal flora. In such a situation the balance between pathogenic and non-
’"s;
■i
■ Itissue kinetics. Commensals in these sites may either develop resistance or undergo one of the
:genetic changes described in this study. Therefore, it may be appropriate for patients on quinolone 
therapy to be monitored for any changing patterns of resistance to unrelated antibiotics.
■ i
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The generation of molecular variation through DNA rearrangements were commonly observed in
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this study. RP4::Tn7 derivatives after Tn7 insertion were isolated, junctional deletions lead to the 
loss of kanamycin resistance in KSVs, and pigmented variants in S. marcescens were isolated 
These findings were also similar in one respect, they all occurred in stationary phase. It is 
proposed a possible 2 common mechanisms are involved. The first is activation of katF, and the
I
second is alteration in the superhelical density of DNA. It is known that certain proteins are 
induced during the onset of stationary phase (Groat et al, 1986) and these enable bacteria to adapt 
to conditions of nutritional deprivation. The katF has been shown to regulate several activities that 
appear in stationary phase (Bohannon et al, 1991). One of which is the production of exonuclease 
III (Sak et al, 1989) which may be responsible in part for the observed DNA rearrangements.
These DNA rearrangements lead to the generation of KSV. Subinfiibitory ofloxacin also altered the 
availability of Tn7 insertion sites in RP4, and reduced the spontaneous reversion mechanism in S. 
marcescens. Both these processes are involved with how the regulation of negative supercolled 
DNA is controlled. Inhibition of DNA gyrase binding sites alters the insertion of Tn7, and gene 
expression in S. marcescens leading to variants in pigmentation and antibiotic resistance. DNA 
supercoiling is thought to interact with transcription and it has been suggested that supercoiling 
enhances expression from some genes (Rouviere-Yaniv et al, 1991). It would therefore seem
i"
plausible that subinhibitory oflloxacin alters the optimal levels of supercoiling for transcription and
this may vary from one gene to another (Brahms et at, 1985). This may then lead to gene 
expression that may be increased, decreased, or unchanged. Such changes in gene expression may 
lead to alteration, in sites available for Tn7 insertion in RP4, and the regulation of pigmentation and 
antibiotic resistance in S. marcescens.
I
The overall results and conclusions of this study are of benefit and concern, as subinhibitory 
ofloxacin has altered the the stable maintenance of plasmids in terms of their elimination, which is of 
benefit to medical practice, since a reduction in the number of R-plasmids in an infecting bacterial
population will reduce the transmission of antibiotic resistance. Of concern, is the mutational
%
action of subinhibitory ofloxacin, which although, alters the the location and mobility of Tn7, it 
nevertheless did not prevent transposition.
Avenues for future investigations
The data presented here is for Tn7, and it would therefore seem appropriate to investigate the 
effects of several subinhibitory concentrations of ofloxacin on other transposons, particularly one 
from each class. Further investigations would also establish if the insertion site changes observed, 
is a phenomenon unique to IncP plasmids, or is this a general mechanism of action for ofloxacin on 
the insertion of transposons into their target site !DNA. This would encompass investigation of 
other plasmid incompatibility groups. Of further interest would be to investigate if subinhibitory 
ofloxacin influences the insertion of Tn7 to the specific atfln?  site using vector that contains TnZ
It is well established that 4-quinolones eliminate susceptible plasmids from their bacterial hosts.
It would be of interest to investigate the effect of further subinhibitory concentrations of ofloxacin 
which could be used to determination plasmid elimination kinetics. What is not known, with so 
many deletions recognised in the pOG660 component, is the effect on the virulence region? If 
deletions have occurred in this region, then a reduction in plasmid encoded virulence would play a 
significant role in the bacterial pathogenesis. Similar experiments that would utilise the nal® strain 
E. coli K12 J62-2 could establish whether nai*’ is indeed important in activation of the rec system.
In addition, the stability of pOG669 could also be investigated in a nal’’ rech' strain. In fact, 
preliminary studies have shown pOG669 to be generally stable in this strain, although detailed 
investigations have not been carried out. Given that junctional fragment were involved it would be 
possible to sequence and clone these fragments into a range of appropriate vectors to study the 
specific effect of the junctional sequence in a more defined system.
The system used, relied on a change in sensitivity at the outset. However, from the data obtained 
it might be possible to select a particular time and study unselected colonies. This would be 
essential to determine whether smaller deletions across the junctions without effect on Km^.
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The demonstration that subinhibitory ofloxacin produced a significant decrease in colonial 
reversion as shown by pronounced left shift in the distribution of EPPs indicates that the system 
could be developed to provide an assay to assess the mutagenic activity of antimicrobial agents 
under devdopment. Whereas the Ames test (Ames et al, 1975) uses a back-mutation of single base 
changes, this reversion is clearly part of more complex system and may therefore provide additional 
information. However, at present no attempt has been made to clarify the mechanism in detail. 
Although this study has extended the information available on G R I2677-8, the next step would be 
to investigate the mechanism. The results indicated that it is clearly not a simple back-mutation 
because of the range of intermediate revertants observed and by inference the primary event 
(generation of GRI 2677-8 from GRI 2677) must have been a complex rearrangement. Systematic 
analysis of the molecular differences between parent and variant would provide not only a more 
solid foundation for the development of the proposed assay system, but may also provide a useful 
model for the study of genomic evolution. In die latter regard the visibility of pigmentation 
variation without the requirement for artificial selection such as antibiotics is of considerable 
benefit.
The first step might be comparison of restriction fragmentation patterns between parent and 
variant followed by cloning, sequencing and Southern Hybridization of fragments that differ 
between the two. Further work on the genetic processes that lead to changes in the regulation of 
pigmentation and antibiotic resistance should incorporate analysis of the pig genes andRA f 
regulator(s), which would provide a better understanding of the physiological basis of the control of 
prodigiosin formation. This would involve establishing those physiological factors that would 
interact with the expression of both genes.
It is not known if  S. marcescens GRI 2677-8 has a functional mar gene, and the use o f
Polymerase Chain Reaction (PGR) and DNA sequencing techniques would establish this 
one way or the other. I f  GRI 2677-8 is a mar A  mutant, then this would also explain the 
observed changes in p-lactam and chloramphenicol resistance.
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